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Summary
Membrane proteins  have become one of  the most  interesting  classes  of  biomolecules  for
structural studies. Located in membranes, they are usually involved in the transfer of information
and substances between cells and their environment and are therefore highly coveted biochemical
targets. One specific class of membrane proteins are G-protein coupled receptors (GPCRs). GPCRs
exist in all eukaryotic organisms and are involved in a plethora of physiological processes. They
function as receivers for extracellular stimuli and are responsible for the signal transduction into the
cell.  GPCRs respond to  a  multitude  of  different  external  signals,  such as  photons,  ions,  small
organic molecules and fatty acids, peptides, hormones and even entire proteins. Therefore, they play
a  key  role  in  visual,  gustatory  and  olfactory  detection,  behavioral  and  mood  regulation,
inflammatory  response  and  the  regulation  of  sympathetic  as  well  as  parasympathetic  nervous
system.  The human genome contains  information  for  approximately 800 different  GPCRs,  and
because of their involvement in signaling it is not of much surprise that they present the target of
almost 40% of drugs currently on the market or in clinical trials. 
In  spite  of  their  highly  diverse  functions,  all  GPCRs  exhibit  a  very  conserved  overall
structure. They are constructed by a single polypeptide chain that folds into seven alpha-helical
transmembrane helices  (TMs),  which  are  connected  through three  intracellular  (ICL) and three
extracellular loops (ECL). Upon interaction with an extracellular ligand (by binding the ECLs and
potentially interacting with the helices themselves),  structural changes propagate throughout the
transmembrane region. This results in conformational changes in the intracellular region, which in
turn  allows  for  the  interaction  with  downstream  effectors.  These  downstream  effectors,  most
notably heterotrimeric  G-proteins  and arrestins,  thus  trigger  a  cascade of  downstream signaling
events. 
The knowledge of the exact atomic structure of GPCRs therefore permits the design of drugs
specifically inhibiting or facilitating signal transduction. However, to date only a handful of high-
resolution GPCR structures has been solved. The reason for this can be found in several inherent
unfavorable  properties,  such  as  their  low  natural  abundance  and  expression  levels,  instability,
hydrophobic nature and inherent flexibility. 
In this work, we investigated methods and strategies to counter these problems specifically
associated with structural studies of GPCRs, using a divide-and-conquer approach by splitting the
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yeast Ste2p receptor into fragments containing several transmembrane helices, and studying them
using solution NMR spectroscopy. In Chapter 1 general problems encompassed in solution structure
determination of membrane proteins and GPCRs specifically will be discussed in detail. Strategies
for recombinant expression and purification of membrane proteins, specifically GPCR fragments
will  be introduced,  as well  as strategies for the identification of a suitable membrane mimetic.
Furthermore,  solution  NMR spectroscopy as  a  viable  option  for  the  structure  determination  of
membrane proteins will be discussed. The feasibility of different NMR techniques and biochemical
methods, such as different isotope labeling schemes, and approaches for structure determination of
membrane proteins using sparse NMR data will also be debated.
Chapters 2 and 3 will present NMR and biophysical analysis of several fragments from the
yeast  GPCR  Ste2p,  containing  up  to  three  transmembrane  helices.  TM1  (containing  the  first
transmembrane helix), TM12, TM123 and TM127, a construct in which TM7 is covalently linked to
TM2 were expressed as inclusion bodies in  E. coli,  either as fusion proteins with truncated N-
termini using the Trp leader sequence as a signaling peptide, or via direct expression containing
the full  N-terminus.  The fragments have been characterized using various NMR experiments in
detergent  micelles  or  in  organic  solvent  mixtures,  focusing  on the  identification  of  interhelical
contacts. 
Another aspect when investigating GPCR fragments is the study of receptor folding. It is
widely believed, that receptor biosynthesis follows a two-stage model. First, the individual helices
are synthesized and released into the membrane interior via the translocon. Subsequently, folding of
the  individual  helices  occurs  spontaneously,  as  secondary  structure  of  membrane  proteins,  in
contrast to soluble proteins, is mainly dependent on the amino acid sequence and the respective
propensity to form α-helices, and their hydrophobic exterior (compared to a distinct hydrophobic
core in soluble proteins). Then, they diffuse through the the membrane until native contacts are
formed  and  the  mature  receptor  is  assembled.  Therefore,  systematic  elongation  of  receptor
fragments by subsequent addition of further helices permits the investigation of the formation of
interhelical contacts during early receptor folding. 
In our study, we see that all constructs are integrated well into the micelle, and that TM1,
which  in  isolation  is  destabilized,  is  rigidified  by  the  addition  of  an  additional  helix  in  the
previously  solved  TM12  fragment  to  form a  stable  hairpin.  Further  elongation  to  the  TM123
construct however, results in several unsatisfied interhelical contacts by polar residues located in the
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center of TM3. This in turn leads to a high propensity of TM123 to aggregate, excluding the use of
more detailed NMR experiments, which are needed for a high-resolution structure. Therefore, a
construct in which TM3 is substituted by TM7 - as based on a homology model, it is believed that
most interhelical contacts form between TM1, TM2 and TM7 - was designed, yielding the fragment
TM127.  TM127  proves  to  be  much  more  stable  than  TM123,  but  exhibits  more  interhelical
dynamics  than  the  rather  stable  TM12 fragment.  Our data  indicate  that  in  case  of  the  TM127
construct, TM2 and TM7 compete for the same interhelical contacts to be formed with TM1. It has
to be noted,  that  the assignment  of  longer  fragments  was greatly aided by knowledge of  their
approximate chemical shifts from the already assigned shorter constructs, at least for overlapping
parts. Close contacts of amide protons, visible in the 15N-resolved NOESY, will almost exclusively
be observed to sequential protons, and are less likely influenced by changes in tertiary structure.
Strips in 3-dimensional NOESY spectra from different size fragments with sequential overlap can
therefore be compared efficiently, and resonance assignments can be adapted through a strip match.
We were able to automate this process and successfully transfer over 90% of assignments from the
TM12 to the TM127 fragment, for example.
High-resolution  structures  of  several  fragments  have  been  determined  using  NMR
spectroscopy in  this  work.  The structure  of  TM123 was  determined in  a  trifluoroethanol/water
mixture and while the three helices were properly formed, tertiary contacts could not be observed.
The structure of TM1 was solved in detergent micelles, showing the formation of a helix, which is
destabilized around a G-XXX-G pentapeptide stretch, known to be a common motif for interhelical
contacts. These contacts are satisfied once the second helix (TM2) is added, as was shown in the
previously  solved  structure  of  TM12 in  detergent  micelles.  As  was  mentioned  before,  TM123
proved to  be  too  unstable  for  structure  determination,  and NMR studies  have  indeed revealed
destabilization around polar residues in the center of TM3, which do not properly insert into the
micelle,  possibly being the cause of the observed aggregation.  Membrane proteins often do not
exhibit enough long-range contacts for complete structure elucidation, which is why other NMR
experiments  utilizing  sparse  data  are  often  employed.  One  example  of  sparse  NMR  data  are
paramagnetic  relaxation  enhancement  (PRE)  measurements.  For  this  purpose,  paramagnetic
spinlabels  are  attached  to  specific  sites  in  the  protein,  effectively  bleaching  signals  in  spatial
proximity, at much longer distances than conventional experiments. Furthermore, residual dipolar
coupling  (RDC)  experiments  allow  the  determination  of  the  absolute  orientation  of  specific
chemical bonds, relative to the overall protein alignment orientation. While at this point we could
not determine a unique structure of TM127 in micelles,  probably due to high flexibility of the
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system,  sparse  sampling  data  experiments  have  allowed  us  to  characterize  overall  topological
features. Even though TM127 appears to be a highly dynamic system and does not present a rigid
helix bundle, we could show that the helices are in place, exhibit at least transient contacts and are
firmly integrated into the micelle.
The implications of those findings for further work of our group on the study of membrane
proteins,  in  particular  GPCRs,  will  be  reviewed  in  Chapter  4.  Apart  from  strategies  for  the
expression and purification of membrane protein fragments, their usefulness as an instrument to
study interhelical contacts and more importantly GPCR folding will be discussed. Experiments to
probe for conformational preferences of GPCR fragments expressed directly in the  E. coli  inner
membrane, using reporter assays through fusion proteins, will be highlighted. Furthermore, Chapter
4 will introduce another concept for the study of extracellular loops of GPCRs, by grafting them




In der  Strukturbiologie sind Membranproteine in  letzter  Zeit  zu einer  der  interessantesten
Klassen  von  Biomolekülen  avanciert.  Da  sie,  wie  der  Name  erahnen  lässt,  in  Membranen
vorkommen,  besteht  ihre  Hauptaufgabe  im Transfer  von  Molekülen  und  Information  zwischen
Zellen und deren Umwelt, weshalb sie auch ein äusserst begehrtes biochemisches Ziel darstellen.
Eine  bestimmte  Gruppe  von  Membranproteinen  sind  die  'G-Protein  gekoppelten  Rezeptoren'
(GPCRs –  engl. G-protein coupled receptors). GPCRs sind in allen eukaryontischen Organismen
vorhanden und bestimmen eine Vielzahl an physiologischen Prozessen. Sie dienen als Empfänger
für  extrazelluläre  Stimuli  und  sind  für  deren  Signalübertragung  ins  Zellinnere  verantwortlich.
GPCRs werden von einer Vielzahl an unterschiedlichen externen Signalen angesprochen, wie zum
Beispiel Photonen, Ionen, kleinen organischen Molekülen und Fettsäuren, Peptiden, Hormonen und
sogar vollständigen Proteinen. Deshalb spielen sie auch eine Schlüsselrolle in der Detektion von
visuellen,  geschmacklichen  und  olfaktorischen  Reizen,  Gefühls-  und  Verhaltenssteuerung,
Entzündungsreaktionen,  sowie  der  Regulation  des  sympathischen  als  auch  parasympathischen
Nervensystems. Das menschliche Genom enthält die Information für ungefähr 800 verschiedene
GPCRs, und aufgrund ihrer prominenten Rolle in Signalvorgängen ist es keine Überraschung, dass
sie zum jetzigen Stand das Ziel von fast 40% aller am Markt erhältlichen oder gerade in klinischen
Studien getesteten Medikamente sind.
Trotz  ihrer  höchst  diversen  Funktionen  besitzen  GPCRs  jedoch  eine  sehr  konservierte
Grundstruktur. Sie bestehen aus einer einzelnen Polypeptidkette, die sich in sieben alpha-helikale
Transmembranhelices (TMs) faltet. Diese sind wiederum durch drei intrazelluläre (ICLs) und drei
extrazelluläre (ECLs) 'loops' verbunden. Bei der Interaktion mit einem extrazellulären Liganden,
der durch die ECLs gebunden wird und potentiell auch mit den Helices selbst interagiert, werden
strukturelle  Änderungen  in  der  Transmembranregion  hervorgerufen.  Diese  resultieren  in
konformationellen Änderungen in der intrazellulären Region, was wiederum die Interaktion mit
nachgeschalteten Effektoren bewirkt. Diese Effektoren, hauptsächlich heterotrimere G-Proteine und
Arrestin, lösen dann eine Signalkaskade im Zellinneren aus.
Die Kenntnis der exakten atomaren Strukturen von GPCRs erlaubt daher die Gestaltung von
Medikamenten, welche die Signalübertragung spezifisch inhibieren oder verstärken. Dennoch sind
bis heute nur eine Handvoll an hochauflösenden GPCR Strukturen bestimmt worden. Als Grund
hierfür  gelten  einige  ungünstige,  inhärente  Eigenschaften  von  GPCRs,  so  wie  ihr  geringes
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natürliches  Vorkommen,  die  geringen  Expressionsausbeuten,  Instabilität,  Hydrophobizität  und
Flexibilität.
In  dieser  Arbeit  werden  Methoden  und  Strategien  untersucht,  diesen  mit  der
Strukturaufklärung von GPCR spezifischen einhergehenden Problemen entgegenzuwirken. Hierfür
wurde  eine  'divide-and-conquer'  Strategie  entwickelt,  bei  welcher  der  Hefe  Rezeptor  Ste2p  in
Fragmente  mit  einer  oder  mehreren  Transmembranhelices  aufgeteilt  und mittels  Lösungs-NMR
Spektroskopie untersucht wird. Im ersten Kapitel werden die spezifischen Probleme, die mit der
Strukturaufklärung  von  Membranproteinen  und  GPCRs  im  Speziellen  in  löslicher  Umgebung
einhergehen,  im  Detail  diskutiert.  In  diesem  Rahmen  werden  Strategien  für  die  rekombinante
Expression und Aufreinigung von Membranproteinen und im speziellen GPCR-Fragmenten, sowie
Strategien für die Bestimmung eines geeigneten Membranmimetikums, vorgestellt. Ausserdem wird
die  Tauglichkeit  von  verschiedenen  NMR  Techniken  und  biochemischen  Methoden,  wie  zum
Beispiel verschiedener Isotopenmarkierungsmodelle und Vorgehensweisen zur Strukturaufklärung
von Membranproteinen, bei denen traditionell nur relativ wenige NMR Restraints ermittelt werden,
erörtert.
In Kapitel 2 und 3 wird die Analyse von mehreren Fragmenten des Hefe GPCRs Ste2p mit bis
zu  drei  Transmembranhelices  mittels  NMR  und  biophysikalischen  Methoden  präsentiert.  TM1
(enthält die erste Transmembranhelix), TM12, TM123 und TM127 (ein Konstrukt, in dem TM7
kovalent  mit  TM2 verbunden wurde)  wurden als  Einschlusskörperchen in  E. coli,  entweder  als
Fusionsprotein  mit  gekürztem  N-terminus  und  der  Trp  Signalsequenz  oder  direkt  mit
vollständigem N-terminus, exprimiert. Die Fragmente wurden mithilfe von unterschiedlichen NMR
Experimenten  in  Detergenzmizellen  oder  in  Mischungen  mit  organischen  Lösungsmitteln,  mit
Fokus auf der Identifikation von interhelikalen Kontakten, untersucht.
Ein  weiterer  wichtiger  Aspekt  bei  der  Untersuchung  von  GPCR-Fragmenten  ist  die
Erforschung  der  Faltung  von  Rezeptoren.  Die  vorherrschende  Meinung  ist,  dass  die
Rezeptorbiosynthese einem zweistufigen Modell folgt. Als erstes werden die einzelnen helikalen
Peptidsegmente  über  das  Translocon in  die  Membran  eingespeist,  da  die  Sekundärstruktur  von
Membranproteinen im Gegensatz zu löslichen Proteinen hauptsächlich von der Aminosäuresequenz
und  deren  entsprechender  Neigung  zur  Bildung  von  α-Helices,  sowie  von  deren  hydrophober
Aussenseite (im Kontrast zum hydrophoben Kern in löslichen Proteinen) definiert wird. Dort wird
die helikale Sekundärstruktur spontan gebildet. Anschliessend diffundieren die einzelnen Helices
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durch  die  Membran  bis  sich  native  interhelikale  Kontakte  gebildet  haben  und  schließlich  der
gesamte Rezeptor aufgebaut ist. Die systematische Erweiterung von Rezeptorfragmenten durch die
Addition  weiterer  Helices  ist  daher  gut  geeignet,  interhelikale  Kontakte  im  Frühstadium  der
Rezeptorfaltung zu untersuchen.
In unseren Studien sehen wir, dass alle Konstrukte gut in die Mizelle integrieren und dass
TM1, welches isoliert destabilisiert ist, durch die Addition einer weiteren Helix stabilisiert wird, wie
in der bereits gelösten Struktur des TM12 Fragmentes, das einen stabilen 'hairpin' formt, zu sehen
ist. Eine weitere Verlängerung zum TM123 Fragment resultierte jedoch in einigen unbefriedigten
polaren Resten in der Mitte von TM3. Dies wiederum führte zu einer hohen Neigung von TM123 zu
aggregieren, wodurch es nicht möglich war, komplexere und zeitintensivere NMR Experimente, die
für die Strukturaufklärung nötig wären,  durchzuführen.  Deswegen wurde ein weiteres Fragment
entworfen,  TM127,  in  dem  TM3  durch  TM7  ersetzt  wurde,  da,  basierend  auf  einem
Homologiemodell,  die meisten interhelikalen Kontakte zwischen TM1, TM2 und TM7 vermutet
werden. Obwohl TM127 sehr viel stabiler als TM123 ist, zeigte es mehr interhelikale Dynamik als
das eher rigide TM12. Unsere Daten weisen darauf hin, dass TM7 mit denselben interhelikalen
Kontaktstellen  an  TM1  konkurriert  wie  TM12.  Ausserdem  muss  erwähnt  werden,  dass  die
Zuordnung der chemischen Verschiebungen in NMR Spektren von längeren Fragmenten durch die
Kenntnis  ihrer  ungefähren  Position  in  überlappenden  Teilen  aus  kürzeren  Fragmenten  sehr
erleichtert wurde. Nahe Kontakte von Amidprotonen, die  in  15N-edititierten NOESY Spektren zu
beobachten  sind,  werden  fast  ausschliesslich  von  sequentiellen  Protonen  beeinflusst,  ohne
nennenswerten  Einfluss  der  Tertiärstruktur.  Strips   3-dimensionaler  NOESY  Spektren  von
Fragmenten mit unterschiedlichen Grösse, aber überlappender Sequenz, können deshalb effizient
miteinander verglichen und mittels 'strip matching' angepasst werden. Wir konnten diesen Prozess
erfolgreich automatisieren und so zum Beispiel über 90%  der Zuordnung von TM12 auf TM127
übertragen.
Ausserdem werden in dieser Arbeit hochauflösende Strukturen mehrerer Fragmente mittels
NMR  Spektroskopie  gelöst.  Die  Struktur  von  TM123  wurde  in  einer  Trifluorethanol/Wasser
Mischung bestimmt. Während sich alle drei Helices richtig geformt haben, konnten keine tertiären
Kontakte festgestellt werden. Die Struktur von TM1 wurde in Detergenzmizellen bestimmt, wobei
wiederum die Bildung einer Helix zu sehen war, die jedoch im Bereich einer G-XXX-G Sequenz –
ein bekanntes Motiv zur Bildung von interhelikalen Kontakten – destabilisiert war. Dieser Bereich
wurde jedoch durch die Addition von TM2 gesättigt, wie in der bereits veröffentlichten Struktur von
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TM12 zu sehen ist. Wie bereits erwähnt, entpuppte sich das TM123 Fragment als zu instabil für
ausgiebige Strukturanalysen. NMR Untersuchungen zeigten in der Tat einige destabilisierte polare
Reste im Zentrum von TM3, die nicht richtig in die Mizelle integriert werden und vermutlich der
Grund für das hohe Aggregationspotential von TM123 sind. Membranproteine weisen häufig leider
nicht genügend weitreichende Kontakte für eine umfassende Strukturaufklärung auf, weshalb oft
NMR Experimente, die nur eine geringe Anzahl von NMR Daten liefern, angewendet werden. Eines
dieser  Experimente  ist  die  paramagnetische  Relaxationsverstärkung  (PREs  engl.  Paramagnetic
relaxation  enhancement).  Zu  diesem  Zweck  wird  ein  paramagnetisches  Spinlabel  an  einer
bestimmten Position im Protein angebracht, das die Signale in räumlicher Nähe (aber auch in viel
grösseren Distanzen als in herkömmlichen Experimenten) effektiv abschwächt. Im Weiteren können
residuale  dipolare  Kopplungen  (RDCs)  Informationen  über  die  absolute  Orientierung  von
spezifischen chemischen Bindungen in  Relation  zur  globalen  Orientierung des  Proteins  liefern.
Während  wir  zu  diesem  Zeitpunkt  noch  keine  eindeutige  Struktur  von  TM127  in  Mizellen
bestimmen  konnten,  was  vermutlich  auf  die  hohe  Flexibilität  des  Systems  zurückzuführen  ist,
konnten  wir  mithilfe  der  zuvor  beschriebenen  NMR  Daten  dessen  grundlegende  topologische
Eigenschaften charakterisieren. Obwohl TM127 ein hochdynamisches System zu sein scheint und
kein rigides Helixbündel aufweist, können wir zeigen, dass die Helices gebildet wurden, dabei fest
in die Mizelle integriert waren und zumindest transiente Kontakte zueinander zeigten.
Die  Implikationen  dieser  Erkenntnisse  für  weitere  Projekte  unserer  Gruppe  in  der
Untersuchung von Membranproteinen  werden in  Kapitel  4  diskutiert.  Neben  Strategien  für  die
Expression  und  Aufreinigung  von  Membranproteinfragmenten  wird  deren  Nützlichkeit  zur
Untersuchung von interhelikalen  Kontakten  und,  noch wichtiger,  zur  GPCR Faltung  diskutiert.
Experimente zur Untersuchung von konformationellen Vorlieben von Membranproteinfragmenten
durch die direkte Expression in die innere Membran von  E. coli   mithilfe von 'Reporter-assays'
durch Fusionsproteine werden aufgezeigt. Ausserdem wird in Kapitel 4 ein weiteres Konzept zur
Analyse  der  Ligandenbindung  von  extrazellulären  loops  von  GPCRs  mittels  'chemical  shift
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1   Introduction
1.1   GPCRs
G-protein coupled receptors (GPCRs) are membrane proteins involved in signaling processes
and therefore constitute one of the most important classes of proteins in nature, as is evidenced by
their  abundance (3% of the human genome encode for  GPCRs) and their  diversity (over 2000
GPCRs are known in nature)1, 2. They function as receivers for extracellular stimuli and transduce
signals to the inside of the cell. They interact with a bevy of different classes of ligands, such as
light, peptides and even proteins, fatty acids, hormones, ions, as well as a multitude of small organic
molecules  and  are  involved  in  numerous  physiological  processes.  Their  importance  is  further
confirmed by the fact that a multitude of currently available drugs target GPCRs3, 4 and culminated
in the bestowal of the Nobel prize in chemistry in 2012 to Brian Kobilka and Robert Leftkowitz for
their work on GPCRs5.
All  GPCRs  consist  of  a  single  polypeptide  chain  that  folds  into  seven  α-helical
transmembrane helices (TMs) which are linked by three intracellular (IL) and three extracelluar
(EL) loops, with an extracellular N-terminus and the C-terminus located in the cytosol6. While the
transmembrane  helix  bundle  displays  a  comparatively  conserved  overall  fold  among  different
receptors,  individual helices can still  exhibit  significant structural differences.  Their  topology is
determined by the existence and location of  tertiary interhelical  contacts,  such as  characteristic
hydrophobic patterns and hydrogen bonds, as well as conserved signature motifs and conserved
microswitches, which are imperative for function and activation, such as the G-XXX-G motif7, or
the D[E]RY8,  9 and NPXXY motives10. As ligand binding induces structural changes in the TM-
bundle, it is often quite flexible, with proline-induced kinks in helices11, that are imperative for
signal  transduction,  not  uncommon.  Despite  relative low sequence homology between different
receptors, the topology of the helix bundle remains comparatively conserved with the most notable
differences developing more distinctly towards the extracellular domain. 
The extracellular domain, containing the three extracellular loops as well as the N-terminus, is
mainly responsible for ligand binding and therefore exhibits noticeable differences depending on
the nature of the ligand. The mode of ligand binding can be highly diverse, as ligands can bind just
to  the  extracellular  part  or  be  directed  into  the  transmembrane  region  via  a  'fly-casting'
mechanism12. This diversity on one hand presents the basis for the categorization of different GPCR
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classes13 and on the other hand results in a high variation of arrangements and secondary structure
elements.
While several classifications of GPCRs based on sequence and structural similarities have
been proposed, the most commonly used groups GPCRs into six classes13: Class A or Rhodopsin-
like, which contains 19 subgroups and presents the largest group, Class B (the Secretin receptor
family),  Class  C  (Metabotropic  glutamate/pheromone),  Class  D  (Fungal  mating  pheromone
receptors), Class E (Cyclic AMP receptors) and Class F (Frizzled/Smoothened). 
The  primary  function  of  the  intracellular  domain  including  the  C-terminus,  which  often
contains  an  eighth  helix,  is  the  signal  transmission  into  the  cell.  It  interacts  with  downstream
effectors,  most  importantly G-protein  heterotrimers  and arrestins.  Differences  in  the  IC-domain
therefore  are  comparably smaller  than  in  other  compartments  of  GPCRs and  commonly affect
selectivity and specificity of the signaling pathway or G-protein subtype preference. At the same
time, intracellular domains undergo consequential conformational change upon receptor activation,
which causes them to exhibit a high degree of flexibility in general14. As highly dynamic systems,
GPCRs in nature (and to a lesser degree also in vitro) alternate between several conformations, their
ground  state,  their  excited  state  and  possibly  several  intermediate  states,  even  without  a
corresponding ligand, which results in basal activity for most receptors. One important property that
has been discussed recently extensively is  biased signaling. The latter refers to the fact that the
same GPCR, depending on the exact nature of the ligand, can signal in different ways.
In spite  of  their  pharmacological  importance and recent  advances  in  structure elucidation
techniques, a limited number of high-resolution GPCR structures has been determined to date9, 15-43.
The reason for this can be found in several characteristics of GPCRs. First of all, the hydrophobicity
of  GPCRs  presents  a  major  challenge.  Naturally  located  in  membranes,  GPCRs  require  to  be
solubilized  by  membrane  mimetics  at  all  times,  considerably  complicating  protein  expression,
purification  and  sample  preparation  in  active  form  for  structural  studies.  Another  problem
encountered when working with GPCRs is  their  inherent  conformational  flexibility,  which is  a
necessary feature for effective signal transduction,  but  can interfere with the formation of well
ordered crystals and cause significant line-broadening in NMR spectroscopy.
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1.1.1   Expression and Purification
The first step in obtaining a sample feasible for structural studies obviously is the successful
expression and purification of a GPCR. Even though the first structure of a GPCR, the structure of
bovine rhodopsin15, could be determined by extraction from natural sources (in this case retina of
the  bovine  eye),  GPCRs  in  general  exhibit  quite  low  natural  abundance,  demanding  the
implementation of recombinant expression techniques. Furthermore, over-expression of GPCRs in
cell membranes frequently interferes with native cell signaling and consequently exhibits significant
cell toxicity.
Cultured mammalian cells in general present the optimal expression system for mammalian
GPCRs, as they possess the native membrane composition and provide the necessary machinery for
correct post-translational modifications, which are known to stabilize GPCRs and play a role in
their  activity.  While  there have been some cases  of  successful  cases44-46,   GPCR expression in
mammalian cells proves to be extraordinarily cumbersome and relatively expensive and often does
not  produce  sufficient  amounts  of  protein  needed  for  crystal  screening  or  NMR spectroscopy.
Furthermore,  the  introduction  of  isotope  substitutions,  which  is  necessary  for  some  structural
determination techniques, such as NMR, can be quite tedious and expensive.
The most common GPCR expression system for crystallography studies are insect cells16, 19-21,
27,  28,  32,  35,  37-39,  47,  48. While also time-consuming and quite costly, expression in insect cells often
results in acceptable amounts of receptor (in the milligram per liter range) with a similar degree of
post-translational modifications compared to mammalian cells. However, it may be necessary to
supplement  the  growth  medium  with  additional  lipids  to  better  mimic  natural  membrane
composition. Moreover, isotopic labeling is not yet established in all cases. Additionally, expression
in yeast cells, such as Pichia pastoris, proved to be a viable expression system due to it's relative
simplicity to scale up, cost efficiency and possible isotope substitution as well as deuteration49, 50.
Even though the E. coli expression system lacks the molecular machine to correctly process
eukaryotic integral membrane proteins, it is one of the most efficient expression systems, due to the
fast doubling time, inexpensive growth media that allows for easy isotope labeling, and most of all
the relative effortlessness with which it can be manipulated genetically51, 52. Expression in  E. coli
often requires  the implementation  of  a  fusion  protein  to  either  direct  expression  into the  inner
membrane with  cytoplasmic  β-galactosidase53,  MBP54,  55,  TrxA56 and  Mistic57,  or  into  inclusion
bodies, using GST58 or TrpΔLE59. The utilization of a fusion protein commonly increases expression
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yields,  however,  additional  cleavage  and  purification  steps  might  become  necessary.  Recently,
another  related  expression  system,  cell-free  protein  expression60,  has  become  increasingly
important. The easiest and most common application of cell-free expression is the utilization of E.
coli extract, which allows for background-free expression, expression of toxic proteins and highly
specified isotopic labeling schemes without isotope scrambling.
The purification of heterologously expressed GPCRs generally includes the solubilization in
detergent, purification with chromatography and subsequent refolding of the receptor or isolation of
a distinct (usually active) species.
1.1.2   Identifying a suitable membrane mimetic
Identifying the optimal solubilization agent for structural determination experiments can be
rather  challenging.  As  it  is  quite  difficult  to  generally  mimic  natural  membranes  of  different
chemical composition, the right membrane mimetic needs to be determined on a case-by-case basis,
depending  on  protein  characteristics  and  limitations  of  the  relevant  structure  determination
technique employed.  In  general,  a  feasible  membrane mimetic  has  to  be chosen as  a  trade-off
between two important factors: it needs to i) sufficiently solubilize the membrane protein to keep it
stable and in solution, while at the same time  ii)  not being too harsh to denature the protein or
impose artificial conformational constraints (reviewed here61).
There are two principal strategies that are employed during membrane protein preparation in
regard to membrane model media, depending on expression and protein specific properties. The
first approach is to directly express the properly folded protein in membranes and then solubilize it
using  a  mild  detergent  that  is  suitable  to  extract  the  protein  from  the  membrane,  while  not
disrupting  its  native  fold.  The  most  prevalent  detergent  for  this  purpose  is  dodecylmaltoside
(DDM), which has been shown to mostly preserve protein functionality62, 63 which can usually be
maintained throughout subsequent purification steps. However, direct expression into membranes is
often accompanied by overall low yields, possible cell toxicity and the requirement for a signal
sequence, which generally needs to be removed in an additional purification step, which in turn
introduces another source of potential loss of protein.
Therefore,  another  strategy directing  expression  into  inclusion  bodies  is  often  employed,
generally leading to higher amounts of protein. As dense protein-lipid aggregates, inclusion bodies
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most of the time can only be solubilized with the use of harsh detergents or in high concentration of
chaotropic agents, such as urea or guanidinium hydrochloride, or even a combination of both64-66.
During subsequent purification, the protein requires to be refolded by exchanging the membrane
mimetic  to  non-denaturing  detergents  or  detergent-lipid  mixtures.  Finding  the  right  membrane
mimetic to achieve proper refolding of the protein that is compatible with the desired application
(this  naturally also applies  to  direct  membrane expression)  can  be  quite  challenging and often
requires  extensive  optimization.  The  following  subsections  will  highlight  the  advantages  and
disadvantages of the most prevalent membrane mimetics.
1.1.2.1   Micelles
Detergent  micelles  are  the  most  common  agent  in  membrane  protein  solubilization,
purification  and sample  preparation.  Micelles  are  formed when the  concentration  of  detergents
monomers in a solution reaches a detergent specific concentration, the critical micelle concentration
(CMC), at which point aggregates with solvent exposed hydrophilic head groups on the outside and
hydrophobic tails in the center are assembled. Dependent on alkyl chain length and bulkiness of the
head group, detergent micelles can be found in oblate and prolate, and in very rare cases spherical
forms67. Micelles can solubilize membrane proteins by assembling around the hydrophobic patches
in a belt-like fashion and therefore can be utilized to either solubilize a membrane protein as a first
step for purification or consequently as an environment for structure determination.
For structure determination studies it is often helpful to keep the protein-detergent complex
relatively small to favor the formation of crystal contacts when employing x-ray crystallography or
to improve tumbling rates in case of NMR spectroscopy. It has to be mentioned that the size of the
detergent-protein complex depends largely on the surface area of the transmembrane domain of the
protein, therefore introducing detergents that tend to form smaller micelles by themselves will not
necessarily  reduce  the  size  of  the  detergent-protein  complex  (mixed  micelles).  Furthermore,
solubility is not necessarily indication for the best possible detergent for structure determination,
and thus detergent exchange between purification and measurement is frequently necessary.
While micelles do not play a big role in membrane protein structure determination using x-ray
crystallography, they are still the most abundant membrane mimetic, when utilizing solution state
NMR, mostly due to  their  relative  small  compared to  other  membrane-like  systems.  As stated
above, the determination of the optimal detergent(s) for a specific membrane protein needs to be
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established empirically in each individual case.  While theoretically any detergent could be well
suited for structure determination, a relatively short list of useful detergents for NMR-spectroscopy
has emerged. Very harsh detergents, such as sodium dodecylsulfate (SDS) or lauryldimethylamine
oxide (LDAO) often result in poor spectral quality, at least for -helical membrane proteins, while
alkyl glucosides as dodecyl dimaltoside (DDM), which are favored in x-ray crystallography, often
do not prove powerful enough to efficiently solubilize membrane proteins for NMR spectroscopy.
Therefore,  the  most  common  classes  of  detergents  that  yield  reasonable  spectra  are  alkyl
phosphocholines, such as dodecyl phosphocholine (DPC), and lysophospholipids, such as palmitoyl
lysophosphatidyl glycerol (LPPG) and myristyl lysophosphatidyl choline (LMPC), which have been
successfully employed66,  68,  69,  sometimes as a mixture of two or more components70.  Schematic
representations for the most commonly used detergents can be found in Figure 1.1.
Micelles, however, are dynamic systems, in which detergent molecules from micelles are in
constant exchange with residual free monomers in the solution. This might cause instability, if the
detergent concentration is close to the CMC. Additionally, it is recommended to ensure a high ratio
of empty micelles to reduce the chance of dimerization and aggregation. In fact, it has been shown
that  it  is  favorable  to  utilize  detergent  concentrations  orders  of  magnitude  above  the  CMC to
improve sample stability71.
1.1.2.2   Bicelles
Another useful system for the solubilization of membrane proteins are bicelles72, 73. Bicelles
are aggregates of short stretches of lipidic bilayers that are stabilized by short-chain detergents and
therefore perfectly simulate native membranes, while at the same time retaining relatively small
sizes. The effective size of bicelles can be regulated by the ratio of the concentration of lipid to
concentration of detergent. An accurate representation of this ratio is the q-factor, which can be
calculated by dividing the total molarity of lipids by the total detergent concentration minus the
CMC of the detergent to correct for the amount of free detergent in solution. For NMR studies, a q-
factor  of  around 0.25 to  0.5 is  desired,  equating  a  relatively low lipid to  high detergent  ratio,
resulting in stable and comparatively small bicelle sizes. Q-factors above 0.5 result in bicelles too
large for practical NMR spetroscopy, while q-values under 0.25 lead to poorly defined membrane
media, more similar to lipid doted micelles than stable bilayers. In NMR spectroscopy the most
commonly  employed  system  is  a  combination  of  dialkyl  phosphatidylglycerol  or  dialkyl
phosphatidylcholine, such as dimyristoyl phosphatidylcholine (DMPC) as a lipidic component and a
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short-chain dialkyl  phosphatidylcholine,  such as dihexanoyl  phosphatidylcholine (DHPC) as the
detergent.
Thus, small isotropic bicelles present the most membrane-like environment that theoretically
still  allows  solution-NMR  structure  determination,  however,  their  application  so  far  has  been
limited to very stable74 or small membrane proteins75, 76, or to the study of ligand interactions77, not
yet  for  complete  structure  determination  of  larger  proteins.  While  several  membrane  protein
structures  in  bicelles  have  been  solved  using  solid-state  NMR  spectroscopy51 and  X-ray
crystallography78-80, no GPCRs have been crystalized from bicelles yet.
1.1.2.3   Nanodiscs and other membrane mimetics
Similar to bicelles, nanolipoproteins or nanodiscs stabilize the lipid bilayer by surrounding it
with two molecules of a helical, amphiphatic protein, the membrane scaffold protein (MSP)81,  82.
Their size still makes them useful for solution NMR studies, as their tumbling rate corresponds to a
globular protein of roughly 200kDa83. It has been possible to functionally incorporate and study a
variety  of  membrane  proteins  in  nanodiscs84,  85,  including  bacteriorhodopsin86 and  the  β2-
adrenergenic  receptor87.  Similarly to  nanodiscs,  it  is  possible  to  stabilize  the  uni-lamellar  lipid
bilayer using copolymers instead of the protein belt, forming so-called lipodisqs88, 89.
Another  recent  development  has  been  the  emergence  of  amphipols  as  an  alternative  to
conventional  detergents.  Amphipols  are  polymers  with  alternating  hydrophobic  and hydrophilic
elements  that  have  been  shown to  stabilize  internal  membrane  proteins,  often  preserving  their
functionality90-92. Furthermore, it has been shown that it is possible to refold GPCRs in an amphipol
environment93. Amphipols theoretically can be used in combination with lipids or detergents, or just
by themselves  as  the  main  solubilization  agent.  While  NMR spectra  of  membrane  proteins  in
amphipols  have  shown  promising  results94,  further  characterization  and  optimization  will  be
required.
Reverse micelles, in which detergents are dissolved in an organic solvent and therefore form
inverse micelles  with a  'water  pocket'  in  the center  have also drawn some interest  as  potential
membrane  mimetics.  Even  though  the  protein-detergent  complex  is  potentially  larger  than  in
conventional micelles, the low viscosity of organic solvents and subsequent faster tumbling rate has
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resulted in quite satisfying NMR spectra. In fact, in some cases the correlation time of membrane
proteins has decreased by factor 3-695 in reversed micelles compared to conventional micelles.
Lipidic  cubic  phases  (LCP)  have  also  greatly  aided  in  the  crystallization  of  membrane
proteins (reviewed  here96) and have been used to identify a number of GPCR structures9, 19, 20, 22-24, 26-
35. However, their excessive size and the limited mobility of the incorporated membrane proteins
prevents them from being used in solution NMR spectroscopy so far.
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Figure 1.1: Membrane mimetics
Schematic representations of membrane mimetics: Micelles with most commonly used detergents (A), bicelles with 
detergents (B), nanodiscs (C), amphipols (D) and reverse micelles (E) are shown.
1.1.3   The flexibility problem
As mentioned before, GPCRs possess an inherent flexibility, due to the dynamical nature of
the receptors and imperfect lipid-protein contacts as well as the mode of their action, which requires
large  conformational  changes,  that  makes  structure  determination  quite  challenging.  Successful
attempts to solve this  problem for crystallographic studies have included thermostabilization of
receptors52, 97, 98, truncations and deletions of flexible regions, or substitutions by small crystallizable
proteins. Especially the substitution of ICL3 with the T4 lysozyme proved to be quite rewarding16, 22,
28,  29,  32,  99, even though the replacement of ICL3, which plays a vital role in signal proliferation,
renders the fused receptor inactive.
On the other hand, the flexibility of GPCRs presents one of the most interesting aspects to
investigate  as  it  is  directly  related  to  their  function.  Unlike  'snapshot'  techniques  like
crystallography,  NMR  spectroscopy  has  the  ability  to  observe  dynamic  processes.  However,
dynamic  systems  can  also  present  additional  problems  for  NMR spectroscopy  in  the  form of
exchange-broadening,  depending  on  the  time-scale  of  the  dynamic  process.  Conformational
exchange in the nano- to millisecond time range, which overlaps with the NMR time-scale, can lead
to  severe  line-broadening and consequent  loss  of  signals.  While  there  have not  been any high
resolution GPCR structures determined by solution-NMR to date,  the structures of the bacterial
receptors sensory rhodopsin100, 101 and proteorhodopsin102, which exhibit similar structural properties
as GPCRS, have been solved recently. Some of the advances in NMR spectroscopy that can help
with the investigation of GPCRs are outlined in section 1.2.4.
1.2   NMR spectroscopy
1.2.1   Introduction
Nuclear  magnetic  resonance (NMR) spectroscopy is  one  of  the  most  powerful  analytical
techniques  in  protein structure determination,  that  capitalizes  on quantum mechanical  magnetic
properties  of  certain  atomic  nuclei103-105.  In  NMR  spectroscopy,  nuclei  are  placed  in  a  static
magnetic field, where they align to form a magnetic dipole. If electromagnetic radiation, in the form
of radio frequency pulses, is applied at the right frequency, it is possible to achieve excitation of
specific nuclei, which can be observed at a specific resonance frequency. This resonance frequency
is dependent on the strength of the magnetic field as well as the specific properties of the observed
nucleus and is therefore routinely expressed as a normalized chemical shift scale in ppm. While
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equivalent nuclei in the same field should exhibit the exact same chemical shift, differences in the
local environment slightly affect the resonance frequency, which in turn facilitates the deduction of
information about the local chemical environment . One of the most compelling aspects of NMR
spectroscopy for structure determination is it's  temporal resilience, allowing for the detection of
unstructured and flexible regions, as well as the characterization of dynamical systems and transient
interactions.
Conveniently, the most important nuclei in NMR spectroscopy are 1H, 13C and 15N, which also
constitute almost all atoms in proteins. Whereas 1H is the most naturally abundant hydrogen isotope,
13C (1.07% natural abundance) and  15N (0.37%) have to be enriched in proteins to be efficiently
observed. Isotopic labeling therefore is a critical requirement for protein NMR.
1.2.2    Correlation Experiments
Via scalar or dipolar couplings  it is possible to transfer magnetization of one excited nucleus
onto  another,  effectively  correlating  the  resonances  of  two  or  more  spins.  This  creates  the
opportunity to, on the one hand, connect sequentially or spatially proximal nuclei, and, on the other
hand, eliminate spectral overlap by the addition of further frequency dimensions. Magnetization can
be transferred between practically all  NMR-active nuclei,  albeit  with quite different efficiencies
depending on specific  characteristics  of  the  relevant  nuclei  and the  magnitude of  the  involved
couplings. Several transfers can be conducted in sequence,  resulting in the possibility to obtain
experiments in two, three or even more dimensions, correlating a multitude of nuclei to each other.
However, every magnetization transfer step results in loss of signal dependent on T2 relaxation rate,
setting an effective limit to the number of observable dimensions, especially for larger molecules.
While  4-  and  5-dimensional  spectra  are  feasible  for  small  or  unfolded  proteins106-108,  the
measurement of larger proteins or complexes becomes significantly more challenging due to the
loss in signal-to-noise ratio. This loss can be somewhat compromised with a reduction in observed
data points and respective resolution,  which in turn may not be quite as substantial  due to the
information gained by the addition of further dimensions. 
One of the simplest and at same time most important correlation spectrum is the so-called
heteronuclear  single-quantum  coherence  spectrum  (HSQC).  In  [15N1H]-HSQC  experiments  1H
nuclei are correlated to 15N nuclei to yield a two-dimensional spectrum with the chemical shifts of
1H on one and 15N on the other axis. As a result, a cross-peak for each covalently bound 1H-15N bond
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can be observed. In protein NMR, [15N,1H]-HSQCs exhibit one peak for every backbone amide
bond except proline residues, as well as a peak for each indole N-H of Trp residues and a geminal
pair of Asn and Gln sidechain amides. HSQC spectra exhibit distinctive patterns for each protein
('fingerprint') and are invaluable as a quick quality control tool, even without assignment. Whereas,
signal dispersion provides information about the folding of a protein (well folded proteins exhibit
signals from 6-10ppm, while unstructured proteins show very little dispersion between 8-8.5ppm
for  backbone  amides),  line-widths  report  on  possible  aggregation  or  conformational  exchange
(broad lines indicate larger proteins and therefore aggregation). Furthermore, it is also possible to
record proton-carbon correlations in the form of [13C,1H]-HSQC experiments, but as they express
much smaller  signal  dispersion,  especially in  the  Cα and Cβ regions,  and are therefore  not  as
characteristic  as  their  15N  counterparts,  they  usually  need  to  be  assigned  to  obtain  helpful
information. While 13C,1H-correlation experiments such as methyl-TROSY (vide infra) can be used
to  obtain  valuable  information,  they  usually  require  more  complicated  and  expensive  labeling
techniques, such as reverse methyl labeling (see Section 1.2.4.1).
One major breakthrough in correlation spectroscopy has been the development of Transverse
Relaxation Optimized Spectroscopy (TROSY)109, 110. The line-widths of NMR peaks are defined by
transverse relaxation (1/2 = 1/(πT2)). As particles get larger, their correlation time increases,
leading  to  broader  and  broader  lines,  effectively  demonstrating  the  size  limitation  for  NMR
spectroscopy. The most common pathways for  15N-1H relaxation at high fields are dipole-dipole
interactions and chemical shift anisotropy. In experiments where H-N doublets are observed, such
as  in  non-decoupled  H-N  HSQC  spectra,  the  descriptive  terms  include  additive  as  well  as
subtractive elements for dipole-dipole interactions and chemical shift anisotropy (CSA), which at
high field strengths (where the CSA effect is  strong enough) results  in one severely broadened
(additive) and one still relatively sharp (subtractive) peak. In TROSY experiments, the broadened
components are filtered out and only the optimal component is preserved, leading to significantly
improved line-widths compared to regular HSQC spectra.
While the development of TROSY spectroscopy represents an enormous aid in regards of the
size limitation of solution NMR spectroscopy, several prerequisites must be fulfilled to obtain the
optimal  TROSY effect.  First  of  all,  the  TROSY effect  is  dependent  on  strong  influence  from
chemical shift anisotropy, which effectively limits its scope to nuclei with large enough CSA, such
as  nitrogen atoms.  For  15N,1H-correlation spectra,  the  most  favorable  field strength for  CSA is
between  900 and 1100 MHz,  which  means  that  the  TROSY effect  observed on a  smaller,  for
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example  700MHz  spectrometer  might  not  be  pronounced  enough  to  offer  a  considerable
improvement. Furthermore, TROSY does not cancel out long-range dipolar coupling of protons,
which  often  demands  complete  perdeuteration  of  the  protein.  The  development  of  TROSY
nevertheless signifies a major technological advancement, especially for the elucidation of large
proteins  or  complexes.  In  addition  to  using  TROSY experiments  as  a  substitute  for  standard
[15N,1H]-HSQC spectra, TROSY-based versions of a multitude of multidimensional experiments are
widely available, usually exploiting TROSY optimization for the H,N transfer steps. Even though
CSA of C-H groups is not effective enough to create a noteworthy TROSY effect, other relaxation
interference effects have been identified for methyl and methylene protons111-113,  resulting in the
development of resolution optimized methyl-TROSY experiments, which represent great help in
terms of sidechain assignment.
1.2.3   Assignment
To specifically connect HSQC peaks to their corresponding residue in proteins, it becomes
necessary to obtain more correlations between the amide and the other nuclei in the respective
residues  and  to  subsequently  link  individual  amino  acids  together.  For  backbone  assignments,
resonances of amide bonds (NH) need to be correlated to their respective carbonyl (CO), Cα (CA)
and  Cβ  (CB)  resonances,  as  well  as  their  sequential  neighbors114,  115.  Therefore,  various  three-
dimensional triple-resonance spectra are recorded in pairs, one experiment usually correlating the
amide moiety with the desired carbon shifts of the preceding residue (I-1) and a complementary
experiment containing the information of the preceding residue as well as it's own116. For example,
HNCO experiments report on the preceding carbonyl shift (CO-1), while HN(CA)CO experiments
provide information  about  the preceding as  well  as  the current  carbonyl  shift  (CO and CO-1).
Analogous experiments can be recorded for Cα and Cβ resonances in the form of HN(CO)CACB
and HNCACB spectra. A schematic representation of the most common backbone experiments can
be found in Figure 1.2. By matching the obtained resonances, it is possible to propagate linking
neighboring residues and effectively identify long stretches of sequential amino acid residues. As
most amino acids have characteristic chemical shifts (Ser, Thr, Gly, Ala have very distinct shifts,
whereas the shifts of comparable amino acid, such as Ile and Leu or Asn and Asp are quite similar),
it is now possible to successfully map each NMR signal to the corresponding residue in a protein
sequence.  As prolines only posses tertiary amides, however, they can cause gaps in the assignment,
which for most cases does not present a big problem, as the diversity in assigned fragments is
usually large enough to lead to unambiguous assignment.
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It  has to be mentioned again,  that the practicability of three-dimensional NMR spectra is
highly dependent  on protein size,  number of magnetization transfer  steps and the efficiency of
relaxation pathways of the nuclei involved in recording of the spectra. As a rule of thumb, it can be
deferred  that  short  three-dimensional  experiments  that  observe  only one resonance in  the  third
dimension work better on faster relaxing (i.e. larger) proteins than experiments that include more
third  dimension  resonances  or  magnetization  transfer  pathways,  e.g.  the  HNCA is  much  more
sensitive than the HNCACB. Relaxation of carbon nuclei that have protons attached, such as Cα,
relax considerably faster than carbonyl nuclei, at least at 700 MHz, and therefore experiments that
correlate backbone nuclei (of the predecessor) to  the amide resonances via CO usually present
better spectra than experiments that involve Cα.  While HNCO spectra usually exhibit relatively
high signal-to-noise ratios, even for large proteins with long correlation times corresponding up to
almost  100kDa,  HN(CA)CO spectra  already display significantly less  signal.  The selection  for
additional  peaks in  the third dimension,  for  example when comparing the feasibility of  HNCA
versus  HNCACB  experiments,  further  reduces  signal  intensities,  leading  to  a  limited  set  of
experiments  that  are  still  practicable  for  large  proteins  or  protein  complexes.  Large  membrane
proteins,  for  example,  at  best  only  allow  for  HNCO/HN(CA)CO  and  HNCA/HN(CO)CA
experiments, which can lead to significant difficulties in assignment, as it can be quite challenging
to  unambiguously  distinguish  residues  based  on  only  a  limited  set  of  resonances,  especially
considering the high prevalence of certain hydrophobic amino acids.
An alternative strategy for backbone assignment is the implementation of amino acid-type
selective experiments117. With this method, several  15N, 1H correlation spectra similar to [15N,1H]-
HSQCs, that specifically select for only certain amino acids, are recorded. Amino acid selective
spectra are based on H(CCCO)NH experiments, which typically start on nuclei of the sidechain and
are then relayed to the corresponding amide resonance. Different amino acids are selected based on
the multiplicity certain sidechain groups (CH2 versus CH3) and chemical shifts as well as topology
of the sidechain. Similarly to 'classical' backbone assignment, a set of two different experiments is
recorded for each amino acid, one containing information of the succeeding residue called an (i+1)-
HSQC and one additionally including information about the detected amino acid, (i, i+1)-HSQC,
thus sequentially linking two residues. As it is not possible to select for each amino acid, due to the
high similarity of some sidechains,  several sets  of selective labeling experiments often become
necessary to unambiguously distinguish and assign backbone resonances. Amino acid type selective
experiments  therefore present  a  viable backbone assignment strategy for most  soluble proteins,
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provided  they possess  a  relatively  standard  amino  acid  distribution.  Their  usefulnes  for  larger
proteins or membrane proteins with limited amino acid distributions is less obvious.
15
16
Figure 1.2: Pathways of NMR experiments
Schematic representation of the most common experiments for NMR assignment. Observable nuclei 
for each experiment are shown in blue; nuclei that are involved in magnetization transfer, but are not 
shift labeled are indicated in grey
Whereas  secondary structure  can  be  predicted  solely on  chemical  shifts  of  the  backbone
assignment118,  it  is  indispensable  to  also  assign  the  resonances  of  sidechain  atoms,  especially
protons, to calculate protein structures. Sidechain resonance assignment is possible using the 15N-
edited spectra H(CCCO)NH and hC(CCO)NH or 15N-TOCSY experiments, which directly connect
the proton and carbon sidechain resonances of the preceding or native residue, respectively, to the
observed amide peak. In combination with  13C-edited experiments such as HCCH-COSY, which
permits stepwise discrimination of single sidechain atoms, unambiguous assignment is feasible. The
correlation  of  sidechain  resonances  to  amide  protons,  however,  involves  a  high  number  of
magnetization  transfer  steps  with  additive  signal  loss  for  each  transfer.  Therefore,  15N-edited
experiments require fast tumbling and slow relaxation rates, effectively limiting their use to small
soluble proteins. Consequently, mainly 13C-edited (based on the [13C,1H]-HSQC), three-dimensional
triple resonance experiments,  such as (H)CCH-COSY and (H)CCH-TOCSY are utilized for the
assignment of membrane proteins119, 120. (H)CCH-COSY and (H)CCH-TOCSY experiments permit
the assignment of carbon resonances throughout the entire spin system (I.e. amino acid),  while
H(C)CH-COSY and H(C)CH-TOCSY describe  the  proton analogues.  Additionally,  15N-resolved
[1H,1H]-NOESY and  13C-resolved [1H,1H] -NOESY spectra provide spatial information of proton
nuclei. Nuclear Overhauser effect (NOE) resonances therefore provide the primary tool for protein
structure determination. Schematic representations of some experiments can be seen in Figure 1.2.
1.2.4   Membrane Protein NMR
Membrane  protein  NMR  presents  several  additional  obstacles  compared  to  NMR
spectroscopy of soluble proteins. First of all, particle size is a limiting factor in NMR spectroscopy.
As  stated  above,  membrane  proteins  require  to  be  stabilized  by  the  presence  of  a  membrane
mimetic. The resulting protein-membrane mimetic complex significantly increases the particle size,
potentially up to a multiple of the size of the original protein. This increased size results in an
increase in correlation time and subsequent increased R2 rates resulting in line-broadening. It is
therefore imperative to identify a suitable membrane mimetic, that sufficiently stabilizes the protein
while  at  the  same time maintains  a  manageable  particle  size.  Furthermore,  the  internal  protein
dynamics of membrane proteins present severe complications. Conformational changes set in the
nano- to millisecond time-range result in exchange-broadening, frequently rendering portions of the
protein undetectable. This problem is especially exaggerated for intrinsically flexible systems such
as  GPCRs.  Moreover,  α-helical  integral  membrane  proteins  demonstrate  relatively  little  signal
dispersion,  resulting  in  overlapping  peaks.  As  the  termini  of  membrane  proteins  are  often
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unstructured, they result in comparatively strong signals, which, in case of peak overlap, can easily
conceal crucial peaks from comparably weak helical signals. The transmembrane regions naturally
also favor the occurrence of hydrophobic amino acids,  such as alanine,  isoleucine and leucine,
further  complicating  unambiguous  resonance  assignment.  Additionally,  even  if  the  membrane
protein  can  be  assigned  successfully,  structural  determination  remains  a  challenge,  as  the
predominant source for structure elucidation, NOEs, often can not be observed due to the above
mentioned flexibility and line-broadening effects. In addition, NOEs might be present but could
stem from unassigned sidechain resonances.
In conclusion, structural characterization of membrane proteins using conventional solution
NMR spectroscopy is  often not  feasible.  However,  recent  advancements  in  the development of
NMR methods using sparse, but more relevant data, which can still be recorded and evaluated, as
well as improved computational tools, still provide a viable way to gain structural information. As
mentioned  above,  sidechain  assignment  of  membrane  proteins  is  quite  challenging  and  time
consuming, rarely providing a sufficient number of long-range contacts, which are necessary for
high-resolution  structure  determination.  While  recent  advances  in  the  development  of  ab initio
structure calculation tools such as ROSETTA121, 122 have greatly aided membrane protein structure
determination, it might be necessary to incorporate additional techniques such as small-angle x-ray
scattering (SAXS)123, 124 and cryo-electron microscopy (cryo-EM)125. 
18
However, it is also possible to determine membrane protein structures purely based on NMR
data. A combination of structure prediction tools such as ROSETTA126 with sparse NMR data, such
as paramagnetic relaxation enhancement (PRE)127, 128, residual dipolar coupling (RDC)129-131, pseudo-
contact shifts (PSC)122,  132,  133 and selective NOEs121,  134-136 has proven to be a viable strategy for
membrane  protein  structure  determination126.  Suitable  sparse  NMR  data  may  still  provide
information of long-range contacts or global orientation without the need for complete sidechain
assignment. Using sparse NMR data, it has been possible to determine the structures of several
large α-helical proteins, containing multiple transmembrane helices and domains, such as the 30kDa
homopentamer  human  phospholamban  (PLN)137,  the  43kDa  homotrimer  diacylglycerol  kinase
(DAGK)138,  the 33kDa mitochondrial  uncoupling protein 2 (UCP2)139,  the 18kDa mitochondrial
translocator  protein  (TSPO)140 as  well  as  the  seven  transmembrane  bacterial  receptors  sensory
rhodopsin II (pSRII)100 and proteorhodopsin (PR)102, all of which can be found in Figure 1.3. The
following sections will describe the experimental details as well as advantages and limitations of
methods that are employed in membrane protein NMR.
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Figure 1.3: Membrane protein structures solved with sparse sampling data
Selection of structures of large membrane proteins using sparse NMR data.
1.2.4.1   Isotope Labeling
As mentioned before, it is indispensable to uniformly substitute the nitrogen and carbon atoms
with the respective 15N and 13C isotopes in order to record two-, three- and more-dimensional NMR
spectra.  1H already is  the  most  abundant  hydrogen  isotope  and therefore  does  not  need  to  be
supplanted. However, protons also have the biggest effect on transverse relaxation rates and hence
lead to loss of signal. By substituting proton with deuterium isotopes, dipole-dipole interactions,
which are the primary agent for transverse relaxation, are reduced, therefore lowering relaxation
rates significantly and leading to substantial increases in signal-to-noise ratios. Protein expression in
E. coli expression systems, for example, can be carried out in D2O, which normally results in a
perdeuteration rate of at least 80% (when using non-deuterated glucose), with mostly methyl groups
or other sidechain groups located further away from the backbone still being protonated. Under
standard  measuring  conditions,  amide  protons  rapidly  back-exchange  to  1H,  which  makes  the
application of [15N,1H]-HSQC or [15N,1H]-TROSY based spectra feasible. This is especially useful
for HNCACB and HN(CO)CACB experiments, as the transverse relaxation times for Cα and Cβ
nuclei  is  increased  by  about  an  order  of  magnitude.  As  a  potential  disadvantage,  complete
perdeuteration also eliminates the potential of obtaining experiments that involve or even start on
aliphatic proton atoms, like sidechain or NOESY experiments. It is also possible to express proteins
with  random  fractional  deuteration,  e.g.  50%  deuteration,  which  on  the  one  hand  improves
relaxation rates, while preserving a sufficient density of protons for detecting NOEs. It has to be
mentioned though, that the prolongation of relaxation rates in fractionally deuterated proteins in
some cases  is  not  significant  enough to result  in  decidedly improved spectra.  Furthermore,  the
presence of different isotopomers in partially deuterated proteins result in heterogenous peak shapes
further complicating the determination of peak positions.
A much superior, while also more complicated strategy to improve sample characteristics is
the use of selective isotope labeling. In segmental isotope labeling, only certain parts of a protein
are  visible  via  NMR  spectroscopy.  Therefore,  two  or  more  segments  need  to  be  expressed
individually  under  different  labeling  conditions  and  subsequently  fused  together,  either
chemically141,  142,  enzymatically143,  144 or  transiently  through  electrostatic  interactions145.  Another
approach to utilize selective isotope labeling can be achieved by only labeling specific amino acids.
While enzymatic scrambling during protein expression does not allow the isotopic substitution of
any amino acid,  certain amino acids are quite  amendable to  this  technique.  The most common
application is the selective reverse methyl labeling of isoleucine, leucine and valine (as well as
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alanine, methionine and threonine to a lesser extent). With this approach, only one methyl group in
each Ile, Leu and Val residue is protonated, while the remaining protein remains perdeuterated.
Even though unambiguous assignment of the methyl resonances might still prove quite challenging,
especially  for  membrane  proteins  that  naturally  present  a  high  percentage  of  the  hydrophobic
residues Ile, Leu and Val, this technique enables the observation of tertiary structure interactions in
the  form of  methyl-methyl  and  methyl-amide  NOEs,  which  is  particularly  important  for  large
proteins. For this technique, it is also imperative to achieve complete background deuteration, so in
addition to D2O, also a perdeuterated carbon source (usually 13C,2H-glucose or 13C,2H-glycerol) has
to  be  supplemented  during  protein  expression.  Furthermore,  when  working  with  membrane
proteins, it may also be necessary to use perdeuterated detergents, which presently pose limitations
in terms of price and availability.
The implementation of cell-free expression also expands the scope of labeling schemes as it
effectively limits isotope scrambling. Therefore, techniques such as stereo-array isotope labeling
(SAIL)146,  where  one  of  the  distereotopic  methylene  protons  is  stereospecifically  replaced  by
deuterium  (in  addition  also  equivalent  ring  protons  or  equivalent  Me  groups)  ,  are  feasible.
However, the price of individual SAIL amino acids often are prohibitive.
1.2.4.2   PRE  and PSC
As was described above, the acquisition of long range distance restraints for the structure
calculation of membrane proteins can be quite challenging. Considering the low number of long-
range NOEs, paramagnetic relaxation enhancement (PRE) experiments present a very useful tool to
gather long distance information128. Analogous to NOE experiments, paramagnetic relaxation is a
very effective relaxation pathway that attenuates signals from spins in a distance-dependent manner,
however it affects residues at a significantly farther distance (up to 30 Å) than NOEs (up to 6Å) and
can therefore  tremendously augment  long distance  information.  Furthermore,  signal  attenuation
caused by paramagnetic relaxation can be detected considerably easier than the intrinsically weak
NOEs from long-range interactions. Paramagnetic spinlabels contain unpaired electrons, usually in
the form of stabilized nitroxide groups or paramagnetic metal ions, that can be attached to the
proteins via a linker, and that increase the relaxation rates of close nuclei. The data acquired in PRE
experiments can thus directly be converted in structure calculation restraints102, 128.
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PRE  measurements,  of  course,  demand  a  feasible  strategy  to  introduce  paramagnetic
spinlabels  at  unique  positions.  Most  commonly,  native  cysteine  residues  are  substituted  to
equivalent amino acids such as serine, with the subsequent reintroduction of single cysteines to
which  the  spinlabel,  S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl
methanesulfonothioate (MTSL) as the most common, can be attached. However, the elimination of
native cysteine residues can interfere with protein folding and consequently activity, which means
that the activity of the mutated proteins should be confirmed.
Another  strategy to  gather  topological  information through paramagnetic  relaxation is  the
addition  of  a  soluble,  inert  paramagnetic  probe,  such  as  Gd-(DTPA-BMA)  (Gadolinium
diethylenetriamine-pentaacetic  acid  bis-methyl  amine)  to  the  NMR  sample.  As  it  results  in
attenuation of water accessible residues, this technique can be used to identify protein binding and
dimerization  interfaces  in  soluble  proteins  and  proves  to  be  especially  valuable  for  the
characterization of membrane protein insertion into micelles or other membrane mimetics147.
Additionally to paramagnetic probes that result in fast relaxation, some agents do not cause
signal attenuation, but perturb NMR chemical shifts through the induction of pseudo-contact shifts
(PCS). For this purpose, analogous to PRE experiments chelated Co2+ or lanthanide(III) ions are
attached to certain sites in the protein, which alter the chemical shifts of residues that are close in
space (up to 40Å) in a distance- and orientation-dependent manner. It has been shown that PSC can
greatly aid in structure determination of proteins148.
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Figure 1.4: Spinlabel structures
Chemical structures of the paramagnetic spinlabels MTSL (left) and Gd-(DPTA-BMA)
1.2.4.3   RDC
An additional method to collect structural information is to record Residual Dipolar Coupling
(RDC)149, 150. RDCs provide data about the orientation of a vector connecting two nuclei, relative to
the  overall  orientation  of  the  protein  in  an  alignment  medium,  leading  to  global  structure
information. In solution-NMR, proteins tumble freely in solution, which causes dipolar interactions
to be averaged out isotropically. However, it is possible to manipulate the system so that partial
alignment of  proteins can be achieved, which in turn results in formation of RDCs. Paramagnetic
metal  ions  will  be  affected  by the  strong magnetic  field  in  an  NMR spectrometer  and can  be
attached to the protein, to achieve marginal alignment. The more common strategy, however, is the
addition of macromolecular alignment media, such as bicelles, phage particles or lamellar media
consisting of ether/alcohol mixtures, to the NMR sample151. These media will assume a preferred
orientation relative to the magnetic field, thereby impeding the tumbling of not perfectly spherical
proteins.
However,  the  analysis  of  membrane  proteins  presents  some  additional  challenges,  as
membrane mimetics tend to interact with the alignment medium, consequently resulting in over-
alignment or severe line-broadening since the alignment medium presents a very slowly tumbling
entity. One of the most effective systems suitable for membrane proteins are G-tetrads152, which
consist of  2'-deoxyguanylyl-(3',5')-2'-deoxyguanosine (dGpG) and which form in the presence of
potassium ions.  K-dGpG stacks align perpendicular to the magnetic field,  due to their  high net
negative  charge  and  therefore  can  be  employed  in  combination  with  negatively  charged
macromolecules such as detergent micelles.
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Figure 1.5: RDC scheme
Schematic representation of residual dipolar coupling experiments. Chemical structure of G-tetrade (left), partial 
protein alignment in presence of macromolecular alignment media (center) and approximate relative orientation of 
N-H vectors (right) are shown.
1.3   Scope and Project Goals
As described above, structural investigation of GPCRs is a highly interesting topic. As the
structure determination of whole GPCRs using NMR spectroscopy is still not yet feasible, we have
utilized a 'divide-and-conquer' approach to split GPCRs in fragments of one or more transmembrane
helices (TM), which presents several interesting aspects in the study of GPCRs. In contrast to most
soluble proteins, membrane proteins exhibit secondary and possibly also tertiary strucutre that make
the study of protein fragments worth to pursuit. Whereas soluble proteins derive their structure in
general from the formation of a hydrophobic core,  which would not fold properly if  parts of a
domain are missing, membrane proteins usually do not possess a hydrophobic core and are rather
stabilized by the membrane environment, a hydrophobic exterior, that in concert with the amino
acid sequence defines the secondary structure. The two-stage membrane protein folding mechanism
by Popot and Engelmann153 proposes the initial formation of α-helices upon partitioning into the
membrane, which diffuse within the bilayer and form native tertiary contacts upon addition of the
remaining  helices.  The  study of  receptor  fragments  or  more  accurately  the  addition  of  further
helices to shorter fragments, enables the detailed investigation and characterization of stabilizing
tertiary contacts between helices (illustrated in Figure 1.6),  which in  turn can lead to  valuable
insight about receptor folding and biosynthesis.
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Figure 1.6: Study of interhelical contacts
Schematic representation of the study of interhelical contacts between transmembrane helices. The formation of 
interhelical contacts is indicated by dotted red lines.
The  utilization  of  solution-NMR  spectroscopy  additionally  permits  the  observation  of
dynamic  processes,  which  can  be  used  to  define  flexible  regions  and  consequently  gather
information  about  regions,  which  are  important  for  receptor  folding  and  possibly function.  As
chemical  shifts  are  mostly  dependent  on  the  local  environment,  the  assignments  of  shorter
fragments can be transferred to longer ones, thereby greatly facilitating the assignment of large
fragments and ultimately hopefully whole receptors, as is illustrated in Figure 1.7. Another aspect of
interest would be the investigation of reconstituted split receptors, where it would be possible to
segmentally label different parts of the receptor to significantly reduce effective relaxation rates and
simplify spectra. Preliminary studies in the guided reconstitution of receptors can be found in the
work by Cohen et al154.
The following chapters will describe my work on fragments from the yeast GPCR Ste2p. A
snake-plot representation of Ste2p can be found in Figure 1.8. Ste2p is a fungal mating pheromone
receptor (Class D GPCR) and initiates mating in yeast upon binding the pheromone α-factor155. To
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Figure 1.7: Assignment transfer scheme
Schematic representation of NMR assignment transfer from GPCR fragments.
study structural preferences, interhelical contacts, as well as early receptor folding events, we have
designed an approach to systematically increase the number of transmembrane helices in receptor
fragments.  The  fragments  TM1,  TM12,  TM123  and  TM127  containing  one,  two,  and  three
transmembrane-helices  respectively  that  in  the  native  receptor  form  contacts  were  designed,
expressed, purified and investigated using a range of biophysical experiments, most notably NMR
spectroscopy.  To  achieve  this,  different  expression  designs  and  strategies  were  implemented.
Expression of the desired protein initially in  E.coli was accomplished with a N-terminal fusion
sequence,  which  included  the  optimization  of  different  heterologous  expression  strains  and
conditions as well as the chemical cleavage and subsequent RP-HPLC purification of the fragments.
The implementation of different NMR methods, such as the measurement of PREs, required direct
expression of the fragments, which led to further expression and purification optimization in order
to preserve integrity of the spin label. Samples were studied using NMR spectroscopy by dissolving
them in organic solvent/water mixtures or solubilizing them in micelles, using a mixture of LPPG
and DPC as the detergents.
Almost  complete  backbone  and  partial  sidechain  assignment  could  be  achieved  for  all
fragments using the NMR experiments described above. Assignment was aided tremendously by the
transfer  of  chemical  shifts  from shorter  to  longer  fragments,  a  process  which  we were able  to
automate  utilizing  automated  peak  picking  and  NOESY strip  matching.  Analysis  of  backbone
chemical shifts using the secondary prediction tool TALOSn indicated the correct formation of α-
helices at the positions predicted by homology modeling, confirming the validity of the proposed
two-stage model of membrane protein folding. The formation of stabilizing tertiary contacts could
be observed by expanding the  TM1 fragment  to  TM12,  whereas  the  addition  of  another  helix
resulted in unsatisfied interhelical contacts that consequently led to destabilization in TM123 or the
presence of multiple conformations in case of TM127. Due to the inherently limited amount of
observable long-range interactions in membrane proteins, a series of NMR experiments, including
paramagnetic  relaxation  enhancements,  residual  dipolar  couplings  and  the  use  of  soluble
paramagnetic spinlabels was utilized.
The following three chapters present the results obtained during this PhD project. Chapter 2
will describe the expression, purification and biophysical analysis of Ste2p fragments containing the
first  three  transmembrane  helices  (TM123).  It  will  include  different  cloning  and  expression
strategies, as well as NMR spectroscopy data in trifluoroethanol/water mixtures.  Chapter 3 will
detail the systematic elongation of fragments from one to three transmembrane helices and contrast
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structural  preferences  between  the  different  fragments.  Constituting  the  largest  part  of  work
undertaken during this thesis, it will also detail structure determination by NMR spectroscopy and
the  mapping of  structural  preferences  using sparse  NMR data.  Chapter  4  will  review methods
employed by our group to study topological and structural preferences of GPCR fragments as well
as early receptor folding. While the results presented in Chapter 2 have been published in their
entirety, Chapters 3 and 4 are part of ongoing research and have not been published yet.
27
Figure 1.8: Ste2p snake-plot
Snake plot representation of the Ste2p receptor. Residues studied as part of fragments are colored in yellow (TM1), red 
(TM2), blue (TM3) and brown (TM7). Cysteines and methionines have been replaced by similar residues and are 
indicated in green.
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2.1   Abstract 
This  report  summarizes  recent  biophysical  and  protein  expression  experiments  on
polypeptides containing the N-terminus, the first, second and third transmembrane domains and the
contiguous loops of  the α-factor  receptor  Ste2p,  a  G protein-coupled receptor.  The 131-residue
polypeptide  Ste2p(G31-R161),  TM1-TM3  was  investigated  by  solution  NMR  in
trifluorethanol/water:  TM1-TM3  contains  helical  transmembrane  domains  at  the  predicted
locations,  supported  by continuous  sets  of  medium-range  NOEs.  In  addition,  a  short  helix  N-
terminal to TM1 was detected, as well as a short helical stretch in the first extracellular loop. Two
161-residue  polypeptides,  [Ste2p(M1-R161),  NT-TM1-TM3],  that  contain  the  entire  N-terminal
sequence, one with a single mutation, were directly expressed and isolated from E. coli in yields as
high  as  30  mg/L.  Based  on  its  increased  stability, the  L11P mutant  will  be  used  in   future
experiments to determine long-range interactions. The study demonstrated that 3-TM domains of a
yeast GPCR can be produced in isotopically labeled form suitable for solution NMR studies. The
quality of spectra is superior to data recorded in micelles and allows more rapid data analysis. No
tertiary contacts have been determined, and if present, they are likely transient. This observation
supports earlier studies by us that secondary structure was retained in smaller fragments, both in
organic solvents and in detergent micelles, but that stable tertiary contacts may only be present
when the protein is imbedded in lipids.
Key words: GPCR fragments, biosynthesis, isotopic labeling , solution-state NMR
Abbreviation  List:  G  protein-coupled  receptor,  GPCR;  transmembrane,  TM;  nuclear  magnetic
resonance,  NMR;  Ste2p(G31-T110),  TM1-TM3;  trifluoroethanol,  TFE;  Ste2p  (M1-R161),  NT-
TM1-TM3;  Luria  Broth,  LB;  ampicillin,  Amp;  isopropyl  β-D-1-thiogalactopyranoside,  IPTG;
reverse  phase  high  performance  liquid  chromatography,  RP-HPLC;  Circular  Dichroism,  CD;
sodium  dodecyl  sulfate,  SDS;  lysomyristoylphosphatidylglycerol,  LMPG;  N-terminus,  NT;
extracellular loop 1, EL1; paramagnetic relaxation enhancements, PREs; Ste2p (M1-R161, L11P),
NTL11P-TM1-TM3.   
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2.2   Introduction
In the early 1960s the laboratory of Professor Murray Goodman initiated a seminal series of
studies using synthetic homo-oligopeptides to understand aspects of peptide and protein structure.
These studies led to fundamental insights into the chain length dependence of the formation of α-
helices1.  The  initial  studies  were  significantly  expanded  by  the  Toniolo  group  to  provide
information on -structure formation both in solution and in the solid state2, 3. Most importantly the
use  of  synthetic  peptides  as  surrogates  to  probe  questions  related  to  protein  structure  was
established. Since these early investigations thousands of investigations have been conducted on the
conformational  preferences  of  carefully  designed  peptides  leading  to  breakthroughs  in  our
understanding  of  -hairpin  or  -turn  formation  and  the  assumption  of  structure  by  -and  -
peptides4-7. 
In this report we present studies on folding of a GPCR using a 3-transmembrane containing
peptide surrogate of the  -factor receptor from the yeast  Saccharomyces cerevisiae.  This report
describes our most recent work on Ste2p peptide surrogates, which began in the early 1990s, some
of  which  was  recently reviewed8.  Here  we report  conformational  preferences  of  a  130-residue
peptide corresponding to the first 3 TM domains of the Ste2p receptor and two of its loop regions
encompassing residues 31-161 in an organic:aqueous medium that was used as a membrane mimic
previously9.  This  work  reflects  an  outgrowth of  training  and an  approach that  one  of  us  (FN)
received in the Goodman laboratory and it is dedicated to the memory of Dr. Goodman and to the
myriad of scientists who were trained under his mentorship.  
Structural characterization of G protein-coupled receptors is notoriously difficult due to the
inherent properties of these receptors, with high-resolution crystallographic structural information
available to date for slightly more than 20 of the ~1000 identified GPCRs10-39.  Modifications of
most  of  these  proteins  through  introduction  of  conformation-stabilizing  mutations  resulting  in
higher  melting  temperatures,  crystallization  in  presence  of  antibodies,  truncation  of  flexible
segments,  and  insertion  of  a  crystallization-nucleation  protein  into  the  long  and  flexible  third
intracellular loop were necessary in order to facilitate stability and crystal  packing interactions.
Although crystallographic studies of GPCRs have provided fundamental information, most of those
modifications  compromise the activity of  the proteins,  and therefore  sparse information on the
dynamics of the protein has been obtained so far.  Accordingly, nuclear magnetic resonance (NMR)
spectroscopy investigations are a valuable complement to crystallographic analyses.
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NMR investigations of GPCRs are hampered by a number of technical issues associated with
the production of  the large quantities  of  isotopically labeled receptor  required for NMR in the
expression hosts that were used by crystallographers, by the difficulty of establishing conditions
that mimic the biologically relevant environment of the receptor while still providing good-quality
spectra,  by the tendency of these membrane proteins to aggregate,  and by the large size of the
protein/lipid complexes. To date, NMR investigations have been reported for heptahelical integral
membrane  proteins,  the  vasopressin  receptor,  the  CXCR1  receptor,  the  CB2  receptor,  the  2-
adrenergic receptor, and sensory rhodopsin and proteorhodopsin40-46.  The studies on the CB2 and
2-adrenergic  receptors  have focused on dynamics  utilizing  a  mixture  of  NMR and molecular
stimulations  to  better  understand  conformational  changes45,  46.  High-resolution  solution  state
structures  have  been  reported  for  the  bacterial  GPCR  analogues  sensory  rhodopsin  and
proteorhodopsin44, 47. These proteins are somewhat smaller in size when compared to most GPCRs,
less flexible, and hence more well-behaved.  Solid-state NMR was used for the determination of the
NMR structure of the mammalian CXCR1 receptor in phospholipid bilayers41.  While solid state
approaches hold promise for the future, an NMR structure for a full-length, mammalian GPCR
based strictly on measured constraints has yet to be determined.   
In an effort to overcome some of the difficulties associated with the NMR characterization of
full-length GPCRs, several groups have focused on the characterization of  fragments of GPCRs.
Fragments are often easier to express in high yields, and the smaller number of residues leads to less
crowded spectra.  Our group studies the yeast -factor receptor, Ste2p, a 431-residue peptide ligand
receptor,  which  we  are  using  as  a  model  system for  GPCR methods  development.   We  have
published  the  only  solution  structure  for  a  GPCR fragment  containing  two  TMs  [TM1-TM2;
Ste2p(G31-T110)] in LPPG micelles and in 2,2,2-trifluoroethanol (TFE):water mixtures [9, 50].  In
both cases, the fragment is helical and forms a hairpin.  However, the helical hairpin is more stable
in LPPG and only transiently formed in TFE:water.  The formation of a tertiary structure, even a
transient  tertiary  structure,  supports  the  hypothesis  that  large  domains  of  a  GPCR  can  fold
independently of the remainder of the protein.
All X-ray structures of GPCRs show that every TM domain is in contact with at least two
other TM domains. Therefore, we hypothesized that increasing the size of our Ste2p fragment to
3TM domains would increase the probability of forming tertiary contacts and potentially result in a
more stable structure through increased mutual stabilization. As a result, we expanded our structural
characterization to a 3TM containing fragment of Ste2p(G31-R161), TM1-TM3.  This fragment
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contains 131 residues of Ste2p, including 19 residues from the N-terminal domain, the first TM
through the third TM with connecting loops and five residues of the second intracellular loop. Here
we  report  details  of  a  structure  and  dynamics  study  on  Ste2p  TM1-TM3 in  50%  TFE:water.
Recently, we showed that the addition of the first 30-residues of the Ste2p N-terminus increased
expression and the stability of Ste2p TM1-TM2 in NMR preparations8. We will also report on the
expression and biophysical characteristics of Ste2p (M1-R161) NT-TM1-TM3, which contains 161-
residues of Ste2p including the entire N-terminal domain and the same TMs and loops as above.  
2.3   Materials and Methods
2.3.1   Assignment of Sidechain Resonances
NMR backbone assignment of the TM1-TM3 fragment of Ste2p in TFE:water at 45°C was
previously  reported48.  Side  chain  resonances  were  assigned  using  the  HCCH-TOCSY49,  50,
HCCC(CO)NH  51,  and  (HM)CM(CGCBCA)NH  and  (HM)CM(CBCA)NH52 experiments  using
NMRView 553 and CARA54. Briefly, C and C annotations from the backbone assignments were
confirmed in the HCCC(CO)NH spectra. The latter were also useful to obtain frequencies of the
connected protons. Sidechain assignments of aliphatic resonances were then completed with the
help  of  HCCH-TOCSY spectra starting  from  anchoring  resonances  in  the  2D  [13C,1H]-HSQC
experiments.  In  general,  the  [13C,1H]-HSQC  spectrum  was  very  crowded,  and  assignment  of
sidechain resonances using the CA and CB chemical shifts was difficult.  Assignments of methyl
groups in the ILV-labelled sample was performed using experiments published by the Kay group52,
55 that start on methyl protons and connect to amide moieties. Knowledge of methyl assignments
then facilitated sidechain assignments via HCCH-TOCSY correlations form the methyl moieties.
The spectra were acquired using either a three-channel Varian NMR-S 600 MHz NMR spectrometer
(Varian NMR Instrument, Palo Alto, CA) with a z-axis pulsed-field-gradient and a Varian 5mm
[1H,15N,13C,2D] cryo-probe at the College of Staten Island, a three-channel Bruker AV-700 700 MHz
NMR spectrometer (Bruker, Billerica, MA) equipped with a CRYO TXI inverse triple resonance
cryoprobe at  the  University of  Zurich,  or  a  four-channel  Bruker  800 MHz NMR spectrometer
(Bruker, Billerica, MA) equipped with a CRYO TCI triple resonance cryoprobe at the New York
Structural Biology Center.
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2.3.2   Confirmation of Secondary Structure Localization in Ste2p TM1-TM3 
(G31-R161) using 15N T2 relaxation and H,D Amide Exchange
15N T2 relaxation  experiments  were  performed  on  a  0.5  mM  [15N]-TM1-TM3  sample
solubilized in 50% TFE-d2:(water+0.1% TFA) (Sigma, St. Louis, MO). A series of eight [15N,1H]-
HSQC-based CPMG experiments were performed with varying relaxation times of 0, 10, 30, 50,
70, 110, 150 and 210 ms. The data were processed and the rate analysis function of NMRView5 was
used to calculate the relaxation time for each residue. 
H,D amide exchange analysis was performed on a 0.5 mM [15N]-TM1-TM3 sample obtained
by dissolving lyophilized protein in a fully deuterated solvent 50% TFE-d3:(D2O + 0.1% TFA-d1)
(Sigma,  St.  Louis,  MO).  A series  of  [15N,1H]-HSQC experiments  were  measured  at  40  minute
intervals for a total  of 5 hours.  Additional spectra were collected daily with the final spectrum
collected eight days after the original sample preparation. The rate analysis function of NMRView5
was used to calculate the exchange time for each assigned residue, resulting in a logarithmic plot of
the exchange time vs. residue number (see Figure 2.1A). 
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2.3.3   Assessment of the Relative Flexibility of Ste2p TM1-TM3 (G31-R161) 
using an Analysis of the 15N{1H}-NOE
A 0.5 mM sample of [15N]-TM1-TM3 was solubilized in 50% TFE-d2:water and subject to
analysis of the 15N{1H}-NOE both at 45°C and 30°C. Amplitudes and volumes for each crosspeak
in each data set were calculated using CARA. The  15N{1H}-NOE was derived by computing the
ratio of peaks in the spectra with and without prior proton irradiation.
2.3.4   NOESY Assignment and Structure Calculation for Ste2p TM1-
TM3(G31-R161)
Backbone chemical shift assignments were used to calculate torsion angles for TM1-TM3
using TALOS+56. The ATNOS-CANDID57, 58 component of the UNIO suite, that is interfaced with
the structure calculation program CYANA59, was used for automated assignment of the 3D [13C]-
45
Figure 2.1: Evaluation of the secondary structure of Ste2p (G31-R161) by hydrogen-deuterium amide exhange 
and T2 relaxation
(A) Exchange timeswere calculated from a series of [15N,1H]-HSQC experiments conducted at 45 °Cand plotted as a 
function of residue number with an inverse logarithmicscale. (B) The T2 relaxation times for all residues in TM1–TM3 
weremeasured using the series of experiments conducted at 45 °C as described.The boxed helical boundaries are those 
calculated by sequence-based TMprediction software (average of four programs)
and [15N]-resolved NOESY spectra based on the assigned backbone and sidechain chemical shifts. A
seven-cycle CYANA iteration using the 3D [15N]- and [13C]-resolved NOESY spectra as well as the
TALOS-derived torsion  angle  restraints  was used to  calculate  80 structures,  and the  20 lowest
energy structures for TM1-TM3 were analyzed in detail. 
2.3.5   Direct Expression of NT-TM1-TM3 Protein Fragments
A construct containing an N-terminal His6-tag, followed by the full N-terminal tail and an
S104C mutation (NT-TM1-TM3, Ste2p(M1-R161, S104C) corresponding to Ste2p(M1-R161) was
cloned and expressed. The plasmid containing the NT-TM1-TM3 sequence was transformed into
BL21(DE3),  20 μL of the transformation reaction was used to inoculate 50 mL of Luria Broth
containing ampicillin (LB/Amp). The culture was grown overnight at 37°C and used to inoculate 1
L of LB/Amp, and the cells were grown at 37°C until an OD600 of approximately 1 was reached. The
cells were then pelleted at 4000 rpm for 20 minutes and resuspended in M9 minimal medium using
13C-glucose  and  15NH4Cl  as  the  sole  carbon  and  nitrogen  sources  as  needed,  respectively
(Cambridge Isotope Laboratories, Andover, MA). Expression was induced by the addition of 0.1
mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and the culture was incubated at 30°C for 22h,
after which cells were pelleted at 5000 rpm for 20 min. Inclusion bodies were prepared from the cell
pellets  as  previously  described60,  with  the  addition  of  5  mM  dithiothreitol  to  the  lysis  buffer.
Inclusion body pellets were dissolved in 70% TFA by sonication and purified by preparative reverse
phase  high  performance  liquid  chromatography  (RP-HPLC)  on  a  Zorbax  300SB-C3  Prep  HT
(Agilent, Santa Clara, CA) 21.2 x 150 mm, 7 micron column at 60°C using gradient elution with an
acetonitrile/2-propanol gradient from 30% to 72% Solvent B (80% acetonitrile, 20% 2-propanol,
0.1% TFA) where Solvent A contained 80% water, 20% 2-propanol, 0.1% TFA). After purification,
15N, 15N13C and 15N13C2H-labelled proteins were lyophilized. 
2.3.6   Circular Dichroism Spectroscopy of Ste2p TM1–TM3 and NT-TM1-
TM3 Peptides
CD spectroscopy was used  to  access  the  secondary structure  of  the  TM1–TM3 peptides.
Experiments  were  carried  out  in  both  organic:aqueous  solvents  and  detergents.  Peptides  were
solubilized by sonication in 50% TFE:(water+0.1% TFA) and the concentration of the peptide stock
solution was determined by UV absorbance at 280nm. The molar extinction coefficient of 12,950
M-1cm-1 was used for short M1M3 peptide and 19035 M-1cm-1 for NT-TM1-TM3 and NTL11P-TM1-
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TM3. The extinction coefficients were calculated using 1490 for Tyr, 5500 for Trp and 125 for Cys
residues. This stock solution was portioned and lyophilized to yield approximately 20 M or 7 M
solutions in detergent and TFE:water media, respectively. The detergents were prepared as 20 mM
sodium  dodecyl  sulfate  (SDS)  (Sigma,  St.  Louis,  MO)  or  lysomyristoylphosphatidylglycerol
(LMPG) (Avanti Polar Lipids, Alabaster, Alabama) in 20 mM sodium phosphate buffer, pH 5.0. All
samples were sonicated at 40°C for 5 min at 40 W using a S3000 sonicator (Farminigdale, NY) with
a cup horn. The spectra were recorded on an Aviv Model 410 CD instrument (Aviv Biomedical,
Lakewood, NJ). For the organic:aqueous studies, a quartz cuvette with a pathlength of 1 mm was
used. For the detergent studies, a quartz cuvette with a pathlength of 0.2 mm was used. The spectra
were collected over a wavelength range of 260 nm to 190 nm in increments of 1 nm. An average of
four  scans  was taken in  all  cases,  and the background subtraction  used the spectrum from the
solvent  medium.  The  raw  data  were  then  converted  in  mean  residue  molar  ellipticity
(deg*cm2*dmol-1). Deconvolution analysis was performed using the CDNN software61.
2.3.7   NMR Analysis to Determine Peptide Stability at High Concentrations 
For  NMR  investigations  in  organic:aqueous  media,  2-3  mg  of  lyophilized  protein  were
solubilized in 175 µL of TFE and sonicated as above. After sonication, 175 µL of water containing
0.1% TFA were added and the sample was sonicated again. A clear solution was obtained and the
sample was transferred to a Shigemi NMR tube (Shigemi, Allison Park, PA). 1H NMR experiments
were conducted at 45 °C on a three-channel Varian NMR-S 600 MHz NMR spectrometer (Varian
NMR  Instrument,  Palo  Alto,  CA)  with  a  z-axis  pulsed-field-gradient  and  a  Varian  5-mm
[1H,15N,13C,2D] cryo-probe. Sample stability was assessed by measuring the overall peak integral for
amide NH, NH2 and aromatic area from 6.0 to 9.5 ppm for samples incubated for several days at
45°C.
2.4   Results and Discussion
2.4.1   Assignment of Side Chain Resonances of TM1-TM3
Side  chain  assignments  were  conducted  using  the  HCCH-TOCSY,  HCCC(CO)NH,
(HM)CM(CGCBCA)NH, and (HM)CM(CBCA)NH experiments as described above. Data from all
three experiments were combined to assign all  [13C,1H]-HSQC crosspeaks. Complete side chain
assignments  were  obtained  except  for  the  aromatic  residues.  A  table  of  all  chemical  shift
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assignments is  provided in the Supplemental  Materials  (Supplemental  Material  Table S2.3) and
chemical shifts have been added to the BMRB database under accession code 17211.
2.4.2   Assessment of the Secondary Structure of Ste2p TM1-TM3(G31-
R161) by H,D Amide Exchange and 15N T2 Relaxation Experiments
H,D amide exchange and  15N T2 relaxation experiments  were  conducted in  order  to  gain
additional  insight  into  the  stability  of  secondary  structure  of  the  TM1-TM3 fragment  in  50%
TFE:water. Analysis of the H,D exchange results (Figure 2.1A) reveals that, in general, the residues
in the predicted TM helices (boxed regions) displayed reduced H,D exchange rates when compared
to those in the loop regions. The majority of the exchange times in the predicted helices range from
approximately 10-200 h while they are between 0.02-1 h in the loop regions. Accelerated exchange
is also observed in the middle of TM1, centered around the GXXXG motif. The predicted TM helix
boundaries48 seem to correlate very well with the exchange data for residues of TM1 and TM3, as
slow exchange is only observed within the TM regions (indicated by boxes in Figure 2.1A), while
fast  exchange is  restricted to  loop regions.  Except  for residues in  the very center  of TM2, the
exchange data for TM2 reveal that many residues near the ends of the helix possess exchange times
between  1  and  10  h  indicating  reduced  stability.  This  finding  deviates  from  the  conclusions
previously reported that were derived from chemical shift analysis48. The putative TM3 displays
more stable hydrogen bonds at its N-terminus, however the differences in exchange times across the
helix are, in general,  not as large as in TM2. In addition to the TM helices, the chemical shift
analysis indicated the presence of helices encompassing residues 38 to 49 or 108 to 115 within the
N-terminus (NT) and the extracellular loop 1 (EL1), respectively48. These helices are not detected in
the H,D exchange data indicating that they are rather unstable. 
15N T2 relaxation times (Figure 2.1B) are between 25 and 50 ms in the TM segments, and
adopt values on the order of hundreds of milliseconds at the termini and around 50 ms in the loops.
We observed increased relaxation times for the GXXXG region in TM1. TM1 again appears to be
N-terminally extended, and this extension correlates well with the position of the N-terminal helix.
Interestingly, relaxation times for residues in EL1 gradually increase until residue 120. 
 This gradual increase is consistent with the presence of a short helix in the beginning of EL1.
Furthermore,  the  relaxation  times  in  TM2 are  the  shortest  of  the  3  TM  regions.  Overall,  the
relaxation  results  seem  to  confirm  the  helix  boundaries  previously  identified  from  secondary
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chemical shifts48. We note that exchange data allows us to differentiate different degrees of helix
stability for residues that may display very similar relaxation data as the latter in addition to helix
stability may contain contributions from conformational exchange.
2.4.3   Assessment of the Relative Flexibility of Ste2p TM1-TM3(G31-R161) 
by Analysis of the 15N{1H}-NOE
Analysis  of  the  15N{1H}-NOE has  also  been  used to  gain  insights  into  the  flexibility  of
membrane  proteins62.  Based  on  previous  studies  on  the  TM1-TM2 fragment  of  Ste2p9, it  was
expected that the TM1-TM3 construct would be more structured at lower temperature. Accordingly,
a series of HSQC experiments were run in 5°C decrements from 40°C to 25°C in order to transfer
the  backbone  amide  assignments  (data  not  shown).  It  was  found  that  30°C  was  the  lowest
temperature at which chemical shift adaptations could be performed. Accordingly,  15N{1H}-NOE
experiments were performed at both 45°C and 30°C. 
15N{1H}-NOE data collected at 45°C (Figure 2.2, top) closely reflect trends in the T2 data.
Both the N and C-termini display negative or small positive values, suggesting that these regions of
the fragment are highly flexible. The three major regions with 15N{1H}-NOE above 0.5 fall within
the putative TM regions (dashed lines, Figure 2.2), but also include the short helix N-terminal to
TM1. There is a small dip at the GXXXG motif in TM1. The putative loop regions show increased
mobility relative to the TM regions. Again, the N-terminus of EL1 displays decreased mobility in
agreement with the presence of some degree of order in that part of this loop.
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In general, data at 45°C seem to contain less noise in comparison to the 30°C data, likely due
to the fact that peaks can be integrated more reliably at the higher temperature at which the lines are
sharper and spectral overlap is less of a problem. At 30°C, the 15N{1H}-NOE for most regions of
TM1-TM3 increases  slightly.  For  example,  TM1 appears  to  become  less  mobile  at  decreased
temperature (many ratios >0.7), while the trend for increased mobility within the GXXXG motif is
retained. We believe that, in general, the data supports increased overall rigidity for the protein at
30°C. The most significant differences are observed for EL1, for which the C-terminal half becomes
rigidified as reflected in an increase of the 15N{1H}-NOE from 0 to approximately 0.25. We attribute
the effect to a stabilization of secondary structure triggered by formation of tertiary contacts. The
more frequent formation of these contacts results in part in exchange broadening of resonances,
resulting in the observed problems in integration of spectra and deterioration of spectra quality at
the lower temperature. 
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Figure 2.2: Evaluation of the relativemobility of the Ste2p TM1–TM3 (G31-R161) construct by 15N{1H}-NOE.
[15N,1H]-HSQC experiments were conducted at45 and 30 °C with and without amide proton irradiation. The ratio of 
thepeak amplitude with the pulse to the amplitude without the pulse forevery residue in the fragment was calculated and 
plotted as a functionof residue number. The boxed helical boundaries are those calculatedby sequence-based TM 
prediction software (average of four programs).
2.4.4   NOESY Assignment and Structure Calculation for Ste2p TM1-
TM3(G31-R161)
A total of 342 intraresidual (|i-j|=0), 531 sequential (|i-j|=1), 873 short-range (|i-j| ≤ 1), 544
medium-range  (1<|i-j|<5),  and  5  long-range  (|i-j|≥5)  restraints  were  used  in  the  calculation
(Supplemental Material Figure S2.6 and Table S2.4). The twenty lowest-energy of the computed 80
structures were used to evaluate the structure. They had target function values ranging from 0.6 to
1.41. A total of 10 violations were observed (9 distance and 1 van der Waals violations). 90.3 % of
dihedrals fell within the most favored regions of the Ramachandran plot, with the remaining 9.7%
located in the additionally allowed regions (Supplemental Material Figure S2.7). As expected, the
majority of the residues in the most favored region were in the right-handed α-helix portion of the
plot. 
An analysis of typical NOE contacts identified revealed a large number of  i,  i+3 contacts
throughout  the N-terminus-TM1 region (Figure  2.3)  for  residues  36-49,  51-59,  and 63-74.  The
absence of  i,  i+4 contacts  for  residues  49-51, that  corresponds to  the junction between the N-
terminal helix and TM1, suggests a destabilization of the α-helix at this position. Similarly,  the
absence of i, i+4 contacts around the GXXXG motif in TM1 is consistent with reduced secondary
chemical shifts, accelerated H,D exchange, and decreased T2 relaxation. 
The boundaries of the second helix are consistent with a C-terminal extension. This extension
may also be the result of the helix-inducing properties of TFE:water, as it most likely represents an
elongation of TM2 by part of EL1. Absence of  i, i+4 contacts for residues 102-105 indicates the
transition from TM2 to EL1. Finally, the boundaries of TM3 are consistent with conclusions from
sequence-based secondary structure prediction software63-65. 
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As very few long-range contacts were identified in  the NOESY data,  the final  calculated
conformers showed little convergence resulting in a large RMSD when superimposing the entire
sequence.  Therefore we superimposed only single TMs or  even parts  of them in the following
analysis  (Figure 2.4A,  Table 2.1).  The helices spanning the NT and TM1 (NT-TM1) and TM3
superimpose with backbone RMSDs of 3.02 for and 0.99 Å, respectively.  As expected RMSDs
improved when excluding segments for which no i, i+4 contacts were observed (Figure 2.4B, Table
2.1). The resulting backbone RMSDs were 2.36 ± 1.16 Å for TM1, 1.03 ± 0.41 Å for TM2, 1.49 ±
0.51  Å  for  TM3,  and  0.43  ±  0.18  Å  and  0.69  ±  0.28  Å  for  the  short  NT and  EL1  helices,
respectively. The higher RMSD in TM1 is likely due to fluctuations about the central GXXXG
motif. RMSD calculations performed using the TM boundaries from the sequence-based prediction
software (Figure 2.4C, Table 2.1) and those derived from the homology model from Eilers66 (Figure
2.4D, Table 2.1) resulted in the smallest  RMSDs but these superimposed segments are also the
shortest.  Unfortunately,  significant  peak broadening at  25°C,  did  not  allow recording of  useful
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Figure 2.3: Interresidue NOE connectivities for the CYANA structure calculation of Ste2p TM1–TM3 (G31-
R161).
The ATNOS-CANDID component of the UNIOsoftware suite was used for automatic assignment of the [13C]-resolved 
and [15N]-resolved NOESY experiments. Connectivities are displayed as a function of residue.
spectra under these conditions. This precluded the detection of NOEs that would be expected if
tertiary structure would be present at this temperature. The secondary structure determined based on
NOEs is more accurately reflected in the T2 data in comparison to H,D amide exchange.





Backbone RMSD Heavy Atom
RMSD
Structurea NT-TM1 36-75 3.02 ± 1.41 3.81 ± 1.52
TM2-EL1 83-111 2.09 ± 0.81 2.98 ± 0.84
EL1 118-121 0.24 ± 0.11 1.17 ± 0.31
TM3 132-152 0.99 ± 0.29 1.64 ± 0.29
NOEb TM1 50-75 2.36 ± 1.16 3.05 ± 1.13 
TM2 86-103 1.03 ± 0.41 1.98 ± 0.46
TM3 131-156 1.49 ± 0.51 2.07 ± 0.44
NT 36-49 0.43 ± 0.18 1.31 ± 0.21
EL1 105-115 0.69 ± 0.28 1.53 ± 0.40
Sequence-based TM1 50-72 2.10 ± 1.09 2.77 ± 1.04
Calculationc TM2 80-100 1.47 ± 0.5 2.5 ± 0.56
TM3 132-152 0.99 ± 0.31 1.64 ± 0.29
NT 38-49 0.39 ± 0.18 1.33 ± 0.23
EL1 108-115 0.43 ± 0.22 1.14 ± 0.41
Eilersd TM1 49-66 1.54 ± 0.79 2.1 ± 0.71
TM2 84-100 0.82 ± 0.31 1.8 ± 0.34
TM3 131-150 0.85 ± 0.28 1.49 ± 0.27
NT 38-49 0.39 ± 0.18 1.33 ± 0.23
EL1 108-115 0.43 ± 0.22 1.14 ± 0.41
a Boundaries determined in MOLMOL using the Kabsch-Sanders algorithm from the calculated structure.
bBoundaries from the calculated structure modified based on i, i+4 NOE connectivites.
cAverage boundaries from sequence-based TM prediction software.
dBoundaries from the rhodopsin-templated model of Ste2p 
Our previous  work  has  indicated  that  transient  tertiary  structure  can  be  formed  at  lower
temperatures  (25°C)  in  an  organic:aqueous  solvent9 but  that  more  stable  tertiary structures  are
formed in micellar environments67.  Whether this also the case for TM1-TM3 is presently under
investigation in our laboratories.
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2.4.5   Direct Expression and Purification of NT-TM1-TM3: Maximizing 
Expression through Protein Engineering
Despite extensive attempts to optimize NMR conditions and obtain reproducibly spinlabeled
131-residue  TM1-TM3  for  measuring  paramagnetic  relaxation  enhancements  (PREs),  the
expression of the TM1-TM3(S104C) mutant proved extremely challenging. Direct expression led to
very low and unreproducible yields, and CNBr cleavage of a TrpE fusion S104C protein resulted
in no recoverable product. In contrast, following a recently developed approach for TM1-TM28,
direct  expression  of  the  longer  Ste2p(Met1-R161,  S104C) [NT-TM1-TM3] without  fusion  to  a
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Figure 2.4: Convergence of the lowest 20 energy CYANA-calculated structures for Ste2p TM1–TM3 (G31-R161)
The helices were produced by fitting (A) thehelical boundaries calculated from the structure, (B) those determined from 
inter-residue NOE connectivities, (C) the calculated TM boundaries based onprediction software and the secondary 
shift boundaries for the NT and EL1 helices, and (D) the template-predicted TM boundaries and the secondary 
shiftboundaries for the NT and EL1 helices.
leader sequence (Supplementary Material Figure S2.8A) doubled yields to up to 30 mg per liter of
culture. Expression was not always reproducible, however, and sometimes we experienced trouble
with NMR sample preparation where the protein would go into solution but the solution would
become gelatinous or the protein would precipitate over time. An additional mutation in the N-
terminus,  L11P (NTL11P-TM1-TM3),  resulted  in  more  reproducible  expression  yields  and stable
protein samples (vide infra) (Supplementary Material Figure S2.8B). Previous work demonstrated
that mutations in the N-terminus of Ste2p may result in changes in surface expression and signaling
of this receptor in vivo68-70. SCAM analysis has indicated that downstream of residue 11 there is a -
sheet present69,  70 and this region was also predicted to have  -strand potential between L8 and
T1671-73. The presence of proline at position 11 can disrupt this conformation. Furthermore, recent
work in the Becker lab on the functional implications of NT deletions revealed that Ste2p constructs
missing residues 1-10 or 11-20 have increased biological function as indicated by reporter gene
activity and/or mating efficiency (unpublished results). Since the N-terminus has been implicated in
Ste2p dimerization70 the destabilization of the  -strand by the Leu11Pro could have resulted in
decreased aggregation resulting in more reliable expression yields and protein samples that will be
amenable to NMR analysis. Our preliminary results demonstrate that this is the case for NTL11P-
TM1-TM3.
2.4.6   Biophysical characterization of NT-TM1-TM3 and comparison to TM1-
TM3
CD  spectroscopy  was  used  to  determine  if  the  presence  of  the  NT changes  the  overall
secondary structure and fragment stability in TFE:water samples or micellar solutions. Previous
analysis  has  indicated  that  a  correlation  between  CD  spectra  and  NMR  analysis  is  useful  to
determine solvent conditions for NMR. The CD patterns of TM1-TM3, NT-TM1-TM3, and NTL11P-
TM1-TM3  were  measured  in  two  different  TFE:water  mixtures  and  micellar  preparations.
Furthermore, these samples were analyzed over a week to determine stability of the solution.
No difference in CD spectra was observed between 50% TFE:water and 67% TFE:water for
the  three  protein  samples  TM1-TM3,  NT-TM1-TM3,  and  NTL11P-TM1-TM3  (Figure  2.5,  left
panels).  The  resulting  spectra  were  analyzed  for  secondary  structure  tendencies  using  the
deconvolution program CDNN61 (Table 2.2). There was an overall decrease in helicity of the NT
containing peptides which is likely due to an increase in the amount of  -sheet tendency in these
peptides as described above. The -strand percentage in NTL11P-TM1-TM3 is decreased, presumably
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due to the presence of Pro11 which should lower the -strand tendency of the NT. As a result, the
overall helicity of this peptide fragment increases when compared to the same peptide without the
proline mutation. Similar structural tendencies are observed in micellar environments (Figure 2.5,
right  panels,  Table  2.2).  However,  the  amount  of  -sheet  structure  in  micellar  environments
compared to the organic aqueous mixtures is higher in all of the peptides. No differences were
observed after one week at room temperature indicating that at the low concentration used in CD
measurements, the protein samples are stable.
Table 2.2: Percentages of secondary structures based on deconvolution of CD data using 
CDNN64
Peptide TM1-TM3 NT-TM1-TM3 NTL11P-TM1-TM3
-helix -sheet -helix -sheet -helix -sheet
50% TFE 86.0% 1.6% 56.2% 6.1% 80.0% 2.2%
67% TFE 86.5% 1.5% 61.1% 5.1% 81.2% 2.1%
SDS 53.6% 6.8% 38.8% 12.7% 46.7% 9.1%
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Figure 2.5: Secondary structure analysis of TM1–TM3, NT–TM1–TM3, and NTL11P–TM1–TM3 using CD
Left panels: lyophilized peptideswere solubilized in 50%and 67% TFE as described. Right panels: lyophilized peptides 
were solubilized in 20mM SDS and LMPG as described. The presented spectra represent asolvent-subtracted average of
four scans
LMPG 55.3% 6.4% 34.2% 15.9% 32.0% 18.3%
Preliminary investigations of NMR sample conditions have shown that the NT-TM1-TM3
peptides are more stable in 67% TFE:water than in 50% TFE:water. Under similar conditions and
concentrations the sample of NTL11P-TM1-TM3 remains clear for longer time than TM1-TM3 or
NT-TM1-TM3. After 6 days of incubation at 45°C, the best behaving sample of NT-TM1-TM3 lost
~30% of the peak intensity in both the NH/aromatics region and the aliphatic region. Conversely,
the NTL11P-TM1-TM3 sample retained 86% intensities in these same regions after one week. Most
important is our observation that the NTL11P-TM1-TM3 sample could be reproducibly prepared and
remained NMR-stable for at least one week. This type of stability would allow for measurements of
the 3D and 4D NMR experiments. This was not the case for NT-TM1-TM3 lacking Pro11. Pro11
may decrease the aggregation propensity of the N-terminus leading to a sample that is more suitable
for NMR analysis. This observation may have implications for the development of a full-length
Ste2p construct for NMR investigations. 
2.5   Conclusions
Extensive NMR characterization of the TM1-TM3 fragment of Ste2p has been conducted in
50% TFE:water. Complete backbone and sidechain assignments have been made for data collected
at 45°C. The backbone assignments were used for qualitative secondary structure and dynamics
analysis via chemical shift analysis,  as well as for H,D amide exchange,  15N T2 relaxation,  and
15N{1H}-NOE  measurements.  All  analyses  indicate  the  presence  of  three  TM  helices,  with
boundaries in close agreement with sequence-based predictions, with additional helicity observed in
the N-terminal  region and the N-terminus of  EL1.  Analysis  of  the  15N{1H}-NOE suggests  that
certain areas of the fragment become less mobile at reduced temperatures. Reduction in the relative
mobility of EL1 at 30°C would be consistent with the conclusion that the fragment adopts some
degree of tertiary structure at reduced temperature. As 30°C is the optimal growth temperature for
Saccharomyces cerevisiae,  the organism expressing Ste2p, it  is tempting to speculate that these
tertiary structures are biologically relevant and formed during folding of the receptor.
The NOE-restrained structure calculation using data collected at 45°C reveals the presence of
4 helices. Three of them are in good agreement with the homology and secondary chemical shift
predictions. Alignment of the calculated boundaries for the TM regions and the secondary shift
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boundaries for the NT and EL1 helices reveals acceptable convergence and relatively low RMSD
values.  PRE  experiments  will  need  to  be  performed  to  identify  possible  long-range  contacts.
However,  our  preliminary  results  (data  not  shown)  have  not  revealed  such  contacts  in  the
organic:aqueous medium. 
Our initial hypothesis was that increasing the number of TMs in a GPCR fragment would
increase the probability for formation of interhelical contacts resulting in a better defined tertiary
structure  in  TFE:water.  Comparison  of  the  TM1-TM2  and  TM1-TM3  structural  analyses  in
TFE:water suggests that additional work is necessary to test this hypothesis. TM1-TM2 adopted a
transient  tertiary  structure  with  observable  tertiary  contacts  as  judged  by  PRE  experiments.
However, to date we have not been able to run reproducible PRE experiments with the analogous
TM1-TM3 construct. As the size of the fragment has increased, the degree of difficulty of the NMR
analyses  has  also  increased.  To  a  large  extent  this  may  be  due  to  the  tendency of  the  larger
fragments to aggregate in membrane mimetic media, even in organic:aqueous mixtures. It may also
be possible that TM2 and TM3 compete for overlapping helix association sites on TM1. This is
likely not the case within the entire receptor, but in the fragments part of the interhelical contacts
are missing, and hence alternative association modes may occur. As we have recently suggested in
review articles,  the  NMR analysis  of  GPCRs is  complicated  by both conformational  exchange
broadening and intermolecular interactions8,  74. Part of this conformational flexibility is related to
the mode of receptor activation, and the fact that most receptors display basal activity in absence of
agonists. GPCRs often have regions with -strand potential, which would create surfaces that can
lead to aggregation at the high concentrations used in NMR anlaysis. Furthermore numerous studies
have concluded that GPCRs form dimers and higher protomers in membranes (as reviewed in75-77).
Our initial  work with the Leu11Pro mutant of NT-TM1-TM3 suggests that properly engineered
constructs  may lower  the  tendency to  aggregate  which  will  lead  to  more  stable  NMR sample
preparations and increased spectral quality for NMR analyses. 
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32 N 8.56 118.98 175.13 52.74 4.81 38.27 2.86
33 G 8.44 109.49 174.06 45.15 3.98
34 S 8.06 115.84 174.64 58.46 4.49 63.22 3.93
35 T 7.96 116.29 174.64 62.72 4.28 69.00 4.28 δ CG 20.74, δ HG 1.22,
36 I 7.77 122.17 176.31 62.34 4.15 37.84
1.88
δ CG  27.46, 16.19, δ HG
1.56, 1.23, 0.87,
δ CD 11.64, δ HD 0.86
37 T 7.62 115.99 175.25 63.90 4.08 69.04 4.23 δ CG  20.39, δ HG 1.20
38 F 8.10 121.43 176.78 60.51 4.30 38.23 3.16
39 D 8.28 117.80 177.43 55.28 4.40 36.56
3.02,
2.86
40 E 8.07 120.58 177.76 57.25 4.09 27.46 2.09
δ CG  32.38, δ HG 2.42,
2.58
41 L 8.11 121.50 178.09 57.40 4.08 41.23 1.70
δ CG  26.19, δ HG 1.68,
δ CD 22.61, δ HD 0.87
42 Q 8.15 117.31 178.29 58.49 3.83 27.78 1.97
δ CG 33.35, δ HG 2.13,
2.21
43 G 7.89 106.76 175.98 46.36 3.88
44 L 8.07 125.55 179.88 57.66 4.17 41.29 1.86,
1.37
δ CG 26.05 δ HG 1.43,
δ CD 22.48, 22.90, δ HD
0.85, 0.87
45 V 8.54 122.80 177.56 66.55 3.59 30.86 2.12
δ CG 19.79, 21.14, δ HG
0.92, 1.00
46 N 8.45 117.90 178.29 56.12 4.44 38.05
2.93,
2.78
47 S 8.36 116.73 175.41 61.52 4.03 62.45 3.59
48 T 8.00 119.62 175.89 66.37 3.98 68.44 4.37 δ CG 19.81, δ HG 1.25
49 V 8.39 122.51 177.23 66.25 3.69 31.17 2.12
δ CG 19.90, 21.46, δ HG
0.96, 1.03
50 T 7.91 114.44 175.69 66.93 3.84 68.24 4.28 δ CG 20.10 δ HG 1.21
51 Q 7.81 119.00 177.37 59.03 3.96 28.01 2.19 δ CG 33.77, δ HG 2.44
52 A 7.96 122.85 180.44 54.90 4.16 16.90 1.57
53 I 8.32 120.70 178.16 64.52 3.78 37.32 2.03
δ CG 28.28, 15.69 δ HG
1.16, 1.76, 0.91
δ CD 11.66, δ HD 0.81
54 L 8.29 120.07 179.13 57.50 4.08 40.93
1.85
δ CG 26.15, δ HG 1.44,
δ CD 21.56, 23.89, δ HD
0.83
55 F 8.47 119.21 178.60 60.26 4.31 38.22 3.24
56 G 8.35 110.24 175.74 46.58 3.74
57 V 8.43 122.71 178.10 65.45 3.80 31.32 2.21
δ CG 19.94, 20.74, δ HG
0.94, 1.06
58 R 8.30 119.75 177.78 58.17 4.07 29.51 1.89
δ CG 26.47, δ HG 1.70, δ
CD 42.59, δ HD 3.13
59 S 8.07 113.77 175.47 59.97 4.18 62.90
3.61,
3.82
60 G 7.81 110.47 174.45 45.62 4.02
61 A 8.08 123.77 179.43 54.06 4.14 17.13 1.43
62 A 7.98 121.82 178.48 54.37 4.08 16.99 1.44
63 A 7.69 120.31 178.59 54.36 4.06 17.13 1.46
64 L 7.80 117.06 178.01 57.10 4.10 41.28
1.79
δ CG 26.12, δ HG 1.71,
δ CD 22.57, 24.32, δ HD
66
0.88, 0.92
65 T 7.73 113.30 174.99 66.43 3.80 68.14 4.29 δ CG 19.96, δ HG 1.25
66 L 7.60 120.89 178.45 57.78 3.98 40.92
1.80
δ CG 26.09, δ HG 1.55,
δ CD 21.98, 23.03, δ HD
0.80, 0.85
67 I 7.82 119.70 177.52 64.90 3.84 37.34
2.10
δ CG 28.32, 16.26, δ HG
1.08, 1.00
δ CD 11.34 δ HD 0.82
68 V 8.19 120.37 180.00 66.80 3.69 30.91 2.28
δ CG 20.02, 21.57, δ HG
0.94, 1.07
69 V 8.58 124.21 178.26 66.84 3.55 30.80 2.30
δ CG 19.81, 21.67, δ HG
0.98, 1.07
70 W 8.74 124.55 178.65 60.99 4.27 28.26
3.44,
3.59
71 I 9.13 119.26 179.26 64.95 3.57 37.57
1.88
δ CG 28.14, 16.01, δ HG
1.08, 0.94
δ CD 12.07 δ HD 0.89
72 T 8.48 114.65 176.71 65.66 3.94 68.53 4.28 δ CG 20.25 δ HG 1.25
73 S 8.28 117.76 175.58 60.87 4.56 62.68 3.93
74 R 7.69 121.10 177.23 56.64 4.06 29.30 1.73
δ CG 26.07, δ HG 1.36, δ
CD 42.15, δ HD 2.64
75 S 7.82 114.57 174.44 59.28 4.30 63.08 3.89
76 R 7.68 120.81 175.65 56.16 4.22 29.04 1.80
δ CG 26.53, δ HG 1.59, δ
CD 42.69 δ HD 3.13
77 K 7.82 119.66 175.49 55.40 4.36 32.22
1.73
δ CG 24.09, δ HG 1.39, δ
CD 28.22,
δ CE 41.65, δ HE 2.94
78 T 7.62 114.88 172.88 60.57 4.57 68.90 4.21
79 P 176.80 63.75 30.68
1.81
δ CG 26.74, δ HG 2.00, δ
CD 50.02,
δ HD 3.82, 3.67
80 I 7.43 117.79 176.22 62.52 3.86 37.20
1.81
δ CG 27.49, 16.19, δ HG
1.22, 0.85,
δ CD 11.44, δ HD 0.87
81 F 7.50 120.00 176.87 59.58 4.38 38.35 3.19
82 I 7.44 119.79 176.82 63.18 3.83 37.25
1.90
δ CG 27.86, 16.35, δ HG
1.26
δ CD 11.24, δ HD 0.86,
0.86
83 I 7.83 120.15 178.18 63.68 3.75 37.15
1.91
δ CG 27.86, 15.84, δ HG
1.64
δ CD 11.56, δ HD 0.81
84 N 8.15 120.00 176.09 55.61 4.43 37.98 2.78
85 Q 7.90 119.36 177.60 58.57 4.02 27.95 2.12 δ CG 33.89, δ HG 2.53
86 V 8.37 120.05 177.25 65.94 3.75 30.96 2.15
δ CG 19.86, 21.26, δ HG
0.91, 1.02
87 S 8.06 114.81 175.19 61.99 4.18 62.58
88 L 7.68 121.80 177.90 57.35 4.07 40.87
1.74
δ CG 26.11, δ HG 1.43,
δ CD 22.46, 23.01 δ HD
0.74, 0.85
89 F 8.00 119.33 176.80 60.47 4.25 38.04 3.30
90 L 8.34 117.92 180.19 57.71 3.98 40.91
1.38
δ CG 26.22, δ HG 2.06,
δ CD 21.44,  24.01, δ HD
0.91
91 I 8.18 123.14 179.12 64.94 3.75 37.38
2.15
δ CG 28.05, 15.77, δ HG
1.15, 0.90
δ CD 11.58, δ HD 0.83
92 I 8.48 125.11 178.22 65.18 3.63 36.90
2.00
δ CG 27.91,  15.20, δ HG
1.08, 0.87,
67
δ CD 11.48, δ HD 0.84
93 L 8.66 121.37 178.61 57.62 3.96 40.97
1.37
δ CG 25.97, δ HG 1.46,
δ CD 22.31, 22.92, δ HD
0.76, 0.69
94 H 8.25 114.46 176.39 59.30 4.16 27.18 3.33
95 S 8.24 116.44 174.73 61.54 4.17 62.43 3.93
96 A 8.41 125.77 179.71 54.84 4.21 17.01 1.53
97 L 8.09 118.30 178.68 57.15 4.08 40.97
1.49
δ CG 26.06, δ HG 1.54,
δ CD 22.60, 23.70, δ HD
0.86, 0.83
98 Y 8.01 120.29 177.07 60.54 4.30 37.15 3.25
99 F 8.27 119.06 177.04 60.78 4.26 37.81 3.21
100 K 8.14 118.74 178.95 59.26 3.90 31.08
1.98
δ CG 24.69, δ HG
1.61,1.38, δ CD 28.65,
δ CE  41.59, δ HE 2.90
101 Y 8.22 122.40 177.81 60.43 4.14 37.16
3.10,
3.21
102 L 8.38 122.87 179.12 57.86 3.79 41.05
1.71
δ CG 25.85, δ HG 1.46,
δ CD 22.26, 23.77, δ HD
0.80, 0.74
103 L 8.37 119.14 179.72 56.96 3.98 40.88
1.54
δ CG 26.23, δ HG 1.58,
δ CD 22.22, 23.93, δ HD
0.76, 0.83
104 S 8.06 115.42 175.44 60.69 4.19 62.54 3.96
105 N 7.77 120.92 175.71 55.17 4.50 38.55
2.47,
2.51
106 Y 8.32 120.70 177.40 59.82 4.29 37.44 3.08
107 S 8.23 115.72 175.08 60.45 4.27 62.58 3.96
108 S 7.79 117.67 175.48 60.53 4.30 62.47 4.01
109 V 7.85 121.92 176.75 65.16 3.83 31.22 2.10
δ CG 19.93, 20.55, δ HG
0.94, 0.98
110 T 7.71 113.43 176.44 64.89 68.19 4.06 δ CG 20.41, δ HG 1.28
111 Y 7.88 122.51 177.11 59.99 4.29 37.27 3.09
112 A 7.87 122.71 178.92 54.12 4.04 17.31 1.48
113 L 7.94 116.72 178.08 56.11 4.23 41.83 1.80,
1.55
δ CG 26.16, δ HG 1.81,
δ CD 21.53, 23.88, δ HD
0.80, 0.79
114 T 7.65 109.20 175.13 62.58 4.24 69.61 4.23 δ CG 20.19, δ HG 1.21
115 G 7.88 109.65 173.65 44.89 3.93
116 F 7.88 121.28 173.81 58.56 4.67 37.72 3.10
117 P 177.54 64.30 30.47
1.72
δ CG 27.06, δ HG 1.90,
δ CD 49.63, δ HD 3.72,
3.50
118 Q 8.05 117.91 176.48 58.01 4.06 27.46 2.33 δ CG 33.17, δ HG 2.29
119 F 7.77 119.21 176.73 58.75 4.43 38.34 3.14
120 I 7.70 119.06 176.57 61.92 3.93 37.45
1.78
δ CG 16.53, 26.96, δ HG
1.37, 1.12, 0.82,
δ CD 11.49, δ HD 0.78
121 S 7.74 116.16 174.76 58.86 4.33 63.08 3.95
122 R 7.75 121.21 176.58 56.41 4.25 29.56
1.81
δ CG 26.81, δ HG 1.81,
δ CD 42.69, δ HD 3.14
123 G 7.99 107.47 173.74 44.99 3.87
124 D 7.94 118.42 174.72 52.67 4.68 37.19
2.83,
2.91
125 V 7.64 119.56 175.52 62.41 3.96 31.67 2.05
δ CG 19.66, 19.75, δ HG
0.86, 0.83
126 H 8.30 120.58 173.80 54.99 4.66 28.08
3.18,
3.12
127 V 7.70 119.81 175.38 62.31 4.01 32.10 1.98 δ CG 19.57, 20.02, δ HG
68
0.86, 0.84
128 Y 7.82 122.44 176.02 57.82 4.52 38.00
3.05,
2.93
129 G 8.00 109.45 173.66 45.01 3.93
130 A 7.83 123.44 177.67 52.83 4.30 18.02 1.41
131 T 7.89 110.99 174.54 63.34 4.21 68.73 4.21 δ CG 20.54, δ HG 1.26
132 N 7.96 119.89 175.63 53.88 4.67 38.21 2.83
133 I 7.72 120.34 176.06 62.54 3.94 37.38
1.91
δ CG 27.77, 16.21, δ HG
1.53, 0.91,
δ CD 11.58, δ HD 0.86
134 I 7.66 120.35 176.84 63.66 3.75 36.66
1.92
δ CG 28.11, 16.01 δ HG
1.59, 0.92,
δ CD 10.83, δ HD 0.83
135 Q 7.59 117.70 177.22 59.11 3.96 28.02 2.14 δ CG 33.84, δ HG 2.33
136 V 7.41 118.25 177.30 65.92 3.60 30.96 2.25
δ CG 19.79, 21.08, δ HG
0.93, 1.02
137 L 7.97 119.66 180.08 57.20 4.07 40.97
1.91
δ CG 25.81, δ HG 1.53,
δ CD 21.32, 23.84, δ HD
0.80, 0.84
138 L 8.48 122.61 178.86 58.09 4.09 41.18
1.84
δ CG 26.24, δ HG 1.70,
δ CD 22.37, 22.92, δ HD
0.84, 0.71
139 V 8.09 120.17 177.96 66.76 3.59 30.80 2.19
δ CG 19.85, 21.67, δ HG
0.93, 1.08
140 A 8.63 121.95 181.00 54.89 4.11 16.82 1.49
141 S 8.33 116.94 176.08 62.12 4.20 3.95
142 I 8.32 126.22 178.16 64.67 3.74 37.69
2.01
δ CG 28.24, 15.69, δ HG
1.30, 0.89
δ CD 11.72, δ HD 0.82
143 E 8.76 119.16 177.81 59.26 3.98 27.35
2.22,
2.11
δ CG 32.40, δ HG 2.37,
2.63
144 T 8.16 112.48 175.68 66.04 3.93 68.51 4.29 δ CG 20.17, δ HG 1.24
145 S 7.77 117.66 175.83 61.52 4.13 62.60 4.02
146 L 8.13 124.30 178.18 57.74 4.20 41.19
1.89
δ CG 26.02, δ HG 1.66,
δ CD 22.19, 23.26, δ HD
0.85, 0.87
147 V 7.99 118.37 177.52 66.19 3.63 30.86 2.18
δ CG 19.97, 21.46, δ HG
0.92, 1.06
148 F 8.06 119.53 176.76 60.92 4.19 38.33 3.24
149 Q 7.97 117.49 177.63 58.87 3.89 28.35 2.33 δ CG 34.03, δ HG 2.64
150 I 8.22 119.44 177.35 64.40 3.74 37.22
1.99
δ CG 28.00, 15.40, δ HG
1.09, 0.66,
δ CD 11.40, δ HD 0.81
151 K 8.15 119.48 179.24 59.21 3.99 31.46 1.97,
1.85
δ CG 24.51, δ HG 1.38,
1.57,
δ CD 28.69, δ HD 1.63,δ
CE  41.56, δ HE 2.90
152 V 8.05 120.96 177.95 65.88 3.59 30.82 2.06
δ CG 20.05, 21.08, δ HG
0.81, 1.02
153 I 7.98 121.40 178.12 64.14 3.70 37.14
1.87
δ CG 28.05, 15.84, δ HG
1.84, 0.66,
δ CD 11.51, δ HD 0.82
154 F 8.50 118.73 177.46 59.69 4.42 38.23 3.17
155 T 7.95 112.79 175.65 62.90 4.16 69.05 4.32 δ CG 20.84, δ HG 1.25
156 G 8.02 110.07 174.42 45.64 3.94
157 D 8.12 118.47 175.00 53.16 4.62 37.03 2.86
158 N 7.98 117.96 174.52 53.62 4.56 38.14
2.61,
2.58
159 F 7.75 119.15 174.92 57.48 4.56 38.44 3.04,
69
3.16
160 K 7.68 121.35 175.33 55.64 4.29 32.24
1.85
δ CG 23.87, δ HG, 1.39,
δ CD 28.42, δ HD 1.73, δ
CE 41.70, δ HE 2.98
161 R 7.83 121.68 177.13 54.40 4.37 30.04
1.93,
1.77
δ CG 26.41, δ HG 1.64, δ
CD 42.69, δ HD 3.17
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Figure S2.6:  Number of restraints used for the CYANA structure calculation for Ste2p TM1-TM3 (G31-R161)
White bars indicate intra-residue connectivities.  Light gray bars indicate short-range connectivities.  Dark gray bars 
indicate medium-range connectivities.  Black bars indicate long-range connectivities.
Table S2.4: NMR Constraints and Structural Statistics for 20 Structures of TM1-TM3 in 50%
TFE:water
Distance Constraints 1422
Short Range |i-j|≤1 873
Medium Range 1<|i-j|<5 544
Long Range |i-j|≥5 5
Hydrogen Bond Constraints 80
Dihedral Angle Constraints 240
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Figure S2.7: Ramachandran plot from CYANA structure calculation for Ste2p TM1-TM3 (G31-R161)
The majority of residues, 90.3%, are found within the most favored regions of the plot, with the remaining 9.7% in the 
additionally allowed regions.  Most of the residues fall within the right-handed α-helix region of the plot.
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Figure S2.8: Expression and Purification of NT-TM1-TM3 peptides.
Large-scale expression of Ste2p NT-TM1-TM3 (M1-R161, S104C)(A) and Ste2p NTL11P-TM1-TM3 (M1-
R161,L11P/S104C)(B). Expression was performed as described in the Materials and Methods. SDS-PAGE (gel, top left)
was used to evaluate expression levels. Preparative HPLC purification of IB pellets revealed that the desired product 
eluted from the column at approximately 34-35 minutes (top right chromatogram in each box). ESI-MS analysis of the 
eluted product revealed that the polypeptides had the expected molecular weight with >96% [15N]-incorporation 
(bottom right spectra in each box). Analytical HPLC (bottom right chromatogram) indicated that the peptides were 
pure. The shoulder in the top analytical chromatogram is likely some conformational variant as judged by mass 
spectroscopy
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3.1   Abstract 
GPCRs are one of the most interesting classes of biomolecules to study as potential drug
targets.  As  membrane  proteins,  containing  seven  transmembrane  helices  (TMs),  structural
characterization  of  GPCRs  remains  quite  challenging.  In  this  work,  we  describe  the  study  of
fragments from the yeast GPCR Ste2p using solution-state NMR spectroscopy. Therein, several
constructs containing one or more TMs, namely TM1 (containing the first transmembrane helix),
TM12, TM123 and TM127, a construct in which TM7 is covalently linked to TM2, are investigated
to identify interhelical contacts.  Systematic  elongation of receptor fragments by the addition of
further helices allows the investigation of early receptor  folding.  It  can be observed that TM1,
which is destabilized around a G-XXX-G motif, becomes rigidified upon the addition of TM2, as
demonstrated in the previously solved TM12 fragment1. The addition of a further helix in case of
the TM123 fragment, however, appears to destabilize the tertiary fold and the membrane integration
due  to  unsatisfied  polar  residues  in  the  center  of  TM3,  which  also  makes  TM123  prone  to
aggregation.  The  addition  of  TM7  yielded  the  much  more  stable  TM127  fragment,  which
nonetheless seems to be highly dynamic. Making extensive use of sparse sampling NMR data, such
as paramagnetic relaxation enhancement (PRE) and residual dipolar couplings (RDC), it could be
demonstrated that interhelical contacts are formed, and that the helices are well embedded in the
micelle. However, TM7 is performing a hinge motion about the central Leu-Pro-Leu motif, and the
3-TM bundle appears to be less compact when compared to a homology model.
KEYWORDS: GPCR, membrane proteins, structural biology, Ste2p receptor
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3.2   Introduction
 G-protein coupled receptor present a large family of integral membrane proteins that help
transmitting signals into the cell2. They are activated by a set of highly chemically heterogeneous
moieties, such as light, small organic molecules such as adrenaline, or peptides, lipids to name just a
few. Structurally, GPCRs form a seven-transmembrane helical bundle joined by three intracellular
and extracellular loops, an extracellular N-terminal domain of highly variable size and structure and
a mostly flexible C terminus, that sometimes often contains an eighth helix3 4, 5. Upon binding of an
agonist a structural transition occurs through which the otherwise occluded binding surface for the
G-protein becomes accessible6.  While the importance of the pharmacology of GPCRs has been
recognized in  the  40ies  by Ahlquist7,  the  first  high-resolution  structure  of  a  GPCR,  of  bovine
rhodopsin,  was published only in 20005,  followed by the first  X-ray structure of recombinantly
produced GPCRs in 20078. Since then we have witnessed an ever-accelerating avalanche of new
GPCR structures,  and the  importance  of  these  was  acknowledged by the  Nobel  price  in  2012
awarded to Levkowitz and Kobilka. In the meantime, even the structure of an agonist-bound GPCR
coupled to a G-protein has been released9, and attempts at solving the structure of a GPCR-arrestin
complex are well underway.
While our knowledge of the structure of GPCRs in various states and their mode of activation
and  desensitization  is  rapidly  increasing,  detailed  information  on their  folding  pathway is  still
lacking.  The  refined  three-stage  model  from  Popot  and  Engelman  postulates  that  secondary
structure forms when the peptide chain partitions into the membrane-water interface10-12. Individual
helices  will  then insert  into the membrane,  diffuses  laterally within the membrane until  native
contacts are formed and the bundle fully assembles. Of course this biophysical model does not take
into account participation of membrane-protein folding by the translocon machinery. Therein, the
signal-recognition particle  targets  the nascent  chains  emerging from the ribosome tunnel  to the
translocon  (Sec61p)  complex13.  In  the  co-translational  folding  model,  segments  of  sufficient
hydrophobicity are laterally gated from the translocon into the membrane interior, while formation
of the helices may occur already within the translocon, or may even be initiated in the exit tunnel of
the ribosome. Interestingly, a remarkable agreement of the biophysical Wimley-White scale14 and
the translocon scale from the van Heijne group15 have been observed, indicating that formation of
the TM helices and their insertion into the membrane are largely governed by hydrophobicity of the
amino  acids  and  hence  by  general  properties  amino  acid  sequence16,  17.  Folding  of  polytopic
membrane proteins can be described by a alternating series of events of helix-insertion into the
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hydrophobic core and sequestering of loop-sequences into cytosolic or extracellular space15. What
has become apparent is that this simple model is not always true but that helices may change their
location during synthesis of later portions of the polypeptide chain18-20.
In membrane proteins with helical bundles interhelical contacts are often formed between
polar or even charged residues21-23. We noticed that some TM segments do not display favorable
energies for full membrane insertion24, 25. In nascent chains in absence of some of the other helices
these polar or charged residues would be exposed to lipids, and it may be questionable whether the
TM  parts  then  still  insert  into  the  membrane.  We  here  therefore  investigate  conformational
preferences  of  N-terminal  fragments  of  a  yeast  G-protein  coupled  receptor  (GPCR),  the  Ste2p
receptor. The overall topology of GPCRs is fairly well conserved, and in particular the TM helices
usually form the  same contacts.  Considering  that  proteins  are  synthesized  starting  with  the  N-
terminus of the polypeptide chain, TM1 is expected to be the first segment to be inserted into the
hydrophobic core, followed by TM2 and so on. We report on studies of polypeptides corresponding
to the overlapping fragments TM1, TM12 and TM123. In the seven-helical bundle of GPCRs TM1,
TM2 and TM7 form a core, and often more contacts exists between TM7 and TM1 and TM2 than
between TM3 and TM24. To investigate how TM7 influences helix stability and integration into the
membrane, we have also looked at TM127, in which the N-terminal end of TM7 was directly linked
to TM2. We determined the structures of these proteins by solution NMR methods. The investigated
proteins contain overlapping stretches (e.g. TM1 is contained in all of them). We have additionally
probed  whether  chemical  shift  assignments  can  be  transferred  from  the  smaller  to  the  larger
fragments.  Considering  that  NMR  spectra  of  membrane  proteins  of  increasing  size  rapidly
deteriorate in quality adapting chemical shifts from smaller fragments may present an interesting
and useful technical advance in assigning the technically challenging membrane proteins.
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3.3   Results
3.3.1   Protein expression and purification
Heterologous expression of membrane protein fragments often presents a significant problem
due to their hydrophobicity and flexibility, which can result in misfolding and aggregation, and
possible toxicity, which leads to overall low expression levels. Therefore, fusion proteins are often
utilized to enhance over-expression and act as signaling sequences to direct the protein into specific
cell  compartments26-30.  In the past our laboratory has mainly utilized two different fusions: The
TrpΔLE sequence introduced by the Naider lab, as well as the N-terminal domain of the Y4 GPCR.
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Figure 3.1: Schematic representation of the study of receptor fragments
The N-terminal half of the entire Ste2p receptor, schematically depicted on the top, is dissected into various 
fragments of increasing length. Typical [15N,1H]-HSQC spectra are depicted on the bottom.
Whereas  the former  is  highly hydrophobic,  the latter  presents  a  small  (40 amino acid)  soluble
protein. Despite their different solubilities both fusions direct the expression product into inclusion
bodies. Both fusion partners have to be removed after expression, and this task can be achieved
using chemical  or  enzymatic  cleavage.  Chemical  cleavage works  best  with  cyanogen bromide,
which however  precludes occurrence of  internal  Met residues.  Enzymatic  cleavage is  generally
problematic since the fusion protein is highly hydrophobic and therefore must be solubilized in
rather  high  concentrations  of  denaturant  –  and  conditions  must  be   chosen  carefully  to  be
compatible with retaining enzymatic activity of the protease. When starting this project with TM123
and TM127 TrpΔLE fusions were used as constructs, and the sequence contained only a truncated
part of the N-terminal domain to reduce the overall size of the proteins. Problems with producing
the single Cys mutants required for PRE measurements, due to side-reactions of the CNBr reagent
with Cys residues, then forced us to investigate whether these proteins cannot be expressed directly,
and this was indeed the case when adding the entire N-terminal domain to the constructs.
The Ste2p fragments TM1 (G31-T78), TM12 (G31-T110), TM123 (G31-R161) and TM127
(G31-T114, T274-L340) were expressed as C-terminal fusions to the TrpΔLE sequence. Cysteine
and methionine residues have been replaced by amino acids with similar properties (Ser for Cys;
Ile,  Leu  and  Val  for  Met  residues)   to  retain  feasibility  of  chemical  cleavage  and  preserve
functionality of the receptor as reported before31, 32 . Several E. coli expression strains (BL21 (DE3),
BL21-AI, BL21 (DE3) pLysS, BL21 (DE3) STAR pLysS, BL21 Rosetta pLysS, C41 and C43) were
screened for expression, as expression levels differed considerably between different fragments and
strains, to achieve acceptable expression yields in minimal media. Inclusion bodies were solubilized
in 70% TFA and, following chemical cleavage of the fusion proteins with CNBr, proteins of interest
were purified  using RP-HPLC. This  resulted in  expression yields  of  about  15mg and 5mg  of
purified protein per liter of 15N13C-labeled and 15N13C2H-labeled M9 culture, respectively, for TM1
(using the strain BL21-AI), 11mg/L and 5mg/L  for TM123 (BL21-AI)33 and 15mg/L and 5mg/L for
TM127 (BL21(DE3)STARpLysS). Expression details of TM12 have been reported previously1.
To obtain additional  long-range distance  restraints  for  TM127,  single cysteine mutants  to
specifically attach the paramagnetic spinlabel MTSL were also designed. As described in  34about
one spinlabel per TM helix is required to unambiguously establish the relative TM arrangements.
Accordingly  we  have  placed  single-Cys  residues  at  positions  S47,  S75  and  S104.  Single  Cys
mutants of TM127 were expressed directly containing the full N-terminus (S2-T114, T274-L340) as
well as an N-terminal His10-tag in BL21(DE3) cells. After RP-HPLC purification, 40mg of protein
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per liter of  15N-M9 medium culture were obtained. After coupling of the MTSL maleimide, the
protein was again purified by Ni-NTA chromatography with a relative yield of 60%. For all proteins
purity was checked by SDS-page and ESI-MS.
For NMR measurements, samples were measured in 150mM LPPG/DPC (4:1) micelles as the
membrane mimetic, using 40mM potassium phosphate buffer at pH 6.4.  
3.3.2   Backbone and side chain assignments 
The NMR samples of TM1, TM123 and TM127 all  exhibit  good signal dispersion,  when
considering their highly alpha-helical nature, as well as homogeneous line-widths (see Figure 3.1
and  Supp.  Mat.  Figures  S3.11-14).  Analogous  residues  in  different  fragments  exhibit  similar
chemical shifts, which greatly facilitated assignment of the larger fragments (vide infra). Almost
complete backbone assignment and partial sidechain assignment could be achieved for all fragments
(vide infra).
In agreement with common experience we noticed that residues located in transmembrane
regions generally exhibited dramatically lower intensities than their terminal counterparts, which, in
peak clusters made it difficult to uniquely identify the number of peaks, as well as their correct
position. In those cases, HNCO experiments proved to be critical to specify the correct number of
peaks and their distinct positions. Further assignment problems occurred in loop regions and around
charged/polar  residues  located  in  transmembrane  helices,  where  conformational  exchange  is
believed to cause line broadening. In general, no assignments were obtained for aromatic moieties.
TM1 was assigned using standard triple-resonance spectra such as the related HN(CO)CACB
and  HNCACB  or  HNCO  and  HN(CA)CO  experiments35,  36.  Sidechains  were  annotated  by  a
combination of HCCH-TOCSY37,  38 and  13C-resolved NOESY spectra. Almost complete backbone
(97%) and partial sidechain (66%) assignment could be achieved for TM1. 
Assignment procedures for TM1-TM2 as well as details of its structure calculation have been
published previously1. Samples containing TM123 exhibited a strong disposition to form soluble
aggregates,  with all  TM123 samples in general being less stable compared to TM1 or TM127
samples. Depending on the labeling scheme of the protein as well as detergents, TM123 aggregated
completely in a matter of hours, for the sample with reverse ILV methyl labeling in deuterated
detergents, or up to several days, for samples without deuteration, which was confirmed by SEC-
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MALS experiments  (see  Supplementary Material  Figure  S3.15).  Nevertheless,  we could  assign
about 95% of the backbone resonances of TM123, with the only missing residues being the two N-
terminal amino-acids, as well as two prolines and two residues at the beginning of TM2 (N54 and
Q55). In contrast, only 55% of sidechains could be assigned, the reason again being high residue
redundancy and subsequent spectral overlap, as well as broad line-width resulting in low-quality
HCCH-TOCSY and 13C NOESY spectra. 
In case of TM127, it was possible to achieve almost complete backbone assignment (93%),
with the exception of the two N-terminal amino acids, as well as a region in the center of TM7
containing the Leu-Pro-Leu sequence. We suspect that this broadening is due to conformational
exchange.. For TM127, it was possible to assign 63% of sidechain resonances. Most remaining
problems during assignment were related to the high occurrence of certain amino acids, resulting in
significant resonance overlap, especially for hydrophobic residues. Moreover, non-protonated sites
in the otherwise perdeuterated detergents d36-LPPG and d38-DPC result in strong detergent signals
from  the  central  glycerol  unit  predominantly  in  the  Cα  region,  thus  further  complicating
assignments.
Through selective reverse methyl labeling of Ile, Leu and Val, most of the methyl groups
could be assigned successfully, even though the remaining sidechain atoms could not be uniquely
assigned. However,  as is often the case with membrane proteins, only a small number of these
assignments have yielded unambiguous NOE restraints.
3.3.3   Assignment by shift adaptation from fragments
TM12 and TM127 or TM123 constitute two pairs of proteins in which nearly 80 residues are
identical, namely those from TM12. We have investigated whether chemical shift assignments can
be obtained by adapting peaks from the previously assigned, shorter fragment TM12 to the longer
one.  Corresponding  peak  pairs  in  the  two  [15N,1H]-HSQC spectra  are  identified  based  on  two
criteria: First, we assume that the peak in the spectrum of the longer construct, e.g. TM127, will be
close to  the position of the peak in  the shorter  TM12 fragment.  However,  there will  still  be a
number of peaks in vicinity to the original peak that may present the correct solution. The second
criterion therefore comprises a  peak pattern match of the strip in  the 3D  15N-resolved NOESY
corresponding  the  original  peak  anchor  with  those  from  potential  candidates  in  the  TM127
spectrum. Amide moieties will  be close to protons from its  own sidechain or from neighboring
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residues, but, taking the larger distance to sidechain protons from other helices into account, likely
not from sidechains that are close due to tertiary contacts. We suspected that chemical shifts of
sidechains will not change substantially unless secondary structure is formed or changes. In that
respect it is important that our previous work demonstrated that secondary structure in fragments is
largely correct. The procedure is schematically shown in Figure 3.2:
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Figure 3.2: Representation of automatic strip matching
Overlay of the [15N,1H]-HSQC spectra of TM12 and TM127 (top). 3-D 15N-NOESY strip 
comparison (bottom). 3-D NOESY strips from assigned peaks in TM12 (blue) are compared to 
possible candidates of TM127 (black)
In our initial trials using only spectra from the 700 MHz spectrometer and 15N NOESY spectra
with only 22 complex points in the 15N dimension only approximately 65 % of amide peaks were
correctly adapted. The major problem originated in peak overlap in the [15N,1H]-HSQC spectrum.
Due to the insufficient resolution in the 15N domain NOE correlations could not be unambiguously
attributed to individual peaks, and hence much cross-talk (missing or wrong NOE correlations)
appeared in the strips. When [15N,1H]-HSQC and 3D  15N NOESY spectra were recorded at 900
MHz, this time using 192 complex points in the 15N domain 70 (93 %) out of the 75 strips of TM12
have been correctly matched to the total  of  144 strips  of  TM127 (see  Figure  3.3).  We like  to
emphasize here that both [15N,1H]-HSQC spectra as well  15N-NOESY spectra were automatically
picked and integrated. 
Unsuccessful cases occurred when peaks in either the original TM12 or target [15N,1H]-HSQC
spectra overlapped. In these cases strips will contain NOEs originating from two or perhaps even
more amide protons. Whether a correct assignment solution is then found depends on how different
the hypothetic strips are, and hence how much they are deteriorated by adding “wrong” NOEs.
Other  misassignment  occur  when  the  location  of  the  target  peak  is  either  very  different,  as
encountered by residues at the termini, for which chemical shift are rather different, or for peaks in
highly overlapping (central) parts of the [15N,1H]-HSQC spectrum. 
3.3.4   Conformational preferences
Usually,  structure  calculations  of  helical  membrane  proteins  suffer  from  an  insufficient
number of long-range restraints due to the fact that complete sidechain assignments are difficult to
obtain. More importantly, sub-optimal packing of helices, deficiencies of the detergents to perfectly
mimic biological membranes and the inherent flexibility result in exchange broadening that tends to
damp out the weak but structurally important long-range NOEs. To compensate for that RDCs,
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Figure 3.3: Success of 3D NOESY strip matching of TM12/TM127
Green and yellow coded residues are matched to the correct position, while orange and red colored residues are 
matched incorrectly. For details see text. Uncolored residues are not assigned in TM12
PREs as well as chemical shift restraints are applied. Since the backbone assignment of TM127 was
rather complete predictions from TALOS-N resulted in a fairly high number of backbone torsional
angle restraints. Since those restraints only define secondary structure we complemented them with
PRE data from two sets of spinlabel derived distance restraints originating from spin labels attached
a the end of TM1 and at the end of TM2. In addition, NH dipolar couplings were measured to learn
about  the  relative  helix  orientations.  We have  also  probed solved  access  from a  water-soluble
spinlabel. All these data were used to obtain restrains for the final structure calculations. Back-
prediction  of  the  raw data  from conformers  of  the  NMR ensemble  allowed  judging how well
primary NMR data were represented by the ensemble. In case of TM1 the structure calculations
used NOEs-derived distance restraints and chemical–shift derived torsion angle restraints. In case of
TM123 we have only probed secondary structure from NOEs and chemical shifts.
3.3.5   Chemical shifts
The propensity to form helices predicted from backbone chemical shifts is depicted in Figure
3.4. In general, all putative helices seem to be in place. However, it can clearly be seen that TM1 is
destabilized in the center of the helix around the G-XXX-G motif, which becomes rigidified upon
packing against TM2 in TM12. The N-terminal end of TM2 also seems to be destabilized in TM127
as  well  as  in  TM123,  where  some  peaks  are  missing,  possibly  indicating  the  presence  of
conformational  exchange.  A short  surface-associated  helix  at  the  N-terminus  encompassing  the
segment from Phe-38 to Val-45 is also visible in all fragments. The loop regions between TM2 and
the  third  helix  in  both  TM123  and  TM127  show  some  disposition  to  form helical  secondary
structure. In TM127, secondary structure in the center of TM7 is not well defined, largely due to the
missing assignments for residues Leu-Pro-Leu. The fact that no peaks were found for Leu-289 and
Leu-291 indicates that conformational transitions occur close to the central Pro residue. Similarly,
the center of the third helix in TM123 is destabilized around several polar residues.
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3.3.6   Paramagnetic relaxation enhancements
To obtain long-range distance restraints  derived from PREs,  S-(1-oxyl-2,2,5,5-tetramethyl-
2,5-dihydro-1H-pyrrol-3-yl)methyl  methanesulfonothioate  (MTSL),  was  attached  to  unique  Cys
sites  in  the  protein.  Unfortunately,  the  presence  of  cysteine  residues  was  incompatible  with
successive chemical CNBr cleavage, and therefore His-N-TM127, a construct containing the full
native N-terminus of the Ste2p receptor, that could be directly expressed (His10, S2-T114, T274-
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Figure 3.4: Secondary structure predictions obtained from TALOS
Secondary structure predictions obtained from TALOS for TM1, TM12, TM123 and TM127. The propensity of 
residues for forming α-helices is shown
L340),  was used instead.  We designed three different  single-cysteine mutants  of  this  construct:
S47C at the N-terminus of TM1, S75C in the short loop between TM1 and TM2, and S104C at the
beginning  of  the  relatively  long  loop  between  TM2 and  TM7.  Signals  from residues  close  in
sequence to  the spinlabel  completely disappeared in  two of  three cases,  indicating quantitative
coupling and full functionality of the spinlabel for constructs S74C and S104C. For some residues,
signal  intensities  in  PRE samples  were  as  large  as  120%,  suggesting  an  error  of  up  to  20%.
Therefore, all PREs were classified in three different classes: Strong PREs, with less than 10% of
the original signal intensity (<14Å), medium PREs, with residual peak intensities between 10-80%
(14-20Å)  and  unaffected  residues,  with  residual  intensities  larger  than  80% (>20Å)  following
methodology originally introduced by the Wagner lab39.
The S47C spinlabel resulted in incomplete bleaching of resonances from residues close in
sequence, indicating that the spinlabel was partially deactivated. Therefore, no restraints derived
from this  spinlabel  were used  for  structure  calculations.  The PREs from the S75C and S104C
mutants  are  summarized  in  Figure  3.5.  The  S75C  mutant  exhibited  decreasing  attenuation
throughout the whole TM2 helix and the first half of TM1. Signal attenuations can also be observed
at the end of TM7 and the C-terminus, revealing spatial proximity between the first intracellular
loop  and  the  C-terminal  end  of  TM7.  The  S104C  single  cysteine  mutant  also  display  linear
attenuations extending towards the ends of TM2 and TM7, while showing weak PRE effects to the
N-terminus of TM1, as well as medium attenuations for residues of the surface associated short N-
terminal helix, indicating weak interactions between the second loop and the N-terminus.
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3.3.7   Probing relative helix orientations by RDCs
Residual  dipolar  coupling  (RDC) measurements  present  a  valuable  tool  to  determine  the
vector  orientation  between  two  nuclei,  relative  to  a  molecular  axis  system,  leading  to  global
structure  information.  In  this  case,  dinucleotide  2'-deoxyguanylyl-(3',5')-2'-deoxyguanosine
(dGpG), which forms G-tetrades in the presence of potassium, was used as the alignment agent.
RDCs for the backbone amide moieties of TM127 were measured using the TROSY-based ARTSY
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Figure 3.5: Residual intensities for site-directed spinlabels
Residual intensities for site-directed spinlabels S75C (top) and S104C (bottom). 
Red bars indicate residues with no observable intensities; blue bars residues up to
80% and green bars residues above 80% residual intensity.
experiment, and resulted in RDC values between -24Hz to +14Hz (Figure 3.6). TM1 and the N-
terminal  part  of  TM7 display negative  RDCs  throughout,  while  those  from TM2 are  positive,
indicating  that  TM1  and  TM7  are  largely  collinear  and  TM2 is  roughly  orthogonal  to  these.
Frequent sign changes in the C-terminal half of TM7 indicate sampling of multiple conformations.
Negative RDCs can also be observed for the short N-terminal helix and the second loop. RDCs
from the mostly unstructured C-terminus have been omitted from the further analysis.
3.3.8   Probing the integration into the micelle from water-soluble 
spinlabels
To map  the  topology of  membrane-integration  of  TM123  and  TM127,  the  soluble,  inert
paramagnetic probe Gd-(DTPA-BMA) ( Gadolinium diethylenetriamine-pentaacetic acid bis-methyl
amine) was added to the NMR-sample. In general, residues outside the micelle or closer to the
micelle surface experience stronger signal attenuations compared to residues that are buried in the
micelle interior. To minimize integration errors that result from peak overlap, PREs were quantified
using HNCO experiments. At 15mM Gd-(DTPA-BMA) water exposed residues exhibit less than
20% residual signal intensity, while residues that are buried in the micelle still display intensities of
up to 90%. 
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Figure 3.6: RDCs for TM127
Intensity of H-N RDCs for TM127 in Hertz, cataloged by residue.
Overall, the transmembrane regions of both fragments, TM123 and TM127, seem to be well-
integrated into the micelle, while the termini as well as the loop regions are located outside of the
micelle.  Signals  from  the  short  N-terminal  helix  as  well  as  part  of  the  second  loop  display
moderately weaker attenuations, indicating that they interact with the micelle surface. TM1 appears
to  be  the  firmly  embedded,  especially  in  TM127,  where  most  signals  display  minimal  signal
attenuations while TM2 is slightly destabilized relative to TM1, especially at the termini. TM7 in
the  TM127  fragment  displays  limited  signal  attenuation  at  the  N-terminus,  with  residual  peak
intensities decreasing towards the C-terminus.
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In case of TM127 restraints for structure calculations were initially derived from these PREs,
but omitted for later structure calculation rounds, as they seemed to over-restrain the helix bundle.
Residues with signals weaker than 30% (blue), which are water exposed, were defined with a lower
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Figure 3.7: Residual intensities using soluble spinlabels
Relative HNCO peak intensities of TM127 and TM123 after addition of 15mM Gd-(DTPA-BMA). Red 
bars indicate residual intensities above 65%, blue bars those under 30%
limit of 19Å to the micelle center, and residues with signals stronger than 65% (red), which are
integrated into the micelle, were defined with an upper limit of 15Å.
The  Gd-(DPTA-BMA)  data  indicate  that  TM123  generally  seems  to  be  less  well-folded
compared to TM127. For example, the center of TM3 is partially solvent exposed, in agreement
with the occurrence of polar residues in that part. The poor packing of the helices in TM123 may
explain the instability and proclivity of TM123 to aggregate. 
3.3.9   Structure calculation
The structure determination for TM127 did not yield one unique structure, indicating that
TM127 is a highly dynamic system, not a rigid helix bundle, which is clearly supported by the PRE
measurements. Whereas the helices appear to be firmly integrated into the micelle (as can be seen
above  in  Chapter  3.3.8),  interhelical  contacts  seem to  be  transient.  The  observation  of  mirror
topologies (those with a wrong sense of relative helix arrangements) also implies that TM2 and
TM7 compete for the same interhelical contacts in TM1. In general, it can be seen that TM2 packs
against TM1 at an angle, which is confirmed by the RDC data, whereas TM7 occupies a multitude
of conformations, mostly exhibiting a kink around the Leu-Pro-Leu sequence.
To obtain a representative statistical analysis of the different conformations of TM127, we
calculated 5000 structures, clustering the 500 structures with the lowest energies based on their
backbone  RMSD  (<3Å)  in  the  helical  regions.  This  resulted  48  clusters  contained  up  to  95
structures.  25  clusters  accommodated  three  or  less  structures,  and  were  therefore  too  lowly
populated  and  hence  omitted  from  further  analysis.  As  mentioned  above,  mirror  topologies
compared to the 'correct' topology derived from a homology model can be observed in roughly 25%
of the structures. The four most prominent clusters with at least 30 structures have been analyzed by
back-calculation of the raw PRE and RDC data and subsequently compared to the experimental
values, as well as to the back-calculated values for the structure based on a homology model (Figure
3.8). Whereas the simulated RDC values of all four clusters only exhibited differences of up to 3Hz
compared  to  the  experimental  data,  RDCs  based  on  the  model  deviated  up  to  18Hz  (see
Supplementary Material Figure S3.16).
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Figure 3.8: PRE simulations
PRE simulation for the 4 largest clusters from the structure calculation as well as for the homology model. 
Structures containing TM1 (red), TM2 (orange) and TM7 (blue) are shown on the left. The back-calculated 
PREs are shown in red for the S75C spinlabel (center) and for the S104C spinlabel (right). The respective 
experimental values (blue) can be found in each diagram
In comparison to the simulated values derived from the homology model, the experimental
restraints  show much gentler  slopes,  especially from the S75C spinlabel  affecting TM2, which
indicates dynamic averaging from different confirmations. Our data therefore indicate, that TM127
in micelles does not exist as a rigid helix bundle. It also has to be mentioned that the simulated
PREs from the four largest clusters of the structure calculations indicate proximity of the end of
TM7 and the S75C spinlabel, as signals at the C-terminus of TM7 are almost completely attenuated
(less  than  20% residual  signal).  This  does  not  correspond to  the  experimental  data,  where  the
equivalent signals still exhibit over 40% of the original signal. The reason for this can likely be
found  in  conformational  averaging,  as  the  C-terminus  of  TM7  does  exhibit  conformational
exchange around the Leu-Pro-Leu region, and hence may not pack against TM1 at all times.
One problem with the structure calculation of dynamic systems is  the fact  that  restraints,
which are derived from transient data, are averaged. In a structure calculation they are treated to fit
for a single, unique structure and not to an ensemble of different conformers. However, in systems,
where one part of the protein is flexible, as is expected for the C-terminal part of TM7 in this case,
it is much more likely that a restraint is only fulfilled for the population-weighted average of the
ensemble.  To  counter  this  problem  we  are  currently  trying  to  establish  multi-state  structure
calculations. In these calculations, the sequence is multiplied several times and restraints only have
to be fulfilled in at least one of those structures. 
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3.4   Materials and methods
3.4.1   Chemicals and solutions
15NH4Cl, 13C-d7-D-Glucose and D2O were purchased from Spectra Stable Isotopes (Andover,
Massachusetts,  USA).  1-palmitoyl-2-  hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)]  (LPPG)/
dodecyl-phosphocholine (DPC) were bought from Avanti Polar Lipids (Alabaster, Alabama, USA).
All other chemicals were obtained from Sigma-Aldrich (Buchs, Switzerland).
3.4.2   Cloning procedures: 
Construction  of  the  Ste2p  TM127  (G31-T114,  T274-L340)  expression  vector  was
accomplished using a two-step process.  PCR was performed using primers designed to remove
residues G115-G273 and the pBluescriptSK(-) BEC2(M54L, M69V, M71I, M165I) Ste2p vector as
a template.  The resulting sequence was PCR amplified using a forward primer containing a HindIII
site and a sequence complementary to the N-terminal sequence of the TM127 construct,  and a
reverse primer containing a BamHI site and a sequence complementary to the C-terminal sequence
of the TM127 construct.  The amplified fragment and the pSW02 vector were digested with HindIII
and  BamHI, gel purified, ligated using T4 DNA ligase, and transformed into DH5α.  DNA from
some  of  the  resulting  colonies  was  purified  and  sequenced.  The  resulting  plasmid,  pSW127,
contained the TrpΔLE leader sequence in phase with Ste2p(G31-T114,T274-L340, M54L, C59S,
M69V, M71I, M294L).
3.4.2.1   Cloning of TM127 cysteine mutants for PRE labeling
To test direct expression of TM127 three different expression vectors were constructed: One
containing the full native N-terminus of Ste2p (S2-T114, T274-L340), as well as two constructs
additionally containing either a N- and C-terminal His10-tag. The N-TM127 fragment was derived
from the expression vectors pSW127 and pRE01. The latter plasmid contains the N-terminus in
front of the TM1-TM3 fragment. Both plasmids were used as templates to construct N-TM1-TM2-
TM7 using suitable overlapping primers in the TM1 region, a forward primer containing a  NdeI
restriction site and a reverse primer containing a BamHI site. The amplified fragment as well as the
pSW02 vectors were digested with NdeI and BamHI, gel purified, ligated using T4 DNA ligase, and
transformed into DH5α cells. Several colonies were picked and sequenced, resulting in the verified
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pMP01 expression vector containing N-TM127. N- and C-terminal His10-tags were introduced using
FX cloning40. The N-TM127 insert was amplified using the pMP01 vector as template with primers
encompassing SapI restriction sites. Precompiled FX cloning vectors were used, containing ORF-
verified sequences of either N- or C-terminal His10-tags with a C3 protease cleavage site adjacent to
the HIS10-tag. The insert and vectors were mixed, digested using SapI, ligated using T4 DNA ligase,
transformed into DH5α cells and sequenced, resulting in expression vectors pMP02 (His-N-TM127)
and pMP03 (N-TM127-His).Point mutations of single Cys residues were introduced using standard
Quickchange® protocols. Using the vector containing the HIS-N-TM127 insert as a template, three
cysteine  mutants  were  designed,  His10-N-TM127(S47C),  His10-N-TM127(S75C)  and  His10-N-
TM127(S104C).
3.4.2.2   Cloning of TM1
The Ste2p TM1(G31-T78) construct was cloned as a direct expression vector from a vector
encoding TM1-TM3, that itself was constructed from the vector pKC01, that contains the  Trp
fusion of TM1-TM3. The TM1-TM3 direct expression vector,  pRE01, was constructed by PCR
amplification  of  the  G31-R161  region  of  the  Ste2p  sequence  from the  pKC01 vector  using  a
forward  primer  containing  a  His  tag  and  an  NdeI  restriction  site  and  a  TM3  reverse  primer
containing a BamHI restriction site. The resulting PCR product and the pKC01 vector were digested
with NdeI and BamHI.  The digests were gel purified and then ligated using T4 DNA ligase.  The
resulting reaction mixture was transformed into DH5α and the DNA was purified and sequenced.
The amplified plasmid,  pRE01,  contained a 6 residue His  tag  in  frame with Ste2p(G31–R161,
M54L, C59S, M69V, M71I).  
Double stranded mutagenesis was performed on this pRE01 plasmid using primers designed
to incorporate two stop codons after residue T78.  The resulting PCR product was digested with
DpnI.  The digested DNA was transformed into DH5α, ten colonies were isolated, and the plasmid
DNA was extracted from each of the colonies.  The extracted DNA was sent for sequencing.  The
resulting expression vector, pKC03, contained a 6 residue His tag in frame with Ste2p(G31-T78,
M54L, C59S, M69V, M71I).
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3.4.3   Expression
3.4.3.1   Expression of TM123 and TM127
As expression in BL21-AI cells was found to be optimal for the fusion protein  Trp-TM1-
TM333, initial expression attempts for Trp-TM127 were also made in these cells, but a small-scale
test expression revealed that the construct did not express well.  Following further optimization the
protein was finally expressed in BL21 Star(DE3)pLysS, using 0.5 mM IPTG as the inducer and
induction at 22°C for 18h.
Trp-TM1-TM3  was  also  expressed  to  selectively  protonate  the  methyl  carbons  of  the
isoleucine, leucine and valine (I, L, V, respectively) in an otherwise perdeuterated background41.
This was accomplished using 2-keto-3-methyl-d,3-d1-1,2,3,4-13C butyrate and 2-keto-3-d2-1,2,3,4-
13C butyrate as the metabolic precursors for V and L and I, respectively.   The pKC01 expression
vector was transformed into BL-21 AI cells.  A small pre-culture was prepared in LB and used to
inoculate 100 mL of M9 minimal medium prepared with 15NH4Cl, [13C]-glucose, and D2O.  The 100
mL culture was grown to OD600 of  0.4 and then diluted to 200 mL with M9 minimal medium
prepared with 15NH4Cl, 13C-glucose, and D2O.  The 200 mL culture was grown to OD600 of 0.4 and
then diluted to 1L with M9 minimal medium prepared with  15NH4Cl, [13C]-glucose, D2O, and the
labeled I, L, V metabolic precursors.  The cells were again grown to OD600 of 0.4, expression was
induced  with  0.2% L-arabinose,  and  the  culture  was  incubated  at  37°C for  9.5  h.   After  the
incubation,  the  cells  were  pelleted  by  centrifugation,  and  IBs  were  prepared  as  previously
described42.
For selective reverse methyl labeling of TM127, the pSW127 plasmid was transformed into
BL21 Star(DE3)pLysS cells. 1 mL of LB (H2O)/Cam,Amp overnight culture was used to inoculate
6 mL of LB (D2O)/Cam, Amp culture and grown overnight. 1.5 mL of this overnight culture was
subsequently transferred to 40 mL M9 (D2O)/50% Cam, 20% Amp medium with 15NH4Cl as well as
[13C]-glucose, grown to OD600 of 1.2 and added to 1L of M9 medium. After growth to an OD600 of
1.0, the culture was cooled to 22ºC, metabolic precursors were added, and expression was induced
with 0.5 mM IPTG for 18 h. Subsequently, the cells were harvested, lysed by ultra-sonication for 10
minutes, inclusion bodies were isolated by centrifugation at 14 000 rpm for thirty minutes and
aliquoted into 8 equal parts to not overload the column.
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3.4.3.2   Direct Expression of TM1
Direct  expression of  TM1 was done in  BL21-AI cells.   Two 500 mL expressions  in  M9
medium containing 15NH4Cl and 15NH4Cl/13C-glucose, respectively, were conducted with induction
at 37°C overnight.  The entire culture volume for each expression was pelleted and inclusion bodies
were prepared as described below.
3.4.4   Cleavage and Purification of TM1-TM3 and TM127, TM1
For the purification of TM1-TM3 and TM127, inclusion bodies of the  Trp-fusions were
solubilized in 70% TFA and the TrpΔLE was removed chemically by incubation with 75mM CNBr
for 90 minutes at room temperature. The mixture was then directly injected onto a Sorbax 300SB-
C3 RP-HPLC column at 60ºC. The protein was purified, using a gradient from 40% to 100% buffer
B (buffer A: H2O/ 10% isopropanol/ 0.1% TFA; buffer B: acetonitrile/ 10% isopropanol/ 0.1% TFA)
and subsequently lyophilized as described before (Caroccia 2011).
Purification  of  the  TM1  from  direct  expression  was  performed  using  RP-HPLC  with  a
water/acetonitrile/isopropanol gradient at 60°C. The reservoirs contained water/isopropanol/0.1%
trifluoroacetic acid (TFA) and acetonitrile/ isopropanol/0.1% TFA and the gradient was from 36%–
72%  acetonitrile  with  a  constant  isopropanol  concentration  of  10%.   Preparative  HPLC  was
performed on a Zorbax 300SB- C3 Prep RP-HPLC column at 60°C using gradient elution with a
water/acetonitrile/isopropanol/ 0.1% TFA gradient from 36%–81% acetonitrile with a constant 10%
isopropanol concentration.  
3.4.4.1   Direct Expression and Purification of TM127 cysteine mutants
To determine the best possible conditions for direct expression of TM127 fragments, three
expression vectors, namely pMP01 (N-TM127), pMP02 (His6-N-TM127) and pMP03 (N-TM127-
His6), were transformed into a number of different E.coli cells. 10 mL LB (H2O) test expressions at
37ºC and 20ºC for each transformation were evaluated,  from which it  was concluded that only
BL21 (DE3) cells exhibit reliable over-expression. Single cysteine mutants were expressed in 500
mL M9 (H2O)/50% Kan medium with 15NH4Cl, grown to an OD600 of approximately 0.7, cooled to
20ºC and  induced  with  0.5  mM  IPTG.  Cells  were  harvested  after  16h  and  lysed  using  ultra-
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sonication.  Inclusion bodies were isolated by centrifugation at 14 000 rpm for 30 minutes,  and
aliquoted into six equal parts.
Each inclusion body aliquot was dissolved in 70% TFA and injected directly onto a Sorbax
300SB C3 RP-HPLC column. The protein was purified using a gradient from 40 – 100% buffer B
(buffer A: H2O/ 10% isopropanol/ 0.1% TFA; buffer B: acetonitrile/ 10% isopropanol/ 0.1% TFA)
and subsequently lyophilized.
3.4.5   MTSL spinlabel coupling to single cysteine mutants
Coupling of the MTSL spinlabel to single cysteine mutants was achieved by first dissolving
0.4 mM protein in 40mM Tris/HCl buffer at pH 7.5 containing 6M Guanidinium-Hydrochloride
(GdmCl) , followed by addition of  2mM DTT and gentle shaking for 4h at room temperature to
assure complete reduction of cysteines.  After  the solution was purged with nitrogen to remove
oxygen for several minutes, a 15- to 20-fold excess of MTSL spinlabel dissolved in DSMO was
added, and the solution was incubated at room temperature over night.
The reaction mixture was injected directly onto a Ni-NTA column and washed with about 100
column volumes  of  the  reaction  buffer  to  remove  unreacted  spinlabel  and residual  DTT.   The
reaction product was eluted with 500mM imidazole after another wash step with 10mM imidazole,
and collected fractions were dialyzed against water and lyophilized. 
For NMR sample preparation the protein was dissolved in hexafluorisoropanol (HFIP)/H2O
(50:50),  and  half  of  the  solution   was  deactivated  with  10mM  ascorbic  acid  and  afterwards
neutralized with sodium hydroxide. Subsequent sample preparation was carried out as described
below.
To  evaluate  the  effect  of  PREs,  the  ratio  of  peak  intensities  in  [15N,1H]-HSQC  spectra
measured on freshly prepared samples was computed relative to samples in which the MTSL label
was deactivated by ascorbic acid. Peaks that were not sufficiently separated and therefore could not
be integrated reliably were omitted from further analysis.
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3.4.6   NMR sample preparation
NMR samples contained 40 mM K3(PO4) buffer at pH 6.4, and 120 mM LPPG/ 30 mM DPC
and were produced using a protocol slightly modified from the one described by Killian43. Therein,
the  protein  was  first  dissolved  in  small  amounts  of  HFIP/water  (8:1),  while  detergents  were
dissolved in a phosphate buffer equivalent to their final sample concentrations. After mixing the two
solutions, water was added stepwise to dilute the organic solvent and to allow micelles to form.
After two lyophilization steps, the sample was taken up in H2O/D2O (9:1) the final sample volume.
In case of TM1-TM3, several cycles of dissolving the sample in HFIP and H2O and subsequent
lyophilization were necessary to achieve acceptable protein integration into the micelle.
To samples that were used to probe micelle integration, corresponding amounts from 100-
times  concentrated  Gd-(DPTA-BMA)  stock  solution  have  been  added.  Gd-(DTPA-BMA)
concentrations of 5mM, 10mM and 15mM were measured and compared to a blank of 1mM to
reduce effects resulting from T1 relaxation.
3.4.7   NMR spectroscopy
All  samples  for  assignment  purposes  were  measured  at  317K  on  a  Bruker  AV700
spectrometer equipped with a triple-resonance cryoprobe at 317K NMR samples contained 0.2 – 0.4
mM protein in 40mM phosphate buffer, pH=6.4 , 120 mM LPPG and 30 mM DPC as described
previously1.  15N NOESY spectra that were used for strip matching were recorded on an Avance-II
900 MHz spectrometer in the European NMR facility in Frankfurt.  Proton chemical shifts were
referenced to the water line at 4.47 ppm at 317 K, from which the nitrogen and carbon scales were
derived indirectly by using the conversion factors of 0.10132900 (15N) and 0.25144954 (13C). 
Sidechain  assignments  were  obtained  from  standard  TROSY-type  triple-resonance
experiments. Briefly, an HNCO data set was used to pick peaks in the [15N,1H]-TROSY spectrum in
order to early on recognize peak overlap, and to adjust peak positions in cases of peak overlap.
Backbone  and  partial  sidechain  assignments  were  then  obtained  from  HNCACB  and
HN(CO)CACB experiments (or HNCA and HN(CO)CA) spectra.  Sidechain resonance assignment
was accomplished using hCCH-TOCSY/COSY44,  45 in combination with [13C,1H]-HSQC and  13C-
resolved aliphatic/aromatic-NOESY experiments46. Spectra for sidechain assignments required the
use of d36-LPPG and d38-DPC to eliminate the strong residual signals from detergent that would
otherwise obscure the region of C- and methyl resonances. We noticed small changes in peak
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positions  between  spectra  measured  on  deuterated  and  non-deuterated  proteins  as  well  as  for
deuterated and non-deuterated detergent. Therefore, C and C chemical shifts obtained from the
backbone assignments were initially adjusted by using hCCH-TOCSY or hCCH-COSY spectra. All
chemical shifts were finally correlated to peak positions in the [15N,1H]- and [13C,1H]-HSQC spectra.
Spectra were processed within the Bruker spectrometer software Topspin 2.1 and chemical shift
assignments were performed using the software CARA47. 
Studies of membrane insertion topology were performed using the micelle integrating spin
label  4-(3-ʎ1-oxidanyl-2,2-dimethyl-4-tridecyl-1,3-oxazolidin-4-yl)butanoic acid (5-DSA) (Sigma).
Samples for PRE measurements were prepared by addition of concentrated stock solutions of the
paramagnetic substance to the micellar protein solution containing 15N-labelled TM1. After addition
the pH was readjusted to pH 6.0. The final concentrations of 5-DSA was 6mM. 
3.4.7.1   RDC
RDC  samples  were  obtained  by  dissolving  dinucleotide  2'-deoxyguanylyl-(3',5')-2'-
deoxyguanosine (dGpG) in 40mM K3PO4 buffer (pH 6.4),  150mM LPPG:DPC (4:1) containing
0.4mM  15N13C2H-HIS-N-TM127  and  100mM  KCl  to  ensure  G-tetrade  formation,  to  a  final
concentration of 30mg/ml. Several heating-cooling (45º-4ºC) cycles were necessary to completely
dissolve dGpG. Formation of a stable liquid crystal phase was determined by observing the residual
2H2O quadrupol coupling on the solvent signal (see Supplemental Material S3.17).
The  RDC  tensor  was  determined  using  Singular  Value  Decomposition  (SVD),  which  is
implemented in the program CYANA. Back calculation of RDCs with the program MODULE48
showed good agreement with the experimental values (see Supplemental Material Figure S3.18). 
3.4.7.2   Assignment via adaptation of chemical shifts from 
overlapping fragments
The resonance signals of the 3D 15N-NOESY spectra were picked and integrated according
the “root” peaks of the corresponding 15N-HSQC spectra. The so obtained strips are then matched in
the following way:
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For each assigned “old” strip (TM12) a number of potential “new” strips of the unassigned
spectrum (TM127) are selected. This selection is based on the  1H(F3)  and  15N(F2) shifts of the
TM12 strip, defining a spectral window, within all potential new strips are searched. This window is
larger  for  residues  at  the beginning and the tail  of the sequence.  For a  residue at  the terminal
positions 1 or N the search window in the 1H dimension is 0.25 ppm, and linearly decreases to 0.1
ppm over the next ten residues towards the center of the sequence. Similarly the search radius in the
15N dimension decreases from 2.5 to 1 ppm. In the central segment the allowed shift deviation is
0.25 and 1 ppm for 1H and 15N for all residues.
The set of “new” strips are then compared to the “old” strip by calculating the differences of
the “line-spectra”, and the “old” strip is matched to the “new” strip showing the smallest difference
(see Figure 3.9). The differences are calculated by minimizing the following function:
f = Dijå + Aiå + B jå
where Dij  is the “distance” between line i of the “old” strip and line j of the “new” strip,
Dij = c(di -d j )
2 + (Ii - I j )
2
with the chemical shift and  the intensity of the line i and j, and c is a scaling factor. Note that the
intensities have been normalized to the most intense line within a strip. Further we have
 Ai = Ii
0.3
B j = 0.5 × I j
2
 
which are the penalties for lines that are not included in the sum of Dij’s. 
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The  minimum of  f is found  in  a  systematic  search  routine,  where  in  every  row  of  the
“difference  matrix”  (except  the  row  with  just  the  B’s)  exactly  one  element  is  selected  and
calculating the sum after adding the  B’s for empty columns.  Note that in this way a peak of the
“old” strip (A) may be simultaneously matched to two (or more) peaks in the “new” strip (B) while
the  opposite  is  impossible.  It  is  also  worth  noticing  that  in  practice  only  a  small  number  of
permutation must be calculated as the difference matrix can be much reduced by omitting all D’s for
which Dij>Ai+Bj. 
The constants in f are chosen emprically based on the success in matching the strips, and it is
expected that can be further optimized. 
3.4.8   Structure calculation
Distance restraints were obtained from 15N-resolved NOESY spectra recorded on 15N,1H- and
15N,2H-labeled   samples with mixing times of 70 and 120 ms, respectively, and from 100 ms 13C-
resolved NOESY spectra. In general, 15N- or 13C-resolved NOESY spectra were recorded with non-
deuterated and deuterated detergents, respectively.  In addition, dihedral angle restraints obtained
using the program TALOS+49, that uses chemical shifts of  1H,  13C,  13C,  13C’, and  15N nuclei,
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Figure 3.9: Schematic representation of the strip matching routine
Note that lines A3 and B2 are not matched, and hence A3 and B2 are added to the penalty function
were added. Peak lists for each spectrum were picked by the program package UNIO’1050, 51. The
automatically picked peaklists were manually edited to remove artifactual peaks (e.g. t1 noise) or to
pick additional weak peaks. The integrated, non-assigned peak list from UNIO’10 was subsequently
transferred to CYANA52, which annotated the peak list in seven iterative cycles using the build-in
macro “noeassign”. Again, the results from the automatic assignments were carefully checked and
edited when necessary. 
Peak positions in the 13C- and 15N-resolved NOESY spectra differed for samples recorded in
deuterated from those in  non-deuterated detergent.  To account  for  that  deviation chemical  shift
positions were related to  the corresponding NOESY spectrum both manually and automatically
using the sidechain adaptation routine of UNIO’10.
Table 3.1: NOE distance restraints
total 728 100.0%
Intraresidue |i-j |= 0 329 45.2%
sequential |i-j| = 1 283 39.0%
short-range |i-j| <= 1 612 84.2%
medium-range 1 < |i-j| < 5 103 14.2%
long-range |i-j| >= 5 13 1.7%
Due to the limited amount of long-range information (see Table 3.1) the global fold of TM127
could not be calculated based on NOE distance restraints and 166 torsion angle restraints alone.
Therefore,  a  second  round  of  structure  calculations  was  performed  using  auxiliary  sources  of
structural information available in the form of distance restraints derived from PRE measurements
and restraints for residual dipolar couplings.
PRE distances were available in three classes as described above. It was therefore possible to
include 26 PRE distances with an upper distance limit of 14Å and 46 PRE distances with a lower
limit of 20Å. Additionally,  37 PRE distance restrained between 14Å and 20Å were defined by
scaling them using an exponential component as introduced by Battiste  et al39 and implemented
with bounds of ±4Å. PRE distance restraints required cross-checking for compliance with the short-
to medium-range NOE restraint network, as well as the restraints for torsion angle restraints.
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63 RDC restraints complemented the PRE-derived distance restraints. For the first iteration of
structure  calculations,  artificial  upper  and  lower  distance  limits  were  generated  to  incorporate
structural information from soluble paramagnetic spin labels. The restraints were defined between
the amide proton of residues with an attenuated signal due to the influence of the spin labels. The
approach  relied  on  assumptions  made  for  the  detergent  micelle  environment  (detergent  LPPG)
based on reference literature53. The micelle was assumed to have an elongated form with a height of
38-40 Å and a length of 56.8-58.8 Å. Upon insertion of TM127 into the micelle in an orthogonal
orientation, the center of the micelle was expected at 19-20 Å distance from the solvent-exposed
loop regions. In order to represent the micelle nexus, a pseudo residue from the CYANA residue
library was utilized. This residue was attached to the amino acid sequence of TM127 via flexible
linker of sufficient length. The pseudo residue is insubstantial and cannot cause atom collisions.
Signals strongly influenced by the soluble spin labels and displaying a large degree (>80%) of
attenuation received a lower limit of 19 Å to the micelle center. Signals that were not subjected to
line broadening resulting from the spin label influence were assumed to be more deeply embedded
within the micelle and restrained with upper an upper limit of 15  Å. Signal attenuation was also
observed using HNCO experiments. In order to apply information from these measurements to the
structure calculation, ambiguous distance restraints were created for atoms H and N of the residue
corresponding to an observed attenuated signal, as well as for the carbonyl C of the predecessor
amino acid with the aforementioned upper and lower distance limits of 15 Å and 19 Å, respectively.
However, the incorporation of distance restraints derived from soluble PREs led to over-restraint
structures. The uneven number of observable PREs from soluble spinlabels for different regions in
the protein caused the artificially created micelle center to be located outside of the perceived helix
bundle.  This  led  to  very  strong  constraints,  even  at  reduced  weights,  on  certain  parts  of  the
construct,  effectively  'bending'  the  helices.  Restraints  from  soluble  spin  labels  were  therefore
omitted  from  further  structure  calculations  and  rather  used  for  qualitative  validation  for  the
structures.  In total, the restraints shown in Table 3.2 were applied in the structure calculation of
TM127
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Table 3.2: Structure calculation statistics for TM127
Distance restraints
NOE distance restraints 726
Torsion angle restraints 166
PRE-derived distance restraints Upper limit only 26
Upper and lower limit 37
Lower limit only 47
RDC restraints 63
Structure calculation statistics
Ave. target function 7.19 Å2
Ave. backbone RMSD to mean 4.53 Å
Structural clusters 48
In the final structure calculation, 5000 structures were calculated in 10 individual runs with
500 structures each from 10 different random seeds using standard structure calculation routine in
CYANA with 20000 torsion angle dynamics steps. The 50 structures with the lowest target function
were collected  from each run and combined to  a  bundle  containing 500 structures,  which  was
clustered according to the backbone RMSD of helix regions T50-T72, P79-L102 and V276-A299
with a cutoff of 3Å. Clustering resulted in 48 total clusters with the largest containing 95 structures
and 11 clusters containing at least 10 structures. 16 clusters with only 1 structure, 5 clusters with 2
and 4 clusters with three structures could be observed. 
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3.5   Discussion
Despite the pivotal role of GPCRs in biology and despite its importance in pharmacology and
pharmaceutical  sciences  structural  data of  GPCRs in solution are still  lacking.  Here were have
presented an approach based on the study of a series of overlapping fragments of extended size that
aims at providing methodology of assigning entire receptors, that may possibly be more generic for
the study of -helical membrane proteins. Moreover, we suggest that the system provides valuable
insight into conformational preferences of protein segments as they are formed during early stages
of protein biosynthesis.
During structural studies of membrane proteins by solution NMR obtaining chemical shift
assignments presents a significant general bottleneck. Here we demonstrated that the knowledge of
chemical shifts from fragments can be utilized to assign larger proteins for which such assignments
are difficult to obtain otherwise. We suggest a method for chemical shift adaptations that requires
15N,1H correlation maps for the fragment and the entire receptor as well as the corresponding 3D
15N-NOESY spectra. Surprisingly, we could correctly transfer more than 90% of the assignments
from  TM12  to  TM127,  and  during  the  adaptation  process  also  sidechain  assignments  are
transferred. To which extent this method will be also successful for transferring assignments onto
the entire receptor will depend on a number of factors, most important being the quality of the 15N-
NOESY spectrum of the entire receptor (essentially how much NOEs are contained in the strips),
and by which extent sidechain chemical shifts  change upon formation of tertiary structure.  The
quality  of  the  NOESY spectrum depends  on  the  thermal  stability of  the  protein  in  the  chosen
membrane-mimicking  environment,  and  we  expect  that  temperature-stabilized  forms  may  still
display  acceptable  spectra.  In  cases  where  large  portions  of  signals  in  the  [15N,1H]-TROSY
spectrum  are  missing  (e.g.  those  from  the  TM  segments)  success  perspectives  for  any NMR
experiments that go beyond 1D spectroscopy will become small. We like to note here that the 15N-
NOESY experiment is usually the one that works the best even in case of large proteins. Some of
the sidechain resonances will of course change upon formation of tertiary structure. The number of
residues, for which  new sidechain contacts are formed, will be limited though. In any case they
usually do not give rise to new NOEs since the distance to amide protons of adjacent helices is too
large,  but  of  course  such  contacts  result  in  chemical  shift  changes  of  the  involved  sidechain
proteins. There is still a reasonable chance that the chemical shift pattern does not change too much,
so that it can be matched in combination with knowledge of to which type of amino acid the amide
moiety belongs, obtained from amino-acid selectively labeled samples.
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The main focus of this study was to investigate whether addition of one or more helices to
TM1 that in the entire receptor form contacts with it help to stabilize it. Proteins are synthesized
starting at the N-terminus, and the co-translational folding model postulates that folding occurs after
the nascent chain is released via the translocon into the membrane compartment13, 54. The two-stage
model  for  folding helical  membrane proteins  proposes  that  secondary structure forms  once  the
entire TM segment partitions into the membrane11, 12. Helical TM-bundle proteins, however, contain
polar or even charged residues at TM-internal positions. These form contacts with polar or charged
groups in  other  TM helices,  and thereby contribute to  the assembly of  the  TM-bundle,  and in
particular to the specificity of interhelical contacts21,  55,  56. Insertion of single TM helices into the
hydrophobic  core  exposes  these  polar  moieties  to  the  lipids,  an  unfavorable  interaction  that  is
expected  to  expel  the  corresponding  part  from the  membrane  interior  and  transfer  it  into  the
interface. Indeed, we observed that the first helix is significantly destabilized in TM1, and in fact
interrupted  around  the  central  polar  GVRSG  motif.  Packing  of  TM2  against  TM1 apparently
stabilizes secondary structure in TM1 as demonstrated by the fact that TM12 forms a much more
stable  -helical  hairpin.  We  expected  that  adding  another  TM  helix  would  even  stabilize  the
fragment  further.  In  fact,  we  observed  formation  of  a  comparably  stable  hydrophobic  core  in
TM127 (but not in TM123). Our NMR data, however, indicate that TM127 does not exist in one
well-defined conformation. In particular, hinge motions about Pro-290 in TM7 are seen. The nearly
parallel orientation of the TM helices predicted from homology modeling based on the rhodopsin
structure57 is clearly incompatible with the NMR data, and TM2 packs almost orthogonal  against
TM1 and TM7. The presence of exchange-broadened amide resonances as well as the fact that the
interhelical PRE effects are smaller than predicted indicate that either the interhelical packing is not
stable, or that (slightly) differently packed conformers interchange. Interestingly, we can exclude
any  form  in  which  the  individual  helices  present  lipid-associated  but  well-separated  surface-
associated entities despite the presence of various polar or even charged residues at locations central
in the TM helix. The Gd-DPTA-BMA data indicated that solvent access is mostly limited to the
loops,  indicating  that  the  TM  helices  of  TM127  are  integrated  into  the  hydrophobic  core.  In
contrast,  TM3 in TM123 displays significant solvent access in the center of TM3. To conclude,
TM127 in detergent micelles presents a loosely packed bundle of 3 TM helices, all of which are
well-integrated into the hydrophobic core, with non-native topology. Although we cannot present a
structure  of  TM123 at  the  moment,  it  seems structurally to  be more  inhomogeneous,  exists  in
various oligomeric states, and TM3 is not completely integrated into the hydrophobic core.
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Recently we have performed an exhaustive study on folding of N- and C-terminally truncated
forms of the Y4 receptor, a human GPCR24. In these studies the green-fluorescent protein (GFP) or
the alkaline phosphatase (phoA) were added as reporters to the C-terminus, and proteins expressed
in the E.coli inner membrane using a biochemical readout developed by the van Heijne lab58. The
data from this study indicated that dual topologies (C-terminus in and out) are more likely occur for
the  short  fragments  (e.g.  TM1  or  TM12)  while  more  unique  and  correct  topologies  were
encountered for proteins that comprise most of the TM helices (e.g. TM16). Again, we suspected
that the presence of uncompensated polar or charged residues at central position in the TM helices
is responsible for that behavior.
What happens to helices that do not readily insert into the membrane because polar or charged
residues prevent insertion? In case of a sequential exit from the translocon such helices will localize
in the interface, at least to some extent. For example, our Gd-DPTA-BMA data indicate that central
parts of TM3 have solvent access, and hence TM3 is not fully inserted into the membrane. Likely,
its full membrane insertion requires that compensating interactions from other, later synthesized,
helices occur. Alternatively, nascent helices may accumulate within or near the translocon, were the
bundle is already assembled and then fully released into membrane. Photo-crosslinking experiments
demonstrated that TM helices formed either specific or non-specific contacts with residues from the
Sec61 translocon59. Interestingly, the experiments also revealed that the TM helices form contacts
with both the translocon as well  as with the phospholipids. Ismail and coworkers using similar
methodology  demonstrated  that  large  portions  of  opsin  remain  bound  or  associated  to  the
translocon60. The rate by which they were released depended more on the amino acid sequence of
the TM helix rather than by its position in the protein. In their model the nascent chain remains
within the translocon or attached to translocon-associated other proteins until the protein has been
fully synthesized (for a more general discussion of the issue see also the review by Skach13).
In the experiments described in this work we have probed for conformational preferences of
N-terminal  fragments  of  extended  length  of  a  yeast  GPCR.  Thereby  we  were  able  to  obtain
experimental data about how these protein fragments would behave if there were released into the
hydrophobic core from the translocon. The data basically support conclusions from Ismail et al.60 in
that the rate of release is dictated by the amino acid sequence of the TM, and in particular by the
hydrophobicity of the segment. It thus seems more likely that larger portions of the receptor remain
either within the translocon or associated with nearby proteins until tertiary contacts between polar
or  charged  residues  are  made.  Otherwise,  some  of  these  TM  helices  simply  will  not  remain
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integrated into the membrane but rather accumulate in the interface. The exact folding pathway
therefore  seems to  depend very much on the  amino acid  sequence,  and hence may vary from
receptor to receptor.
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Figure S3.10: Het-NOE of TM127
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with the micelle, whereas the C-terminus seems completely unstructured.
116
Figure S3.11:[15N,1H]-HSQC of TM1
TM1 exhibits homogeneous linewidths. 97% of the backbone could be assigned.
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Figure S3.12: [15N,1H]-HSQC of TM12
TM12 exhibits homogeneous linewidths. 95% of the backbone could be assigned.
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Figure S3.13: [15N,1H]-HSQC of TM123
TM123 exhibits some line-broadening in the center region. 95% of the backbone could be assigned.
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Figure S3.14: [15N,1H]-HSQC of TM127
TM127 exhibits homogeneous line-shapes. 93% of the backbone could be assigned
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Figure S3.15: SEC overlay of TM123 and TM127
Freshly prepared TM123 (blue) already forms large soluble aggregates, whereas TM127 (brown) is mostly 
monomeric. A significant amount of TM123 can already be found in the void volume at around 1.0ml and in the 
broad peak from 1.1ml to 1.6ml. SEC runs were performed on an analytical S75 column with a flowrate of 
0.5ml/min 40mM phosphate buffer, containing 15mM LPPG/DPC (4:1) and 150mM NaCl at pH 6.5. The sample
buffer contained 150mM LPPG/DPC (4:1) with a protein concentration of 200µM.
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Figure S3.16: Comparison of simulated RDCs
Difference of simulated versus experimental RDCs for the four most prominent 
clusters as well as the homology model. RDCs based on the model are clearly 
incompatible with the experimental data.
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Figure S3.17: Maturation of the alignment phase as seen in the deuterium splitting. 
Deuterium splitting of dGpG RDC phases. Several heating and cooling cycles (4° to 45°) 
were necessary over the course of one week to completely dissolve the dinucleotides and 
achieve acceptable deuterium splitting. In presence of detergents, the dissolution of dGpG is 
severely impeded, but can be accelerated using high concentrations of nucleotides (in this 
case 30mg/ml), high potassium ion concentrations (100mM) and the implementation of 
heating-cooling cycles.
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Figure S3.18: Validation of NH-RDC values using Single Value Decomposition (SVG). 
RDCs were simulated using the program MODULE and compared to experimental data. 
The bottom part shows Chi2 values.
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4.1   Introduction
4.1.1   Understanding GPCR structure and folding from large fragments
G-protein coupled receptors (GPCRs) constitute a very important class of integral membrane
proteins that help transmitting the signal from the outside to the inside of cells. Accordingly, these
proteins pay a pivotal role in biology, and more than 30% of all commercial drugs are believed to
act via binding to GPCRs.
The important role of GPCR has triggered lots of efforts to determine the structure of these
precious  receptors.  First  low-resolution  data  emerged  from  cryo-electron  microscopy1 but  the
scientific community had to wait for the first crystal structure, bovine rhodopsin, until 20002. In this
report  rhodopsin  was  isolated  from the  retina,  and it  took 6  more  years  until  the  first  GPCR
produced from recombinant sources, the structure of the β2-adrenergic receptor, was released3. Since
then we have witnessed publication of new structures at an ever-accelerating pace culminating in
the awarding of the Nobel Prize in chemistry to Brian Kobilka and Bob Lewkowitz in 20124.
Structural  studies of GPCRs are largely hampered by two major  issues5:  the recombinant
production  of  functional  GPCRs at  sufficient  yields  is  very difficult,  and many receptors  have
proven to be not amenable to structural studies. Most GPCRs that were structurally characterized
have been produced in insect cells,  but  also mammalian,  yeast  or  E. coli cells  were used.  The
second issue is related to the flexibility of the receptors that is partly related to the way they are
activated. In particular most receptors comprise a rather long and flexible third cytosolic loop.
Methods for producing detergent- and temperature-stabilized mutants in  E. coli have been
introduced6.  Initially,  such  mutants  we  obtained  from  a  systematic  mutagenesis  screen,  first
preparing  single mutants  and then combining multiple  beneficial  mutations7.  Recently,  a  clever
system was introduced, in which the cells were coated with a chitin shell, so that cell content was
not released upon addition of detergents8.  Fluorescent ligand in combination with FACS sorting
allowed screening for mutants that still bind receptors in presence of detergents (detergent-resistent
mutants), making the system amenable to work with large libraries. As a result expression yields,
and, even more important, temperature stability could be improved. For the purpose of solution
NMR studies it is of pivotal importance to improve the latter two parameters.
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Despite all the progress seen in crystallography, no solution-NMR GPCR structure has been
published  yet.  Nevertheless,  the  seminal  paper  by  the  Nietlispach  group  reporting  on  sensory
rhodopsin9 and the structure of proteorhodopsin10 from the Frankfurt NMR groups, although both
proteins  strictly  speaking  do  not  represent  true  GPCRs,  have  indicated  that  solution  NMR in
principle is capable of determining the structures of these precious membrane proteins provided
they are well-behaved.  However,  both proteo-  and sensory-rhodopsin present  fairly rigid 7-TM
proteins  when  compared  with  true  GPCRs.  In  the  latter  the  mode  of  activation  requires
conformational  changes,  and  the  inherent  flexibility  for  that  task  results  in  conformational
broadening of resonances. Much of the line-broadening that is present of spectra of GPCRs is likely
not due to efficient relaxation due to slow overall reorientation but rather due to conformational
broadening. Successful NMR studies of GPCRs may therefore require working with temperature-
stabilized mutants that are also selected for improved detergent stability5.
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Figure 4.1:  Approaches to study GPCRs from fragments pursued in our group. 
A) The entire receptor is dissected into 2-3 TM fragments. B) Complementary fragments are differentially labeled and
reconstituted into a split receptor. C) Fragments of increasing length are studied to learn about GPCR folding. D)
Loops of a GPCR are grafted onto a β-barrel protein
Our  group  has  started  working  on  large  fragments  of  GPCRs  almost  ten  years  ago.  We
decided to work on fragments because we thought they were easier to biosynthesize. Moreover,
solution  NMR,  and  in  particular  the  process  of  sequence-specific  resonance  assignments,  was
expected to be facilitated. 
Our strategy for  using fragments  is  depicted in  Figure  4.1.  First  of  all,  we like  to  study
fragments to learn about conformational preferences of these polypeptide stretches (Figure 4.1A).
Using complementary fragments reconstituting a split-receptor would allow us to determine the
conformational preferences of these fragments (Figure 4.1B), however, this time in the context of a
functional receptor, also providing a convenient way to make segmentally labeled receptors. As
described in more detail below, we arealso convinced that we can learn about the folding of GPCRs
from a study of conformational preferences of systematically truncated fragments (Figure 4.1C). We
are additionally interested to know whether we can transfer chemical shift information from these
fragments to the entire receptors to eventually enable determination of the structure of the entire
receptor. Finally we have also tried to transfer the loops onto a well-behaved scaffold in order to
create a mimic that can bind the ligands (Figure 4.1D).
4.1.2   General remarks on studying protein fragments
Does it make sense to look at protein fragments? This question is much disputed. For soluble
proteins this is usually not the case. Dissecting a protein within domain borders will usually result
in unstructured and insoluble aggregates, because not all necessary tertiary contacts can be made
and hydrophobic residues are exposed to solvent. For membrane proteins this is a little different.
Secondary structure formation is promoted by the hydrophobic environment, because only through
formation of hydrogen bonds the polar peptide bond is shielded from making unfavorable contacts
to lipids11, 12. 
The popular two-stage membrane protein folding model proposed by Popot and Engelman has
postulated that segments of membrane proteins form secondary structure upon partitioning into the
water-membrane interface13.  These helices subsequently insert  into the hydrophobic core of  the
membrane and diffuse  within  the  bilayer  until  contacts  with other  helices  are made eventually
leading  to  the  correct  assembly  of  the  helical  bundle.  If  secondary  structure  in  membrane
environments is predominantly determined by sequence and does not depend on the formation of
tertiary contacts, then it should be retained in fragments. As described below we usually observe
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good agreement of the location of helical segments with predictions based on homology models,
indicating that secondary structure of membrane proteins is primarily encoded in the amino acid
sequence. 
How about tertiary structure? A number of features have proposed to be important for the
formation of interhelical contacts14-17.  Those are for example shape-complementary amino acids,
e.g. the knobs-in-hole arrangement in GXXXG motifs18, 19. Another way to mediate helical contacts
is through formation of aromatic sidechains interactions20 or via formation of hydrogen bonds21. The
latter  requires  the  presence  of  polar  residues  in  sequence  locations  where  they  would  not  be
expected based on a match of hydrophobicity with the surrounding lipid environment. It is obvious
that exposure of polar residues to lipids will hamper proper integration of the corresponding stretch
into the membrane, and will additionally destabilize secondary structure22. The location of polar
residues at locations within the membrane is important, and this should be taken into account by
selecting the fragment such that most of the polar residues find their interaction partner within the
fragment if possible. On the other hand, looking at fragments also offers the unique possibility to
study the behavior of an N-terminal part of the protein when it comes off the ribosome and exits the
translocon in the absence of the remainder of the protein. We will come back to that point later on.
4.2   Synthetic aspects of biosynthesis of large fragments
Because of  the  ease  of  genetics,  the  relatively low costs  of  media  and the  possibility to
introduce isotope labels in almost all flavors E. coli has generally been the host of choice for protein
expression in NMR studies. In the case of GPCR fragments proteins have been usually derived from
the insoluble form accumulated in inclusion bodies. Formation of inclusion bodies is believed to
result from an overload of the intracellular chaperon machinery, or may be due to the presence of
exposed hydrophobic  sequences  as  in  the  case of  GPCR fragments23.  GPCR fragments  are,  by
nature,  prone  to  aggregation  since  they  lack  complementary  TM helices  and  therefore  expose
surfaces to solvent or detergent that are usually buried within the helical bundle. 
Purification of membrane proteins from inclusion bodies offers many advantages, e.g. the
protein of interest often is already highly enriched in this compartment and accumulated to a much
higher extent when compared to material that is directed into the inner membrane. Concerns arise
about the refolding process, which for alpha helical membrane proteins is often a cumbersome task,
and dedicated  protocols  have to  be developed for  each protein24,  25.  Solubilization  of  inclusion
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bodies mostly requires a denaturation step in a strong denaturant such as GdmCl or urea, followed
by purification procedures as chromatographic separation, and a final refolding step. 
The first often-encountered problem is to achieve protein overexpression – for NMR studies
that means obtaining sufficient amounts of purified protein from 1-2 L because of the high costs of
isotope-labeled media.  For these reasons, expression as insoluble material into  E. coli inclusion
bodies has become the protocol of choice for most laboratories22, 26-31.
As  high  and  insoluble  expression  is  in  this  case  the  ultimate  goal,  we  would  strongly
recommend to use a vector under the control of the T7 promoter, as it has been shown that the T7
promoter, due to its inherent leaky control and high transcription rates, produces higher amounts of
unfolded membrane proteins when compared to the L-arabinose promoter32. Moreover, the use of
the T7 promoter is compatible with most of the commercial  E. coli strains that can be tested for
expression. 
The first question to be solved is whether the GPCR fragment of interest can be expressed
directly, without the use of any fusion partner. Direct expression, if achievable, if preferable as it
allows to skip enzymatic or chemical removal of the fusion partner, often an inefficient purification
step that can lead to loss of protein33. How to judge whether the GPCR fragment has been produced
to sufficiently high levels? As milligram quantities are required to produce a final NMR sample, in
our experience overexpression should be visible as a consistent band upon coomassie staining of a
cell lysate sample. For the fragments of the Y4 receptor26, direct expression could be achieved only
for a limited portion of the receptor (e.g. for TM567), while mostly fusion to the TrpΔLE sequence
expression was required, e.g. for TM67. While there is no single explanation why certain sequences
are highly expressed and others are not, a body of evidence is suggesting that problems arise from
unfavorable mRNA structures close to the translation initiation region, rather than codon bias34. 
The addition of short stretches of nucleotides close to the starting methionine has also been
shown to greatly enhance membrane protein expression in a  cell  free system  35.  Moreover,  we
recommend to extensively optimize direct expression also by looking at single codon substitutions
in the initiation region36.  When direct expression cannot be achieved, the development of a good
protocol using N-terminal fusions is often a trial-and-error procedure until high expression levels,
stability, efficient proteolytic or chemical removal of the fusion, and homogeneous purification are
achieved. 
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Inclusion  bodies  can  be  solubilized  with  the  help  of  different  agents,  depending  on  the
solubilization efficiency and the chosen purification strategy. Strategies for purifying membrane
proteins from inclusion bodies are summarized in Figure 4.2:
We have successfully solubilized inclusion bodies directly in 70% trifluoroacetiacid (TFA), in
which  cleavage of  the  TrpΔLE sequence was  achieved by addition  of  cyanogenbromide27.  The
reaction  mix  could  be  directly  injected  into  a  reverse-phase  C3  column.  This  strategy  allows
purification in one-step, and was successfully employed by the Naider group for fragments from the
Ste2p receptor. Unfortunately, it could not be applied to the Y4 receptor fragments, as inclusion
bodies containing these proteins could not be solubilized by using only TFA. Instead, we used 6 M
GdmCl26, and after centrifugation the solubilized material was loaded on a Ni-NTA column. For
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Figure 4.2: Schematic representation of the main strategies undertaken for the purification of GPCR fragments 
from E. coli inclusion bodies and subsequent refolding for NMR samples preparation.
fusion  proteins  we  modified  the  protocol  such that  the  C3  protease  was  added  to  the  GdmCl
solution in Tris-buffer at pH 7.5. During removal of denaturant via dialysis, the C3 protease refolds
and starts  to  cut  the  protein.  When the  GdmCl solution  is  lower than approximately 1 M, the
liberated TM and TrpΔLE proteins precipitate. The precipitated material can be further resolubilized
in few milliliters of 6M GdmCl in presence of high concentrations of reducing agents such as DTT
or -mercaptoethanol (bME). The pH is lowered to ~2 and the mix injected into a reverse-phase C4
column. This protocol has been successfully used for expressing at high yields of triple-labeled
TM67 from the Y4 receptor. The fragments TM12, TM45 and TM56 and TM567 could be directly
expressed and investigated by NMR. 
Unfortunately, not every fragment from the Y4 receptor could be efficiently solubilized after
purification from inclusion bodies. While for TM12 very high expression levels were possible37,
expression of TM13 in amounts compatible with NMR studies was only successful after extensive
optimization of the expression conditions (direct expression of the N-terminal His tagged protein in
the E. coli Rosetta pLysS strain at 18˚C). Although the fragment could be purified under denaturing
conditions using a C4-reverse phase column, we have encountered serious problems in solubilizing
the fragments once it was precipitated or lyophilized, both in a variety of detergents or organic
solvents. This prompted us to investigate expression into the inner membrane of E. coli, a method
that may also be advantageous in producing correctly folded material. For fragments insertion into
the membrane with the correct topology is an issue, and we decided to investigate this point in more
detail.  
4.3   Expression into the E. coli inner membrane and the topology of
fragments
Expression of eukaryotic membrane proteins into the inner membrane of E. coli poses several
challenges, and the mechanisms that determine topogenesis must be taken into account in order to
produce well folded, and possibly functional material21. As eukaryotic membrane proteins often lack
a signal sequence that can be recognized co-translationally by the bacterial SEC translocon, the
introduction of an N-terminal bacterial signal sequence can be necessary to achieve correct export.
In the case of GPCRs, the N-terminus needs to be localized into the periplasmic space of E. coli to
ensure proper topology, and for this reason the maltose binding protein (MBP), with its cleavable
signal sequence, has become the N-terminal fusion tag of choice for expressing functional GPCRs
in E. coli6, 38. Insertion of misfolded proteins in the inner membrane of E. coli is mainly attributed to
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failure  of  the  bacterial  translocon  to  correctly  recognize  determinants  present  on  eukaryotic
sequences, and to the fact that membrane protein folding is a slow process in comparison to the high
rates of transcription achieved when using the T7 promoter. Geertsma  et al. 31 demonstrated that
overexpression of bacterial membrane proteins produces detectable amounts of unfolded material,
which is higher when a T7 promoter was used instead of the more tightly regulated L-arabinose
promoter. 
Although  the  topology  of  G-protein  coupled  receptors  is  well  known  as  several  crystal
structures  are  available39,  it  is  difficult  to  predict  the  organization  of  GPCR fragments.  A full
structural analysis using solution NMR will reveal details of membrane insertion, but the amount of
work on a more comprehensive set of fragments is daunting.  Topology analysis presents a useful
alternative as it  provides experimental low-resolution structural information on the number and
organization of transmembrane helices. 
Topology studies using reporters for cytoplasmic or periplasmic localization of the C-terminus
were first established by von Heijne40. They used GFP as a reporter for cytoplasmic localization41
and the alkaline phosphatase (PhoA) as a reporter for periplasmic localization. A schematic of the
approach is presented in Figure 4.3.




transporter42 possesses  two  marginally  hydrophobic  alpha  helices  that  were  known  to  have  a
periplasmic C-terminus from the protein crystal structure, but topology analysis reported their C-
terminus to be instead cytoplasmic. The correct localization could be restored by slightly increasing
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Figure 4.3: Reporter assay used to study the topology of membrane insertion 
When the C-terminus is located in the periplasm PhoA activity can be measured (A). In case of 
cytoplasmic localization of the C-terminus,  GFP fluorescence will occur (B).
the hydrophobicity inserting a single Leu residue in one of the alpha helices. These results highlight
a possible mechanism happening during membrane protein insertion into the lipid bilayer, which
would be otherwise unknown from the sole crystal structure: as the two alpha helices are marginally
hydrophobic, the driving force for their correct insertion is given by the contacts with the other
alpha helices that are already inserted into the membrane. It is in fact known that alpha helices are
inserted co-translationally into the lipid bilayer either singularly, or as pairs if they can form early
stabilizing interhelical interactions.
This example outline how topology studies can also give information on the folding process
of membrane proteins. In an attempt to understand which fragments of the Y4 GPCR would acquire
a unique topology when expressed into the membrane, we have performed a topology analysis by
truncating the entire receptor by one helix at a time, starting from both the N-terminus and the C-
terminus43. Since the N-terminal truncations were made in a way that the N-terminus was predicted
to be localized either in the periplasmic or in the cytoplasmic compartments, depending on how
many helices were removed from the N terminal end, we have used two different N-terminal fusion
proteins to perform the study. The transmembrane region of the bacterial peptidase Lep was used to
ensure proper periplasmic orientation44, while Mistic was used to ensure cytoplasmic orientation to
those fragments that started at truncations made in intracellular loops. 
The  information  acquired  by  combining  the  results  from  the  two  reporters  for  cellular
localization  allowed quantifying  the  fraction  of  expressed  protein  that  folds  in  a  topology that
resembles the organization in the entire receptor. We could observe that N-terminal fragments do
not acquire a unique topology, however, the fraction displaying the correct localization of the C-
terminus increases with the number of added helices. Interestingly, fragments truncated from the C-
terminal end of the receptor possess a more defined topology. A scheme displaying the possible
topologies for the two short fragments TM1 and TM12 of the Y4 receptor and experimental data on
the location of the C-terminus are depicted in Figure 4.4. 
In case of TM1 two topologies are possible for each fusion: a dual topology is observed in
case  of  Lep  (Figure  4.4A),  while  a  predominant  cytosolic  location  exists  for  mistic-TM1.
Conversely, dual topology exists for mistic-TM1-TM2 and a predominant periplasmic localization
of the C-terminus for Lep-TM1-TM2. 
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We believe that these data can be rationalized when considering the propensity of the TM
helices for membrane insertion based on thermodynamic data for partitioning of the amino acids
contained  in  the  corresponding  stretches45 (Figure  4.5A),  and  the  distribution  of  positive  and
negative charges in the loops (Figure 4.5B). In combination with our NMR studies on TM1, TM12
and TM123 (vide infra) the data suggest that the Y4 GPCR might be composed of a folding nucleus
localized at the C-terminus and composed of helices TM5, 6 and 7, while the N-terminal side of the
protein, characterized by an unusual high abundance of polar residues in the TM segments, can
form a stable helical bundle only in presence of the C-terminus of the receptor22. 
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Figure 4.4: Topology studies of the Y4 receptor
Topologies for TM1 fused to Lep (A) or Mistic (B) or for TM12 fused to Lep (C) or Mistic (D). The corresponding 
relative strengths of PhoA activity or GFP signals are depicted on the right.
Figure 4.5: Net charge of loops of Y4 receptor (A) and free energies for 
transferring the corresponding TM stretches into the hydrophobic 
environment (B)
4.4   Conformational preferences of large fragments
The literature of membrane protein fragments studied by NMR has recently been reviewed27.
Much of this work has been done in organic solvent mixtures, and we will not comment on that
work here. Instead we would like to mention studies of GPCR fragments in detergent micelles.
Our group has studies large fragments from two GPCRs in detergent micelles: the work on the
yeast Ste2p receptor was performed in collaboration with the groups of Naider and Becker from the
US. Ste2p presents a class D yeast GPCR that is targeted by the -factor and thereby prepares cells
for mating. The class A (rhodopsin-like) human Y receptors bind to peptides from the neuropeptide
Y (NPY) family of neurohormones and trigger many physiologically important functions involved
in  memory  retention,  food  uptake  etc.  Four  functional  subtypes  of  the  Y receptor  have  been
identified in humans so far (Y1, Y2, Y4 and Y5)46. 
We initially investigated conformational  preferences  of the extracellular  domains of  all  Y
receptors47. They are largely unfolded, however, in case of the Y4 receptor, an amphiphilic helix
anchored  on the  micelle  surface  is  observed,  connected  via  a  long  and  flexible  loop  to  TM1.
Interestingly,  PP  binds  with  50  µM  affinity  to  that  loop  as  determined  by  surface-plasmon
resonance, largely via electrostatic interactions48. We previously postulated that ligands for the Y
receptors in a first step associate with the membrane surface, and diffuse laterally49-52. In proximity a
weak  interaction  of  PP  with  the  N-terminal  domain  helps  transferring  the  peptide  from  the
membrane-bound state to the receptor binding-pocket in a fly-casting mechanism (Figure 4.6).
The constructs were chosen to comprise one or more entire putatively helical stretches. Work
on the Ste2p receptor was performed on TM753, TM1, TM1254, TM123 and TM127 (in preparation,
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Figure 4.6: Model for binding of PP to the Y4 receptor 
Model for binding of PP to Y4 receptor comprising association with the membrane surface (left), formation of transient 
contacts to the N-terminal domain (center) and diffusion into the orthosteric binding pocket (right)
see Chapter 3). In case of the Y4 receptor we studied TM1222, 37, TM123, TM45, TM56, TM6726 and
TM567. Unfortunately, we never managed to obtain quantities of TM123 of the Y4 sufficient for
NMR studies. In addition we investigated the extracellular N-terminal domains of all Y receptors 47,
55. 
The  biochemical  aspects  of  this  work  are  described  above.  Biophysical  properties  of  the
different proteins were quite variable, from pleasant to work with (stable at elevated temperatures,
monomeric, resulting in peaks of homogenous line-widths) to difficult (aggregating in detergent,
resulting in spectra with variable line-widths or lack of many signals, unstable over time as apparent
by the formation of new peaks etc). We do not want to focus on the difficult technical aspects of this
work but rather report on what we have learned from these studies and how that may help us to
understand the underlying biology of these receptors.
Our work on structures of TM domains started with the structure of TM7, a construct that also
comprises  40  residues  from  the  C-terminal  tail,  from  the  Ste2p  receptor53.  The  protein  was
expressed and purified in the lab of Fred Naider, and we determined the structure in DPC micelles.
The NMR data revealed that TM7 is not stably formed, but rather exists in form of two helical
stretches interrupted around a central Pro residue. Experiments with micelle-integrated spinlabels
revealed that the helices are not stably anchored in the hydrophobic portion of the micelles but
likely are only transiently buried.  Likewise,  we determined the structure of  TM1 of  the  Ste2p
receptor in LPPG/DPC mixed micelles. Again, two rather well-defined helices are observed, that are
spaced by a GSRVG pentapeptide stretch (see Chapter 3).
The structure of TM12 of the Ste2p receptor, that contains 20 of the 50 residues from the
extracellular  N-terminal  domain,  the  first  two  TM helices  as  well  as  residues  from EL1,  was
determined by us in LPPG micelles54. Secondary structure was rather well defined, and this was
supported  by  an  almost  complete  set  of  H,H i,i+3  NOEs  in  the  helix-spanning  regions.
Interhelical contacts could be detected as interhelical NOEs between methyl groups. The number of
restraints is still low and compared to a soluble protein the structure is still underdetermined with
respect to experiment restraints but certainly rather well-defined for a helical membrane protein.
The corresponding structure of TM12 of the Y4 receptor did not reveal the presence of tertiary
structure21. Structure prediction using chemical shifts indicated that secondary structure is formed,
137
however, interrupts occur close to Gly, Pro or polar residues. A comparison of these two structures
is depicted in Figure 4.7.
In  addition,  we  have  investigated  two  fragments  from  the  Ste2p  receptor  (TM123  and
TM127), in which yet another TM helix is appended to the TM12 construct, thus systematically
increasing the size of the fragments. While the addition of the second helix in TM12 appeared to
have a structurally beneficial effect compared to TM1, effectively stabilizing the central GSRSVG
hexapeptide stretch (unpublished data), elongation of the construct by the third TM helix to TM123
seems to increase its propensity to aggregate. The reason for this can be found in several polar
residues located in the center of TM3, which presumably are missing their interhelical bonding
partners.  Paramagnetic relaxation enhancement NMR experiments using soluble spinlabels have
indeed confirmed that the center of TM3 around an ETS sequence in the context of the TM123
construct is indeed solvent accessible and therefore not properly integrated into the micelle (see
Chapter 3). This probably results in destabilized species, which are prone to aggregation. 
In the TM127 fragment, the seventh TM helix is covalently linked to TM2, as it is proposed,
based on a homology model, that most interhelical polar contacts are formed between TM1, TM2
and TM7. In contrast  to  TM123,  TM127 does  not  show any tendency to aggregate.  However,
structure determination of TM127 has shown that it  is  a dynamic system, with a kink in  TM7
around the Leu-Pro-Leu motif on the one hand, and with TM2 and TM7 competing for the same
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Figure 4.7: Structures of TM12. 
A 20 lowest energy conformers (left) and single conformer (right) of TM12 from Ste2p. B Single conformer of TM12 
from the Y4 receptor. Predicted regions of TM1 and TM2 based on the rhodopsin homology model are indicated at the 
bottom.
unspecific interhelical contacts with TM1(see Chapter 3). This further confirms the hypothesis that
tertiary  structure  in  α-helical  membrane  proteins  is  determined  predominantly  by  'unspecific'
interhelical interactions, which require only the presence of sequentially undefined α-helix, such as
'knob-in-the-hole'  contacts18,  19,  in  combination  with  several  specific  (mostly  polar)  interhelical
contacts. Secondary structure is essentially defined by the amino acid sequence and its propensity to
form helices.  However,  it  appears  to  be  critical  that  specific  polar  interhelical  interactions  are
satisfied at all times, as can be seen by the comparison of the respective TM12 fragments of the
Ste2p and Y4 receptor22.
Another important technical benefit of the study of systemically elongated membrane protein
fragments  is  that  it  provides  a  tool  for  the  resonance  assignment  through  peak  adaptations  of
overlapping fragments. We have observed that it is possible to transfer assignments from shorter
onto  longer  fragments  for  overlapping  sequences  through  comparison  of  strips  from  the  15N-
resolved 3D NOESY. Membrane proteins exhibit inherently few long-distance NOE peaks, which
makes  structural  determination  quite  difficult,  but  also  means  that  NOE information  is  mainly
dependent on the local chemical environment, which is particularly true for amide protons. As the
secondary  structure  of  membrane  proteins  is  predominantly  determined  by  the  amino-acid
sequence, the 15N-NOESY spectra of analogous residues in fragments can be compared efficiently.
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Figure 4.8: Schematic representation of the investigation of interhelical contacts by the systematic elongation of 
receptor fragments
interhelical contacts are indicated by red dotted lines. Potentially unsatisfied contacts are indicated blue dotted lines
We have managed to automate assignment transfer from shorter to longer fragments by comparing
automatically  picked  NOESY spectra,  based  on  manually  picked  [15N,1H]-HSQC  spectra  (see
chapter 3). Automated assignment transfer from TM12 to TM127 resulted in over 90% correctly
assigned backbone resonances. Indubitably, this process can also be expanded to larger fragments
and subsequently possibly even whole GPCRs as long as the quality of the NOESY spectra is still
acceptable.  Typically,  15N-NOESY experiments  still  exhibit  reasonable  spectra,  even  for  large
proteins.  Furthermore,  it  might be possible to additionally transfer sidechain assignment,  which
would be of great help for structure determination and ligand binding studies of GPCRs.
4.5   Biophysical interpretation 
From a  thermodynamic  perspective,  partitioning of  peptides  or  proteins  into  hydrophobic
environments should promote folding in order to prevent the polar moieties of the peptide bond
from forming unfavorable  contacts  with  lipids.  A vast  amount  of  literature  has  reported  about
folding of peptides in the presence of detergent micelles that are unfolded in plain buffer56.
Insertion  of  helices  into  hydrophobic  environment  obviously  depends  on  biophysical
properties  of  the  amino  acid  sequence  in  the  corresponding  stretch.  Wimley  and  White
experimentally determined the free energy of transferring amino acids into the membrane interior or
the membrane interface45, 57. Similarly, von Heijne has established an in vivo translocon-based scale
that qualitatively largely agrees with the  in vitro data58, 59. The work on TM1 and TM12 of Ste2p
indicates that longer fragments better integrate into the membrane and more likely form tertiary
structure. In addition, the topogenesis study of the series of Y4 receptor fragments clearly indicates
that those fragments that contain more TM helices more stably insert. Importantly, TM1 is predicted
to not partition into the membrane, and when taking this feature into account the topology of the
truncated fragments can be predicted rather reliably (see Figures 4.4 and 4.5).
One particular issue with working with fragments is that polar residues that are located in
central regions of the TM helices may not find their corresponding interaction partner and become
exposed to the lipids. This is depicted in Figure 4.9C. Herein, the surface potential for a model of
the Y4 receptor is depicted and compared to the surface potential of TM12. Clearly, the exposure of
Glu1.42 
and Asp2.50 
in the center of the TM helices result in a charged surface patch that may perturb
proper integration of the segment into the micelles. Our NMR studies on fragments indicate that
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these polar residues result in instable membrane integration and possibly also destabilization of
secondary structure.
4.6   Mimics of GPCR loops
We have designed a loop mimetic in which the 3 extracellular loops of the Y4 receptor were
grafted onto a protein that can be more easily biosynthesized and handled, resides in a membrane
context and that can be characterized by solution NMR. To this end we grafted the loops onto a
beta-barrel protein, the  E. coli outer membrane protein A (OmpA) by replacing three of its four
loops at one side of the barrel by the Y4 receptor native sequences60, 61 (Figure 4.10):
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Figure 4.9: Contacts in entire receptors and fragments
A Top-view of a model of the Y4 receptor. B Topology of the entire (top row left) or TM13 (bottom row left) and their 
contacts (right). C Surface potential of the entire receptor (top) and of TM12 (bottom) from two different views. Note 
that for TM12 a native-like conformation was assumed for simplicity.
The three loops can be transferred in various arrangements onto the scaffold. We decided to
rank the different topomers according to how similar distances of loop-anchoring residues are with
respect  to  known GPCR structures,  and chose  to  biosynthesize  4  candidates  that  most  closely
resemble the native receptors. All of those expressed well and could be refolded. Using chemical
shift  mapping and saturation-transfer  NMR techniques  we could  demonstrate  that  the  chimeric
receptor recognizes the native ligand NPY. We have also transferred the extracellular domain onto
the remaining accessible beta-barrel terminus, but could not detect an increase in binding affinity61.
4.7   Discussion
In this review we have described our efforts to study GPCRs from fragments. To summarize
we have learnt that secondary structure in these fragments largely corresponds to the prediction
from homology models. However, we have seen that tertiary contacts are mostly not formed, and
the persistence of these contacts is related to the location and number of polar or charged residues in
positions within the hydrophobic core of the membrane. 
142
Figure 4.10: Grafting the extracellular loops of a GPCR onto a beta-barrel 
scaffold results in a chimeric receptor
Furthermore, the investigation of systematically elongated fragments by NMR spectroscopy
can provide detailed insights into early GPCR folding. The step-wise addition of helices to shorter
fragments effectively simulates receptor biosynthesis, not only determining if interhelical contacts
are formed, but also permitting the identification of specific contacts, which are required for proper
folding, but also which are still  unsatisfied.  In addition,  the important question can be tackeled
whether these premature forms with unsatisfied polar residues already partition properly into the
membrane  or  not.  Furthermore,  NMR  spectroscopy  allows  the  observation  of  multiple
conformations and regions with high degrees of flexibility. It has to be noted though, that micelles
as a membrane mimetic may have different biophysical properties compared to bilayer systems or
even  true  biological  membranes,  which  could  alter  the  conformational  preferences  of  these
fragments.  It  is  therefore imperative to  compare the topology of fragments  in micelles to  their
conformation in bilayers or even to the topology of the respective analogues expressed in native
membranes.
In eukaryotes membrane protein biosynthesis of the polypeptide chain occurs at the ribosome
in the ER starting at the N-terminus from which the nascent chain is transferred via the signal
recognition particle (SRP), which targets the nascent chain to the ER inner membrane62, 63.  From the
SRP the chain is transferred to a large channel from the translocon machinery (Figure 4.11A). Inside
the  translocon  hydrophobic  segments  are  laterally  gated  through  a  cleft  into  the  membrane
interior64. Which segments are partitioned into the membrane interior is believed to be primarily
decided based on hydrophobicity, a property that is reflected in the biophysical properties of the
amino acid sequence65.
The  two-step  model  for  helical  membrane  proteins  introduced  by  Popot  and  Engelman
proposes that TM helices individually insert into the membrane, diffuse in the membrane until they
form the native contacts. Our data indicate that some of the TM helices of the Y4 receptor, but also
from the Ste2p may not properly insert as entire helices when released into the hydrophobic core.
Therefore,  either  bundling  of  TM  segments  occurs  within  the  translocon  (Figure  4.11B)  or
topological maturation once the polypeptide chain has been released into the hydrophobic interior
(Figure 4.11C). Further experiments with more complex systems are required to analyze the folding
pathway in more detail.
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Figure 4.11: A Model for co-translational folding. B Various modes of formation of TM bundles. 
C spontaneous vs. facilitated folding as observed for aquaporin-4. Figure adapted from 
Skatch62.
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